Reimbursement
Edwards Lifesciences is committed to supporting our customers with reimbursement resources to assist with coverage, coding, and reimbursement for our products. We have several tools below which may assist you in determining the appropriate code(s) to utilize when billing for products and procedures as well as the nationally averaged reimbursement amounts.
HCPCS C Code Finder
The Health Care Common Procedural Coding System (HCPCS) C Code Finder allows you to find the appropriate HCPCS C Code, if applicable, for a specific Edwards product. C codes are used in conjunction with the Medicare prospective payment system for outpatient hospital procedures only. C codes do not apply to inpatient surgical procedures, but should be added to the hospital’s chargemaster to report device costs used in the outpatient setting. Medicare created C codes to track device cost information for future APC rate-setting purposes.
Facility and Physician Billing Guides
These billing guides are intended to provide information to clinicians regarding appropriate coding, coverage, and payment for procedures performed with the Edwards Lifesciences products. These guides contain information regarding most commonly billed CPT, ICD-9, and HCPCS coding, as well as typical DRG payments for procedures related to our products.
2015 Facility and Physician Billing Guide
Facilities and Physicians use Current Procedural Terminology (CPT1) codes to bill for procedures and services. Each CPT code is assigned unique relative value units (RVUs), which are used to determine payment by the Centers for Medicare and Medicaid Services (CMS). All the CPT codes used to bill for TAVR procedures are listed below.
CPT Code1,2 | Description | 2015 National Avg. Physician Payment (Final JUL-DEC) | Each Physician Payment (Modifier-62)* | 2015 Facility RVUs |
---|---|---|---|---|
33361 | Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; percutaneous femoral artery approach | $1,421 | $888 | 39.54 |
33362 | Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; open femoral artery approach | $1,553 | $971 | 43.23 |
33363 | Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; open axillary artery approach | $1,631 | $1,020 | 45.40 |
33364 | Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; open iliac artery approach | $1,691 | $1,057 | 47.06 |
33365 | Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; transaortic approach (e.g., median sternotomy, mediastinotomy) | $1,862 | $1,164 | 51.81 |
33366 | Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; transapical exposure (eg, left thoracotomy) | $2,015 | $1,259 | 56.08 |
Add-on Codes | ||||
33367+ | Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; cardiopulmonary bypass support with percutaneous peripheral arterial and venous cannulation (e.g., femoral vessels) (list separately in addition to code for primary procedure) | $653 | NA | 18.17 |
33368+ | Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; cardiopulmonary bypass support with open peripheral arterial and venous cannulation (e.g., femoral, iliac, axillary vessels) (list separately in addition to code for primary procedure) | $784 | NA | 21.82 |
33369+ | Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; cardiopulmonary bypass support with central arterial and venous cannulation (e.g., aorta, right atrium, pulmonary artery) (list separately in addition to code for primary procedure) | $1,035 | NA | 28.80 |
Note: Medicare will only pay TAVR physician claims with these CPT codes when billed with the Place of Service (POS) code 21 (Inpatient Hospital), modifier 62 (two surgeons/co-surgeons), modifier Q0 (zero) signifying CED participation (qualifying registry or qualified clinical study) and ICD-9 secondary diagnosis code Z00.6 (Encounter for examination for normal comparison and control in clinical research program) Medicare requires reporting of the Clinical Trial (CT) number on the claim form. For example, the CT number for the TVT Registry is CT01737528 and the PARTNER II Trial is CT01314313. Medicare may return other claims as unprocessable. * Codes 33361-33369 have a 0 day global period; Codes 33361, 33362, 33363, 33364, 33365, 33366, 33367, 33368 and 33369 do not include cardiac catheterization [93451-93572] when performed at the time of the procedure for diagnostic purposes prior to aortic valve replacement. Codes 33361, 33362, 33363, 33364, 33365, 33366, 33367, 33368 and 33369 include all other catheterization[s], temporary pacing, intraprocedural contrast injection[s], fluoroscopic radiological supervision and interpretation, and imaging guidance, which are not reported separately when performed to complete the aortic valve procedure.
Additional Notes1
33361-33369 Transcatheter Aortic Valve Replacement
INCLUDES:
Access and Implantation of the aortic valve (33361-33366)
Access sheath placement
Advancement of valve delivery system
Arteriotomy closure
Balloon aortic valvuloplasty
Cardiac or open arterial approach
Deployment of valve
Percutaneous access
Temporary pacemaker
Valve repositioning when necessary
Radiology procedures:
Angiography during and after procedure
Assessment of access site for closure
Documentation of completion of the intervention
Guidances for valve placement
Supervision and interpretation
EXCLUDES:
Percutaneous coronary interventional procedures
Transvascular ventricular support (33967, 33970, 33973, 33975-33976, 33990-33993, 33999)
Code also add-on codes for cardiopulmonary bypass, when appropriate (33367-33369)
Code also cardiac catheterization services for purposes other than TAVR/TAVI
Code also diagnostic coronary angiography at a different session from the interventional procedure
Code also diagnostic coronary angiography at the same time as TAVR/TAVI when:
A previous study is available, but documentation states the patient’s condition has changed since the previous study, visualization of the
anatomy/pathology is inadequate, or a change occurs during the procedure warranting additional evaluation of an area outside the current target area
No previous catheter-based coronary angiography study is available, and a full diagnostic study is performed, with the decision to perform the intervention
based on that study
Code also modifier 59 when diagnostic coronary angiography procedures are performed as separate and distinct procedural services on the same day or session as TAVR/TAVI
Code also modifier 62 as well as al TAVI/TAVR procedures require the work of two physicians
Do not report separately when included in the TAVR/TAVI service (93452-93453, 93458-93461, 933567)
Medicare inpatient hospital reimbursement is based upon the Medicare Severity Diagnostic-Related Group (MS-DRG) classification system, which assigns MS-DRGs based on ICD-9-CM diagnosis and procedure codes. The following codes generally describe diagnosis and procedures associated with the use of the Edwards SAPIEN 3 transcatheter heart valve.
ICD-9-CM3 Diagnosis Code | Description |
---|---|
424.1 | Aortic valve disorders |
ICD-10-CM9 Code (effective Oct. 1st, 2015) | Description |
---|---|
I35.0 | Nonrheumatic aortic (valve) stenosis |
ICD-9-CM3 Procedure Codes | Description |
---|---|
35.05 | Endovascular replacement of aortic valve |
35.06 | Transapical replacement of aortic valve |
ICD-10-CM9 Codes (effective Oct. 1st, 2015) | Description |
---|---|
02RF38Z | Replacement of Aortic Valve with Zooplastic Tissue, Percutaneous Approach |
02RF38H | Replacement of Aortic Valve with Zooplastic Tissue, Transapical, Percutaneous Approach |
MS-DRG5 | Description | FY 2016 Relative Weight | FY 2016 National Average Payment7 | FY 2016 Geometric Mean-LOS |
---|---|---|---|---|
266 | Endovascular Cardiac Valve Replacement with MCC | 8.5986 | $50,772 | 7.3 |
267 | Endovascular Cardiac Valve Replacement without MCC | 6.5575 | $38,720 | 4.4 |
Reimbursement Hotline: 1-800-471-9387
Reimbursement information provided by Edwards Lifesciences is gathered from third-party sources and is presented for informational purposes only. Edwards makes no representation, warranty or guarantee as to the timeliness, accuracy or completeness of the information and such information is not, and should not be construed as reimbursement, coding or legal advice. Any and all references to reimbursement codes are provided as examples only and are not intended to be a recommendation or advice as to the appropriate code for the a particular patient, diagnosis, product or procedure or a guarantee or promise of coverage or payment, nor does Edwards Lifesciences warranty that codes listed are appropriate in all related clinical scenarios. It is the responsibility of the provider to determine if coverage exists and what requirements are necessary for submitting a proper claim for reimbursement to a health plan or payer, including the appropriate code(s) for products provided or services rendered. Laws, regulations, and payer policies concerning reimbursement are complex and change frequently; service providers are responsible for all decisions relating to coding and reimbursement submissions. Medicare’s Correct Coding Initiative and commercial payer policies are reviewed and updated several times each year. Accordingly, Edwards strongly recommends consultation with payers, reimbursement specialists and/or legal counsel regarding appropriate product or procedure codes, coverage, and reimbursement matters.
References
- Current Procedure Terminology (CPT) copyright 2014, American Medical Association (AMA). All rights reserved. CPT is a registered trademark of the AMA. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. Applicable FARS/DFARS restrictions apply to government use.
- Not all codes provided are applicable for the clinical scenarios in which Edwards Lifesciences’ Transcatheter Heart Valve technologies are used. The provider is responsible for selecting the most appropriate code(s) for the patient’s clinical presentation. When diagnostic services are performed, it may be appropriate to add applicable codes according to the service provided following the correct coding guidelines. Services that are considered a component of another procedure may not always be coded and billed separately.
- International Classification of Diseases, 9th Revision, Clinical Modification 6th Edition, 2015 ICD-9-CM for hospitals, volume 1, 2, & 3.
- Centers for Medicare & Medicaid Services (CMS). Updates and Revisions to ICD-9-CM Procedure Codes (Addendum). FY 2012 Medicare Addendum, ICD-9-CM Volume 3, Procedures. 26 October 2011. <http://www.cms.gov/icd9providerdiagnosticcodes/04_addendum.asp> and <http://www.cms.gov/ICD9ProviderDiagnosticCodes/ Downloads/FY2012_Addenda.pdf>. CMS MLN Matters MM7897, National Coverage Determination (NCD) for Transcatheter Aortic Valve Replacement (TAVR), Revised 25 September, 2012 <http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/downloads/MM7897.pdf> CMS MLN Matters MM8255, NCD for TAVR- Implementation of Mandatory Reporting of Clinical Trial Number. Revised July, 2013 <http://www.cms.gov/Outreach-and-Education/Medicare- Learning-Network-MLN/MLNMattersArticles/downloads/MM8255.pdf>
- DRG Expert: A Comprehensive Guidebook to the DRG Classification System, 31st Edition, 2015.
- Centers for Medicare and Medicaid Services, Physician Fee Schedule Relative Value Files http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/Physicia FeeSched/PFS-Relative-Value-Files.html. Accessed 07-15-2015 7.
- CMS IPPS FY2016 Final Rule The FY2016 Final Average standardized amount is $5904.74
- Medicare Access and CHIP Authorization Act of 2015- Public Law 114-10-APR. 16,2015.
- International Classification of Diseases, 10th Revision, Clinical Modification 2015 ICD-10-CM for hospitals, volume 1, 2, &3.
EDWARDS SAPIEN XT TRANSCATHETER HEART VALVE WITH THE NOVAFLEX+ DELIVERY SYSTEM
Indications: The Edwards SAPIEN XT Transcatheter Heart Valve, model 9300TFX, systems are indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis (aortic valve area ≤ 1.0 cm2 or aortic valve area index ≤ 0.6 cm2/m2, a mean aortic valve gradient of ≥ 40 mmHg, or a peak aortic-jet velocity of ≥ 4.0 m/s), and with native anatomy appropriate for the 23, 26, or 29 mm valve system, who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., Society of Thoracic Surgeons operative risk score ≥8% or at a ≥15% risk of mortality at 30 days).
Contraindications: The THV and delivery systems are contraindicated in patients who cannot tolerate an anticoagulation/antiplatelet regimen or who have active bacterial endocarditis or other active infections.
Warnings: Observation of the pacing lead throughout the procedure is essential to avoid the potential risk of pacing lead perforation. There is an increased risk of stroke in transcatheter aortic valve replacement procedures, as compared to balloon aortic valvuloplasty or other standard treatments. The devices are designed, intended, and distributed for single use only. Do not resterilize or reuse the devices. There are no data to support the sterility, nonpyrogenicity, and functionality of the devices after reprocessing. Incorrect sizing of the THV may lead to paravalvular leak, migration, embolization and/or annular rupture. Accelerated deterioration of the THV may occur in patients with an altered calcium metabolism. Prior to delivery, the THV must remain hydrated at all times and cannot be exposed to solutions other than its shipping storage solution and sterile physiologic rinsing solution. THV leaflets mishandled or damaged during any part of the procedure will require replacement of the THV. Caution should be exercised in implanting a THV in patients with clinically significant coronary artery disease. Patients with pre-existing mitral valve devices should be carefully assessed prior to implantation of the THV to ensure proper THV positioning and deployment. Do not use the THV if the tamper evident seal is broken, the storage solution does not completely cover the THV, the temperature indicator has been activated, the THV is damaged, or the expiration date has elapsed. Do not mishandle the NovaFlex+ delivery system or use it if the packaging or any components are not sterile, have been opened or are damaged (e.g., kinked or stretched), or the expiration date has elapsed. Use of excessive contrast media may lead to renal failure. Measure the patient’s creatinine level prior to the procedure. Contrast media usage should be monitored. Patient injury could occur if the delivery system is not un-flexed prior to removal. Care should be exercised in patients with hypersensitivities to cobalt, nickel, chromium, molybdenum, titanium, manganese, silicon, and/or polymeric materials. The procedure should be conducted under fluoroscopic guidance. Some fluoroscopically guided procedures are associated with a risk of radiation injury to the skin. These injuries may be painful, disfiguring, and long-lasting. THV recipients should be maintained on anticoagulant/antiplatelet therapy, except when contraindicated, as determined by their physician. This device has not been tested for use without anticoagulation. Do not add or apply antibiotics to the storage solution, rinse solutions, or to the THV.
Precautions: Long-term durability has not been established for the THV. Regular medical follow-up is advised to evaluate THV performance. Glutaraldehyde may cause irritation of the skin, eyes, nose and throat. Avoid prolonged or repeated exposure to, or breathing of, the solution. Use only with adequate ventilation. If skin contact occurs, immediately flush the affected area with water; in the event of contact with eyes, seek immediate medical attention. For more information about glutaraldehyde exposure, refer to the Material Safety Data Sheet available from Edwards Lifesciences. To maintain proper valve leaflet coaptation, do not overinflate the deployment balloon. Appropriate antibiotic prophylaxis is recommended post-procedure in patients at risk for prosthetic valve infection and endocarditis. Safety, effectiveness, and durability have not been established for valve-in-valve procedures. Safety and effectiveness have not been established for patients with the following characteristics/comorbidities: non-calcified aortic annulus, severe ventricular dysfunction with ejection fraction < 20%, congenital unicuspid or congenital bicuspid aortic valve, mixed aortic valve disease (aortic stenosis and aortic regurgitation with predominant aortic regurgitation > 3+), pre-existing prosthetic heart valve or prosthetic ring in any position, severe mitral annular calcification (MAC), severe (> 3+) mitral insufficiency, or Gorlin syndrome, blood dyscrasias defined as: leukopenia (WBC < 3000 cells/mL), acute anemia (Hb < 9 g/dL), thrombocytopenia (platelet count <50,000 cells/mL),or history of bleeding diathesis or coagulopathy, hypertrophic cardiomyopathy with or without obstruction (HOCM), echocardiographic evidence of intracardiac mass, thrombus, or vegetation, a known hypersensitivity or contraindication to aspirin, heparin, ticlopidine (Ticlid™), or clopidogrel (Plavix™), or sensitivity to contrast media, which cannot be adequately premedicated, significant aortic disease, including abdominal aortic or thoracic aneurysm defined as maximal luminal diameter 5 cm or greater; marked tortuosity (hyperacute bend), aortic arch atheroma (especially if thick [> 5 mm], protruding, or ulcerated) or narrowing (especially with calcification and surface irregularities) of the abdominal or thoracic aorta, severe “unfolding” and tortuosity of the thoracic aorta, access characteristics that would preclude safe placement of 16F, 18F, or 20F Edwards Expandable Introducer Sheath Set, such as severe obstructive calcification, severe tortuosity or diameter less than 6 mm, 6.5 mm, or 7 mm, respectively, bulky calcified aortic valve leaflets in close proximity to coronary ostia.
Potential Adverse Events: Potential risks associated with the overall procedure including potential access complications associated with standard cardiac catheterization, balloon valvuloplasty, the potential risks of conscious sedation and/or general anesthesia, and the use of angiography: death; stroke/transient ischemic attack, clusters or neurological deficit; paralysis; permanent disability; respiratory insufficiency or respiratory failure; hemorrhage requiring transfusion or intervention; cardiovascular injury including perforation or dissection of vessels, ventricle, myocardium or valvular structures that may require intervention; pericardial effusion or cardiac tamponade; embolization including air, calcific valve material or thrombus; infection including septicemia and endocarditis; heart failure; myocardial infarction; renal insufficiency or renal failure; conduction system defect which may require a permanent pacemaker; arrhythmia; retroperitoneal bleed; AV fistula or pseudoaneurysm; reoperation; ischemia or nerve injury; restenosis; pulmonary edema; pleural effusion; bleeding; anemia; abnormal lab values (including electrolyte imbalance); hypertension or hypotension; allergic reaction to anesthesia, contrast media, or device materials; hematoma; syncope; pain or changes at the access site; exercise intolerance or weakness; inflammation; angina; heart murmur; fever. Additional potential risks associated with the use of the THV, delivery system, and/or accessories include: cardiac arrest; cardiogenic shock; emergency cardiac surgery; cardiac failure or low cardiac output; coronary flow obstruction/transvalvular flow disturbance; device thrombosis requiring intervention; valve thrombosis; device embolization; device migration or malposition requiring intervention; valve deployment in unintended location; valve stenosis; structural valve deterioration (wear, fracture, calcification, leaflet tear/tearing from the stent posts, leaflet retraction, suture line disruption of components of a prosthetic valve, thickening, stenosis); device degeneration; paravalvular or transvalvular leak; valve regurgitation; hemolysis; device explants; nonstructural dysfunction; mechanical failure of delivery system, and/or accessories, non-emergent reoperation.
EDWARDS BALLOON CATHETER (9350BC20 and 9350BC23)
Indications: The Edwards balloon catheter is indicated for valvuloplasty of a stenotic aortic valve prior to implantation of the Edwards SAPIEN and SAPIEN XT transcatheter heart valves.
Contraindications:Other than standard risks associated with insertion of a cardiovascular catheter, there are no known contraindications for valvuloplasty. The patient’s medical condition could affect successful use of this catheter.
Warnings: The device is designed, intended, and distributed for single use only. Do not resterilize or reuse the device. There are no data to support the sterility, nonpyrogenicity, and functionality of the device after reprocessing. Do not mishandle the device or use it if the packaging or any components are not sterile, have been opened or are damaged (e.g. kinked or stretched), or the expiration date has elapsed.
Precautions: For special considerations associated with the use of this device prior to transcatheter heart valve implantation, refer to the bioprosthesis Instructions for Use (IFU). Use only appropriate balloon inflation medium. Do not use air or gaseous medium to inflate the balloon. The device is not intended for post-dilatation of deployed transcatheter heart valves. While exposed within the body, device advancement and retrieval should not be done without the aid of fluoroscopy. Do not advance or retract the device unless the balloon is fully deflated under vacuum.
Potential Adverse Events: Complications associated with standard catheterization, balloon valvuloplasty, and the use of angiography include, but are not limited to, allergic reaction to anesthesia or to contrast media, injury including perforation or dissection of vessels, thrombus formation, plaque dislodgement and embolization that may result in myocardial infarction, stroke, distal peripheral occlusion and/or death, arrhythmia development, cardiac perforation, conduction system injury, hematoma, infundibulum injury, annular tear or rupture and/or valve leaflet dehiscence, severe valve insufficiency, valve restenosis, valve damage, balloon rupture, balloon separation following balloon rupture, valvular tearing or trauma, thromboembolic events, and infection. Reference the Edwards SAPIEN Transcatheter Heart Valve with RetroFlex 3 Delivery System, or the Edwards SAPIEN XT Transcatheter Heart Valve with the NovaFlex+ Delivery System Instructions for Use, for a full list of potential adverse events.
EDWARDS BALLOON CATHETER (9350BC25)
Indications: The Edwards balloon catheter is indicated for valvuloplasty of a stenotic aortic valve prior to implantation of the Edwards SAPIEN XT transcatheter heart valve.
Contraindications: Other than standard risks associated with insertion of a cardiovascular catheter, there are no known contraindications for valvuloplasty. The patient’s medical condition could affect successful use of this catheter.
Warnings: The device is designed, intended, and distributed for single use only. Do not resterilize or reuse the device. There are no data to support the sterility, nonpyrogenicity, and functionality of the device after reprocessing. Do not mishandle the device or use it if the packaging or any components are not sterile, have been opened or are damaged (e.g. kinked or stretched), or the expiration date has elapsed.
Precautions: For special considerations associated with the use of this device prior to transcatheter heart valve implantation, refer to the bioprosthesis Instructions for Use. Use only appropriate balloon inflation medium. Do not use air or gaseous medium to inflate the balloon. The device is not intended for post-dilatation of deployed transcatheter heart valves. While exposed within the body, device advancement and retrieval should not be done without the aid of fluoroscopy. Do not advance or retract the device unless the balloon is fully deflated under vacuum.
Potential Adverse Events: Complications associated with standard catheterization, balloon valvuloplasty, and the use of angiography include, but are not limited to, allergic reaction to anesthesia or to contrast media, injury including perforation or dissection of vessels, thrombus formation, plaque dislodgement and embolization that may result in myocardial infarction, stroke, distal peripheral occlusion and/or death, arrhythmia development, cardiac perforation, conduction system injury, hematoma, infundibulum injury, annular tear or rupture and/or valve leaflet dehiscence, severe valve insufficiency, valve restenosis, valve damage, balloon rupture, balloon separation following balloon rupture, valvular tearing or trauma, thromboembolic events, and infection. Reference the Edwards SAPIEN XT Transcatheter Heart Valve with the NovaFlex+ Delivery System Instructions for Use for a full list of potential adverse events.
EDWARDS EXPANDABLE INTRODUCER SHEATH SET
Indications: The Edwards expandable introducer sheath is indicated for the introduction and removal of devices used with the Edwards SAPIEN XT Transcatheter Heart Valve.
Contraindications: This product is contraindicated for tortuous or calcified vessels that would prevent safe entry of the introducer and sheath. Warnings: The devices are designed, intended, and distributed for single use only. Do not resterilize or reuse the devices. There is no data to support the sterility, nonpyrogenicity, and functionality of the devices after reprocessing. The Edwards Expandable Introducer Sheath Set must be used with a compatible 0.035” guidewire.
Precautions: Do not use the introducer sheath set if the packaging sterile barriers and any components have been opened or damaged. The Edwards Expandable Sheath temporarily enlarges to allow the passage of devices; ensure that the vasculature can accommodate the maximum diameter of the expanded sheath. When inserting, manipulating or withdrawing a device through the expandable sheath, always maintain sheath position. When puncturing, suturing or incising the tissue near the sheath, use caution to avoid damage to the sheath.
Potential Adverse Events: Complications associated with standard catheterization and use of angiography include, but are not limited to, injury including perforation or dissection of vessels, thrombosis, and/or plaque dislodgement which may result in emboli formation, distal vessel obstruction, stroke, infection, and/or death.
EDWARDS SAPIEN XT TRANSCATHETER HEART VALVE WITH THE ASCENDRA+ DELIVERY SYSTEM
Indications: The Edwards SAPIEN XT Transcatheter Heart Valve, model 9300TFX, systems are indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis (aortic valve area ≤ 1.0 cm2 or aortic valve area index ≤ 0.6 cm2/m2, a mean aortic valve gradient of ≥ 40 mmHg, or a peak aortic-jet velocity of ≥ 4.0 m/s), and with native anatomy appropriate for the 23, 26, or 29 mm valve system, who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., Society of Thoracic Surgeons operative risk score ≥8% or at a ≥15% risk of mortality at 30 days).
Contraindications: The THV and delivery systems are contraindicated in patients who cannot tolerate an anticoagulation/antiplatelet regimen or who have active bacterial endocarditis or other active infections.
Warnings: Observation of the pacing lead throughout the procedure is essential to avoid the potential risk of pacing lead perforation. There is an increased risk of stroke in transcatheter aortic valve replacement procedures, as compared to balloon aortic valvuloplasty or other standard treatments. The devices are designed, intended, and distributed for single use only. Do not resterilize or reuse the devices. There are no data to support the sterility, nonpyrogenicity, and functionality of the devices after reprocessing. Incorrect sizing of the THV may lead to paravalvular leak, migration, embolization and/or annular rupture. Accelerated deterioration of the THV may occur in patients with an altered calcium metabolism. Prior to delivery, the THV must remain hydrated at all times and cannot be exposed to solutions other than its shipping storage solution and sterile physiologic rinsing solution. THV leaflets mishandled or damaged during any part of the procedure will require replacement of the THV. Caution should be exercised in implanting a THV in patients with clinically significant coronary artery disease. Patients with pre-existing mitral valve devices should be carefully assessed prior to implantation of the THV to ensure proper THV positioning and deployment. Patients presenting with combination AV low flow, low gradient should undergo additional evaluation to establish the degree of aortic stenosis. Do not use the THV if the tamper evident seal is broken, the storage solution does not completely cover the THV, the temperature indicator has been activated, the THV is damaged, or the expiration date has elapsed. Do not mishandle the Ascendra+ delivery system or use it if the packaging or any components are not sterile, have been opened or are damaged (e.g. kinked or stretched), or the expiration date has elapsed. Care should be exercised in patients with hypersensitivities to cobalt, nickel, chromium, molybdenum, titanium, manganese, silicon, and/or polymeric materials. The procedure should be conducted under fluoroscopic guidance. Some fluoroscopically guided procedures are associated with a risk of radiation injury to the skin. These injuries may be painful, disfiguring, and long-lasting. THV recipients should be maintained on anticoagulant/ antiplatelet therapy, except when contraindicated, as determined by their physician. This device has not been tested for use without anticoagulation. Do not add or apply antibiotics to the storage solution, rinse solutions, or to the THV.
Precautions: Long-term durability has not been established for the THV. Regular medical follow-up is advised to evaluate THV performance. Glutaraldehyde may cause irritation of the skin, eyes, nose and throat. Avoid prolonged or repeated exposure to, or breathing of, the solution. Use only with adequate ventilation. If skin contact occurs, immediately flush the affected area with water; in the event of contact with eyes, seek immediate medical attention. For more information about glutaraldehyde exposure, refer to the Material Safety Data Sheet available from Edwards Lifesciences. To maintain proper valve leaflet coaptation, do not overinflate the deployment balloon. Appropriate antibiotic prophylaxis is recommended post-procedure in patients at risk for prosthetic valve infection and endocarditis. Safety, effectiveness, and durability have not been established for valve-in-valve procedures. Safety and effectiveness have not been established for patients with the following characteristics/comorbidities: Non-calcified aortic annulus, severe ventricular dysfunction with ejection fraction < 20%, congenital unicuspid or congenital bicuspid aortic valve, mixed aortic valve disease (aortic stenosis and aortic regurgitation with predominant aortic regurgitation > 3+), pre-existing prosthetic heart valve or prosthetic ring in any position, severe mitral annular calcification (MAC), severe (> 3+) mitral insufficiency, or Gorlin syndrome, blood dyscrasias defined as: leukopenia (WBC < 3000 cells/mL), acute anemia (Hb < 9 g/dL), thrombocytopenia (platelet count <50,000 cells/mL) or history of bleeding diathesis or coagulopathy, hypertrophic cardiomyopathy with or without obstruction (HOCM), echocardiographic evidence of intracardiac mass, thrombus, or vegetation, a known hypersensitivity or contraindication to aspirin, heparin, ticlopidine (Ticlid™), or clopidogrel (Plavix™), or sensitivity to contrast media, which cannot be adequately premedicated, excessive calcification of vessel at access site, bulky calcified aortic valve leaflets in close proximity to coronary ostia.
Potential Adverse Events: Potential risks associated with the overall procedure including potential access complications associated with standard cardiac catheterization, balloon valvuloplasty, the potential risks of conscious sedation and/or general anesthesia, and the use of angiography: death; stroke/transient ischemic attack, clusters or neurological deficit; paralysis; permanent disability; respiratory insufficiency or respiratory failure; hemorrhage requiring transfusion or intervention; cardiovascular injury including perforation or dissection of vessels, ventricle, myocardium or valvular structures that may require intervention; pericardial effusion or cardiac tamponade; embolization including air, calcific valve material or thrombus; infection including septicemia and endocarditis; heart failure; myocardial infarction; renal insufficiency or renal failure; conduction system defect which may require a permanent pacemaker; arrhythmia; retroperitoneal bleed; AV fistula or pseudoaneurysm; reoperation; ischemia or nerve injury; restenosis; pulmonary edema; pleural effusion; bleeding; anemia; abnormal lab values (including electrolyte imbalance); hypertension or hypotension; allergic reaction to anesthesia, contrast media, or device materials; hematoma; syncope; pain or changes at the access site; exercise intolerance or weakness; inflammation; angina; heart murmur; fever. Additional potential risks associated with the use of the THV, delivery system, and/or accessories include: cardiac arrest; cardiogenic shock; emergency cardiac surgery; cardiac failure or low cardiac output; coronary flow obstruction/transvalvular flow disturbance; device thrombosis requiring intervention; valve thrombosis; device embolization; device migration or malposition requiring intervention; valve deployment in unintended location; valve stenosis; structural valve deterioration (wear, fracture, calcification, leaflet tear/tearing from the stent posts, leaflet retraction, suture line disruption of components of a prosthetic valve, thickening, stenosis); device degeneration; paravalvular or transvalvular leak; valve regurgitation; hemolysis; device explants; nonstructural dysfunction; mechanical failure of delivery system, and/or accessories; non-emergent reoperation.
ASCENDRA BALLOON AORTIC VALVULOPLASTY CATHETER
Indications: The Ascendra Balloon Aortic Valvuloplasty Catheter is indicated for valvuloplasty of a stenotic aortic valve prior to implantation of the Edwards SAPIEN or Edwards SAPIEN XT Transcatheter Heart Valve.
Contraindications: Other than standard risks associated with insertion of a cardiovascular catheter, there are no known contraindications for valvuloplasty. The patient’s medical condition could affect successful use of this catheter.
Warnings: The device is designed, intended, and distributed for single use only. Do not resterilize or reuse the device. There are no data to support the sterility, nonpyrogenicity, and functionality of the device after reprocessing. Do not mishandle the device or use it if the packaging or any components are not sterile, have been opened or are damaged (e.g. kinked or stretched), or the expiration date has elapsed.
Precautions: For special considerations associated with the use of this device prior to transcatheter heart valve (THV) implantation, refer to the THV instructions for use (IFU). This catheter has not been tested with any transcatheter valve other than the Edwards SAPIEN and Edwards SAPIEN XT transcatheter heart valve. Use only appropriate balloon inflation medium. Do not use air or gaseous medium to inflate the balloon. The device is not intended for post-dilation of deployed transcatheter heart valves. While exposed within the body, device advancement and retrieval should not be done without the aid of fluoroscopy. Do not advance or retract the device unless the balloon is fully deflated under vacuum.
Potential Adverse Events: Complications associated with standard catheterization, balloon valvuloplasty, and the use of angiography include, but are not limited to, allergic reaction to anesthesia or to contrast media, thrombus formation, plaque dislodgement and embolization that may result in myocardial infarction, stroke, distal peripheral occlusion and/or death, arrhythmia development, cardiac perforation, conduction system injury, hematoma, infundibulum injury, annular tear or rupture and/or valve leaflet dehiscence, severe valve insufficiency, valve restenosis, valve damage, balloon rupture, balloon separation following balloon rupture, valvular tearing or trauma, thromboembolic events, and infection. Reference the Edwards SAPIEN Transcatheter Heart Valve with the Ascendra Balloon Catheter, Edwards SAPIEN Transcatheter Heart Valve with the Ascendra 3 Delivery System, or the Edwards SAPIEN XT Transcatheter Heart Valve with the Ascendra+ Delivery System Instructions for Use for a full list of potential adverse events.
ASCENDRA+ INTRODUCER SHEATH SET
Indications: The Ascendra+ Introducer Sheath Set is indicated for the introduction and removal of devices used with the Edwards SAPIEN XT Transcatheter Heart Valve.
Contraindications: No known contraindications.
Warnings: The devices are designed, intended, and distributed for single use only. Do not resterilize or reuse the devices. There are no data to support the sterility, nonpyrogenicity, and functionality of the devices after reprocessing. Do not mishandle the device or use it if the packaging or any components are not sterile, have been opened or are damaged (e.g. kinked or stretched), or the expiration date has elapsed. Should not be used in patients with left ventricular aneurysm. The Ascendra+ Introducer Sheath Set must be used with a 0.035” guidewire.
Precautions: No known precautions.
Potential Adverse Events: Complications associated with cardiac surgical intervention and use of angiography include, but are not limited to, allergic reaction to anesthesia or to contrast media, injury including myocardial injury, thrombus formation, and plaque dislodgement which may result in myocardial infarction, arrhythmia, stroke, and/or death. Reference the Edwards SAPIEN XT Transcatheter Heart Valve with the Ascendra+ Delivery System Instructions for Use for a full list of potential adverse events.
EDWARDS CRIMPER
Indications: The Edwards Crimper is indicated for use in preparing the Edwards SAPIEN XT Transcatheter Heart Valve for implantation.
Contraindications: No known contraindications.
Warnings: The device is designed, intended, and distributed for single use only. Do not resterilize or reuse the device. There are no data to support the sterility, nonpyrogenicity, and functionality of the device after reprocessing. Do not mishandle the device. Do not use the device if the packaging or any components are not sterile, have been opened or are damaged, or the expiration date has elapsed.
Precautions: For special considerations associated with the use of this device prior to THV implantation, refer to the SAPIEN XT Transcatheter Heart Valve Instructions for Use.
Potential Adverse Events: No known potential adverse events.
EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE WITH THE EDWARDS COMMANDER DELIVERY SYSTEM
Indications: The Edwards SAPIEN 3 transcatheter heart valve (THV), model 9600TFX, and accessories are indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., Society of Thoracic Surgeons operative risk score ≥ 8% or at a ≥ 15% risk of mortality at 30 days).
Contraindications: The THV and delivery systems are contraindicated in patients who cannot tolerate an anticoagulation/antiplatelet regimen or who have active bacterial endocarditis or other active infections.
Warnings: Observation of the pacing lead throughout the procedure is essential to avoid the potential risk of pacing lead perforation. There is an increased risk of stroke in transcatheter aortic valve replacement procedures, as compared to balloon aortic valvuloplasty or other standard treatments. The devices are designed, intended, and distributed for single use only. Do not resterilize or reuse the devices. There are no data to support the sterility, nonpyrogenicity, and functionality of the devices after reprocessing. Incorrect sizing of the THV may lead to paravalvular leak, migration, embolization, and/or annular rupture. Accelerated deterioration of the THV may occur in patients with an altered calcium metabolism. Prior to delivery, the THV must remain hydrated at all times and cannot be exposed to solutions other than its shipping storage solution and sterile physiologic rinsing solution. THV leaflets mishandled or damaged during any part of the procedure will require replacement of the THV. Caution should be exercised in implanting a THV in patients with clinically significant coronary artery disease. Patients with pre-existing mitral valve devices should be carefully assessed prior to implantation of the THV to ensure proper THV positioning and deployment. Do not mishandle the delivery system or use it if the packaging or any components are not sterile, have been opened or are damaged (e.g., kinked or stretched), or if the expiration date has elapsed. Use of excessive contrast media may lead to renal failure. Measure the patient’s creatinine level prior to the procedure. Contrast media usage should be monitored. Patient injury could occur if the delivery system is not un-flexed prior to removal. Care should be exercised in patients with hypersensitivities to cobalt, nickel, chromium, molybdenum, titanium, manganese, silicon, and/or polymeric materials. The procedure should be conducted under fluoroscopic guidance. Some fluoroscopically guided procedures are associated with a risk of radiation injury to the skin. These injuries may be painful, disfiguring, and long-lasting. THV recipients should be maintained on anticoagulant/antiplatelet therapy, except when contraindicated, as determined by their physician. This device has not been tested for use without anticoagulation.
Precautions: Long-term durability has not been established for the THV. Regular medical follow-up is advised to evaluate THV performance. Glutaraldehyde may cause irritation of the skin, eyes, nose, and throat. Avoid prolonged or repeated exposure to, or breathing of, the solution. To maintain proper valve leaflet coaptation, do not overinflate the deployment balloon. Appropriate antibiotic prophylaxis is recommended post-procedure in patients at risk for prosthetic valve infection and endocarditis. Safety, effectiveness, and durability have not been established for valve-in-valve procedures. Safety and effectiveness have not been established for patients with the following characteristics/comorbidities: non-calcified aortic annulus; severe ventricular dysfunction with ejection fraction < 20%; congenital unicuspid or congenital bicuspid aortic valve; mixed aortic valve disease (aortic stenosis and aortic regurgitation with predominant aortic regurgitation > 3+); pre-existing prosthetic heart valve or prosthetic ring in any position; severe mitral annular calcification (MAC), severe (> 3+) mitral insufficiency, or Gorlin syndrome; blood dyscrasias defined as leukopenia (WBC < 3000 cells/mL), acute anemia (Hb < 9 g/dL), thrombocytopenia (platelet count < 50,000 cells/mL), or history of bleeding diathesis or coagulopathy; hypertrophic cardiomyopathy with or without obstruction (HOCM); echocardiographic evidence of intracardiac mass, thrombus, or vegetation; a known hypersensitivity or contraindication to aspirin, heparin, ticlopidine (Ticlid), or clopidogrel (Plavix), or sensitivity to contrast media, which cannot be adequately premedicated; significant aortic disease, including abdominal aortic or thoracic aneurysm defined as maximal luminal diameter 5 cm or greater, marked tortuosity (hyperacute bend), aortic arch atheroma (especially if thick [> 5 mm], protruding, or ulcerated) or narrowing (especially with calcification and surface irregularities) of the abdominal or thoracic aorta, severe “unfolding” and tortuosity of the thoracic aorta; access characteristics that would preclude safe placement of 14F or 16F Edwards eSheath introducer set, such as severe obstructive calcification, severe tortuosity, or diameter less than 5.5 mm or 6 mm, respectively; or bulky calcified aortic valve leaflets in close proximity to coronary ostia.
Potential Adverse Events: Potential risks associated with the overall procedure including potential access complications associated with standard cardiac catheterization, balloon valvuloplasty, the potential risks of conscious sedation and/or general anesthesia, and the use of angiography: death; stroke/transient ischemic attack, clusters, or neurological deficit; paralysis; permanent disability; respiratory insufficiency or respiratory failure; hemorrhage requiring transfusion or intervention; cardiovascular injury including perforation or dissection of vessels, ventricle, myocardium, or valvular structures that may require intervention; pericardial effusion or cardiac tamponade; embolization including air, calcific valve material, or thrombus; infection including septicemia and endocarditis; heart failure; myocardial infarction; renal insufficiency or renal failure; conduction system defect which may require a permanent pacemaker; arrhythmia; retroperitoneal bleed; AV fistula or pseudoaneurysm; reoperation; ischemia or nerve injury; restenosis; pulmonary edema; pleural effusion; bleeding; anemia; abnormal lab values (including electrolyte imbalance); hypertension or hypotension; allergic reaction to anesthesia, contrast media, or device materials; hematoma; syncope; pain or changes at the access site; exercise intolerance or weakness; inflammation; angina; heart murmur; and fever. Additional potential risks associated with the use of the THV, delivery system, and/or accessories include: cardiac arrest; cardiogenic shock; emergency cardiac surgery; cardiac failure or low cardiac output; coronary flow obstruction/transvalvular flow disturbance; device thrombosis requiring intervention; valve thrombosis; device embolization; device migration or malposition requiring intervention; valve deployment in unintended location; valve stenosis; structural valve deterioration (wear, fracture, calcification, leaflet tear/tearing from the stent posts, leaflet retraction, suture line disruption of components of a prosthetic valve, thickening, stenosis); device degeneration; paravalvular or transvalvular leak; valve regurgitation; hemolysis; device explants; nonstructural dysfunction; mechanical failure of delivery system and/or accessories; and non-emergent reoperation.
EDWARDS ESHEATH INTRODUCER SET AND EDWARDS CRIMPER
Indications: The Edwards eSheath introducer set is indicated for the introduction and removal of devices used with the Edwards SAPIEN 3 transcatheter heart valve. The Edwards Crimper is indicated for use in preparing the Edwards SAPIEN 3 transcatheter heart valve for implantation.
Contraindications: There are no known contraindications.
Warnings: The devices are designed, intended, and distributed for single use only. Do not resterilize or reuse the devices. There is no data to support the sterility, nonpyrogenicity, and functionality of the devices after reprocessing. The Edwards eSheath introducer set must be used with a compatible 0.035” guidewire.
Precautions: For the Edwards eSheath introducer set, caution should be used in vessels that have diameters less than 5.5 mm or 6 mm as it may preclude safe placement of the 14F and 16F Edwards eSheath introducer set, respectively. Use caution in tortuous or calcified vessels that would prevent safe entry of the introducer set. Do not use the Edwards eSheath introducer set if the packaging sterile barriers or any components have been opened or damaged. The Edwards eSheath introducer set temporarily enlarges to allow the passage of devices; ensure that the vasculature can accommodate the maximum diameter of the expanded sheath. When inserting, manipulating, or withdrawing the device through the expandable sheath, always maintain sheath position. When puncturing, suturing, or incising the tissue near the sheath, use caution to avoid damage to the sheath. For special considerations associated with the use of the Edwards Crimper prior to transcatheter heart valve implantation, refer to the Edwards SAPIEN 3 transcatheter heart valve Instructions for Use.
Potential Adverse Events: Complications associated with standard catheterization and use of angiography include, but are not limited to, injury including perforation or dissection of vessels, thrombosis, and/or plaque dislodgement which may result in emboli formation, distal vessel obstruction, stroke, infection, and/or death. There are no known potential adverse events associated with the Edwards Crimper.
2016 Facility and Physician Screening Guide and Facility Patient Coding Guide
View the PDF of the Patient Coding Guide2016 Facility and Physician Billing Guide
Clinicians use Current Procedural Terminology (CPT)1 codes to bill for procedures and services. Each CPT code is assigned unique relative value units (RVUs), which are used to determine payment by the Centers for Medicare & Medicaid Services (CMS) and other payers. Some commonly billed CPT codes used to describe procedures related to Edwards Lifesciences’ Heart Valve technologies are listed below.2 This list may not be comprehensive or complete. These procedures may be subject to the CMS multiple procedure reduction rule. When applicable, a payment reduction of 50% is applied to all payment amounts except the procedure with the greatest RVUs, which is paid at 100% unless exempt by CPT instructions or payer policy.
CPT Code | Description | Medicare National Average Physician Payment3 Facility Setting |
33400 | Valvuloplasty, aortic valve; open, with cardiopulmonary bypass | $2,374 |
33401 | Valvuloplasty, aortic valve; open, with inflow occlusion | $1,533 |
33403 | Valvuloplasty, aortic valve; using transventricular dilation, with cardiopulmonary bypass | $1,555 |
33405 | Replacement, aortic valve, with cardiopulmonary bypass; with prosthetic valve other than homograft or stentless valve | $2,368 |
33406 | Replacement, aortic valve, with cardiopulmonary bypass; with allograft valve (freehand) | $2,998 |
33410 | Replacement, aortic valve, with cardiopulmonary bypass; with stentless tissue valve | $2,641 |
33411 | Replacement, aortic valve; with aortic annulus enlargement, noncoronary sinus | $3,503 |
33412 | Replacement, aortic valve; with transventricular aortic annulus enlargement (Konno procedure) | $3,325 |
33413 | Replacement, aortic valve; by translocation of autologous pulmonary valve with allograft replacement of pulmonary valve (Ross procedure) | $3,411 |
33420 | Valvotomy, mitral valve; closed heart | $1,627 |
33422 | Valvotomy, mitral valve; open heart, with cardiopulmonary bypass | $1,749 |
33425 | Valvuloplasty, mitral valve, with cardiopulmonary bypass | $2,854 |
33426 | Valvuloplasty, mitral valve, with cardiopulmonary bypass; with prosthetic ring | $2,484 |
33427 | Valvuloplasty, mitral valve, with cardiopulmonary bypass; radical reconstruction, with or without ring | $2,548 |
33430 | Replacement, mitral valve, with cardiopulmonary bypass | $2,922 |
33460 | Valvectomy, tricuspid valve, with cardiopulmonary bypass | $2,560 |
33463 | Valvuloplasty, tricuspid valve; without ring insertion | $3,232 |
33464 | Valvuloplasty, tricuspid valve; with ring insertion | $2,548 |
33465 | Replacement, tricuspid valve, with cardiopulmonary bypass | $2,883 |
33468 | Tricuspid valve repositioning and plication for Ebstein anomaly | $2,570 |
33999 | Unlisted procedure, cardiac surgery | Contractor priced |
92986 | Percutaneous balloon valvuloplasty; aortic valve | $1,387 |
92987 | Percutaneous balloon valvuloplasty; mitral valve | $1,430 |
CPT Code | Description | Medicare National Average Physician Payment3 Facility Setting |
33510 | Coronary artery bypass, vein only; single coronary venous graft | $2,009 |
33511 | Coronary artery bypass, vein only; 2 coronary venous grafts | $2,213 |
33512 | Coronary artery bypass, vein only; 3 coronary venous grafts | $2,519 |
33513 | Coronary artery bypass, vein only; 4 coronary venous grafts | $2,592 |
33514 | Coronary artery bypass, vein only; 5 coronary venous grafts | $2,730 |
33516 | Coronary artery bypass, vein only; 6 or more coronary venous grafts | $2,862 |
33517 | Coronary artery bypass, using venous graft(s) and arterial graft(s); single vein graft (List separately in addition to code for primary procedure) | $195 |
33518 | Coronary artery bypass, using venous graft(s) and arterial graft(s); 2 venous grafts (List separately in addition to code for primary procedure) | $428 |
33519 | Coronary artery bypass, using venous graft(s) and arterial graft(s); 3 venous grafts (List separately in addition to code for primary procedure) | $564 |
33521 | Coronary artery bypass, using venous graft(s) and arterial graft(s);4 venous grafts (List separately in addition to code for primary procedure) | $675 |
33522 | Coronary artery bypass, using venous graft(s) and arterial graft(s); 5 venous grafts (List separately in addition to code for primary procedure) | $759 |
33523 | Coronary artery bypass, using venous graft(s) and arterial graft(s); 6 or more venous grafts (List separately in addition to code for primary procedure) | $867 |
33530 | Reoperation, coronary artery bypass procedure or valve procedure, more than 1 month after original operation (List separately in addition to code for primary procedure) | $545 |
33533 | Coronary artery bypass, using arterial graft(s); single arterial graft | $1,952 |
33534 | Coronary artery bypass, using arterial graft(s); 2 coronary arterial grafts | $2,293 |
33535 | Coronary artery bypass, using arterial graft(s); 3 coronary arterial grafts | $2,553 |
33536 | Coronary artery bypass, using arterial graft(s); 4 or more coronary arterial grafts | $2,749 |
35600 | Harvest of upper extremity artery, 1 segment, for coronary artery bypass procedure (List separately in addition to code for primary procedure) | $264 |
CPT Code | Description | Medicare National Average Physician Payment3 Facility Setting |
36013 | Introduction of catheter, right heart or main pulmonary artery4 | $133 |
36200 | Introduction of catheter, aorta4 | $161 |
36620 | Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous4 | $53 |
93318 - 26 | Echocardiography, transesophageal (TEE) for monitoring purposes, including probe placement, real time 2D image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis5 | $119 |
93503 | Insertion and placement of flow directed catheter (e.g., Swan-Ganz catheter) for monitoring purposes | $135 |
Medicare reimburses inpatient hospital services under the Inpatient Prospective Payment System (IPPS), which bases payment on Medicare Severity-Diagnosis Related Groups (MS-DRGs). All services and supplies provided during the inpatient admission are bundled into a single MS-DRG payment rate for each patient regardless of the length of stay, intensity of treatments, or number of procedures performed. MS-DRG assignment is usually determined based on the patient’s primary diagnosis or procedure performed, as indicated by the ICD-9-CM codes on the billing form.
MS-DRG6 | Description | FY2016 Medicare National Average Payment | |
---|---|---|---|
Valve Repair/Replacement Procedures | |||
216 | Cardiac valve procedures and other major cardiothoracic procedures with cardiac catheterization with MCC | $55,884 | |
217 | Cardiac valve procedures and other major cardiothoracic procedures with cardiac catheterization with CC | $36,950 | |
218 | Cardiac valve procedures and other major cardiothoracic procedures with cardiac catheterization without MCC or CC | $32,367 | |
219 | Cardiac valve procedures and other major cardiothoracic procedures without cardiac catheterization with MCC | $44,634 | |
220 | Cardiac valve procedures and other major cardiothoracic procedures without cardiac catheterization with CC | $30,158 | |
221 | Cardiac valve procedures and other major cardiothoracic procedures without cardiac catheterization without MCC or CC | $26,811 | |
CABG Procedures | |||
231 | Coronary bypass with PTCA with MCC | $46,090 | |
232 | Coronary bypass with PTCA without MCC | $34,117 | |
233 | Coronary bypass with cardiac catheterization with MCC | $43,448 | |
234 | Coronary bypass with cardiac catheterization without MCC | $28,978 | |
235 | Coronary bypass without cardiac catheterization with MCC | $34,308 | |
236 | Coronary bypass without cardiac catheterization without MCC | $22,446 |
REVENUE CODES7 AND HCPCS CODES
Revenue codes help hospitals categorize services provided by revenue center. Medicare utilizes revenue codes for cost reporting purposes. For Medicare, revenue codes must be included for each service on a CMS 1450 (UB-04) claim form. It may be appropriate for hospitals to capture the cost of products used for the procedures described above within Revenue Code 0278 (Medical/Surgical Supply – Other Implant) or Revenue Code 0360 (Operating Room Services - General). Health Care Common Procedural Coding System (HCPCS) codes include level I codes (CPT, described above) and level II codes (other products, supplies, and services not included in CPT). Level II HCPCS codes, including C codes, are not applicable to Edwards’ products utilized in the procedures described above. C codes are used in conjunction with the Medicare prospective payment system for outpatient procedures only.
Medicare inpatient hospital reimbursement is based upon the Medicare Severity-Diagnosis Related Group (MS-DRG) classification system, which assigns MS-DRGs based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis and procedure codes. Although the compliance date for mandatory use of ICD-10 codes is October 1, 20158, this guide is intended to provide the cross-over codes for testing purposes only. Given Medicare and other payers are encouraging the provider community to perform parallel coding and test the claims systems, this guide will provide the necessary conversion from ICD-9 codes to the appropriate ICD-10 codes.
ICD-9-CM Procedure Code9 | Description | ICD-10-CM Procedure Code10 | Description |
---|---|---|---|
35.00 | Closed heart valvotomy, unspecified valve | 02NF3ZZ | Release Aortic Valve, Percutaneous Approach |
02NF4ZZ | Release Aortic Valve, Percutaneous Endoscopic Approach | ||
02NG3ZZ | Release Mitral Valve, Percutaneous Approach | ||
02NG4ZZ | Release Mitral Valve, Percutaneous Endoscopic Approach | ||
02NH3ZZ | Release Pulmonary Valve, Percutaneous Approach | ||
02NH4ZZ | Release Pulmonary Valve, Percutaneous Endoscopic Approach | ||
02NJ3ZZ | Release Tricuspid Valve, Percutaneous Approach | ||
02NJ4ZZ | Release Tricuspid Valve, Percutaneous Endoscopic Approach | ||
35.01 | Closed heart valvotomy, aortic valve | 02CF3ZZ | Extirpation of Matter from Aortic Valve, Percutaneous Approach |
02CF4ZZ | Extirpation of Matter from Aortic Valve, Percutaneous Endoscopic Approach | ||
02NF3ZZ | Release Aortic Valve, Percutaneous Approach | ||
02NF4ZZ | Release Aortic Valve, Percutaneous Endoscopic Approach | ||
35.02 | Closed heart valvotomy, mitral valve | 02CG3ZZ | Extirpation of Matter from Mitral Valve, Percutaneous Approach |
02CG4ZZ | Extirpation of Matter from Mitral Valve, Percutaneous Endoscopic Approach | ||
02NG3ZZ | Release Mitral Valve, Percutaneous Approach | ||
02NG4ZZ | Release Mitral Valve, Percutaneous Endoscopic Approach | ||
35.03 | Closed heart valvotomy, pulmonary valve | 02CH3ZZ | Extirpation of Matter from Pulmonary Valve, Percutaneous Approach |
02CH4ZZ | Extirpation of Matter from Pulmonary Valve, Percutaneous Endoscopic Approach | ||
02NH3ZZ | Release Pulmonary Valve, Percutaneous Approach | ||
02NH4ZZ | Release Pulmonary Valve, Percutaneous Endoscopic Approach | ||
35.04 | Closed heart valvotomy, tricuspid valve | 02CJ3ZZ | Extirpation of Matter from Tricuspid Valve, Percutaneous Approach |
02CJ4ZZ | Extirpation of Matter from Tricuspid Valve, Percutaneous Endoscopic Approach | ||
02NJ3ZZ | Release Tricuspid Valve, Percutaneous Approach | ||
02NJ4ZZ | Release Tricuspid Valve, Percutaneous Endoscopic Approach | ||
35.10 | Open heart valvuloplasty without replacement, unspecified valve | 02QF0ZZ | Repair Aortic Valve, Open Approach |
02QG0ZZ | Repair Mitral Valve, Open Approach | ||
02QH0ZZ | Repair Pulmonary Valve, Open Approach | ||
02QJ0ZZ | Repair Tricuspid Valve, Open Approach | ||
35.11 | Open heart valvuloplasty of aortic valve without replacement | 027F04Z | Dilation of Aortic Valve with Drug-eluting Intraluminal Device, Open Approach |
027F0DZ | Dilation of Aortic Valve with Intraluminal Device, Open Approach | ||
027F0ZZ | Dilation of Aortic Valve, Open Approach | ||
02NF0ZZ | Release Aortic Valve, Open Approach | ||
02QF0ZZ | Repair Aortic Valve, Open Approach | ||
35.12 | Open heart valvuloplasty of mitral valve without replacement | 027G04Z | Dilation of Mitral Valve with Drug-eluting Intraluminal Device, Open Approach |
027G0DZ | Dilation of Mitral Valve with Intraluminal Device, Open Approach | ||
027G0ZZ | Dilation of Mitral Valve, Open Approach | ||
02NG0ZZ | Release Mitral Valve, Open Approach | ||
02QG0ZZ | Repair Mitral Valve, Open Approach | ||
35.13 | Open heart valvuloplasty of pulmonary valve without replacement | 027H04Z | Dilation of Pulmonary Valve with Drug-eluting Intraluminal Device, Open Approach |
027H0DZ | Dilation of Pulmonary Valve with Intraluminal Device, Open Approach | ||
027H0ZZ | Dilation of Pulmonary Valve, Open Approach | ||
02NH0ZZ | Release Pulmonary Valve, Open Approach | ||
02QH0ZZ | Repair Pulmonary Valve, Open Approach | ||
35.14 | Open heart valvuloplasty of tricuspid valve without replacement | 027J04Z | Dilation of Tricuspid Valve with Drug-eluting Intraluminal Device, Open Approach |
027J0DZ | Dilation of Tricuspid Valve with Intraluminal Device, Open Approach | ||
027J0ZZ | Dilation of Tricuspid Valve, Open Approach | ||
02NJ0ZZ | Release Tricuspid Valve, Open Approach | ||
02QJ0ZZ | Repair Tricuspid Valve, Open Approach | ||
35.20 | Open and other replacement of unspecified heart valve | 02RF07Z | Replacement of Aortic Valve with Autologous Tissue Substitute, Open Approach |
02RF08Z | Replacement of Aortic Valve with Zooplastic Tissue, Open Approach | ||
02RF0JZ | Replacement of Aortic Valve with Synthetic Substitute, Open Approach | ||
02RF0KZ | Replacement of Aortic Valve with Nonautologous Tissue Substitute, Open Approach | ||
02RF47Z | Replacement of Aortic Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RF48Z | Replacement of Aortic Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02RF4JZ | Replacement of Aortic Valve with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02RF4KZ | Replacement of Aortic Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RG07Z | Replacement of Mitral Valve with Autologous Tissue Substitute, Open Approach | ||
02RG08Z | Replacement of Mitral Valve with Zooplastic Tissue, Open Approach | ||
02RG0JZ | Replacement of Mitral Valve with Synthetic Substitute, Open Approach | ||
02RG0KZ | Replacement of Mitral Valve with Nonautologous Tissue Substitute, Open Approach | ||
02RG47Z | Replacement of Mitral Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RG48Z | Replacement of Mitral Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02RG4JZ | Replacement of Mitral Valve with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02RG4KZ | Replacement of Mitral Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RH07Z | Replacement of Pulmonary Valve with Autologous Tissue Substitute, Open Approach | ||
02RH08Z | Replacement of Pulmonary Valve with Zooplastic Tissue, Open Approach | ||
02RH0JZ | Replacement of Pulmonary Valve with Synthetic Substitute, Open Approach | ||
02RH0KZ | Replacement of Pulmonary Valve with Nonautologous Tissue Substitute, Open Approach | ||
02RH47Z | Replacement of Pulmonary Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RH48Z | Replacement of Pulmonary Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02RH4JZ | Replacement of Pulmonary Valve with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02RH4KZ | Replacement of Pulmonary Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RJ07Z | Replacement of Tricuspid Valve with Autologous Tissue Substitute, Open Approach | ||
02RJ08Z | Replacement of Tricuspid Valve with Zooplastic Tissue, Open Approach | ||
02RJ0JZ | Replacement of Tricuspid Valve with Synthetic Substitute, Open Approach | ||
02RJ0KZ | Replacement of Tricuspid Valve with Nonautologous Tissue Substitute, Open Approach | ||
02RJ47Z | Replacement of Tricuspid Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RJ48Z | Replacement of Tricuspid Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02RJ4JZ | Replacement of Tricuspid Valve with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02RJ4KZ | Replacement of Tricuspid Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
35.21 | Open and other replacement of aortic valve with tissue graft | 02RF07Z | Replacement of Aortic Valve with Autologous Tissue Substitute, Open Approach |
02RF08Z | Replacement of Aortic Valve with Zooplastic Tissue, Open Approach | ||
02RF0KZ | Replacement of Aortic Valve with Nonautologous Tissue Substitute, Open Approach | ||
02RF47Z | Replacement of Aortic Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RF48Z | Replacement of Aortic Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02RF4KZ | Replacement of Aortic Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
35.22 | Open and other replacement of aortic valve | 02RF0JZ | Replacement of Aortic Valve with Synthetic Substitute, Open Approach |
02RF4JZ | Replacement of Aortic Valve with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
35.23 | Open and other replacement of mitral valve with tissue graft | 02RG07Z | Replacement of Mitral Valve with Autologous Tissue Substitute, Open Approach |
02RG08Z | Replacement of Mitral Valve with Zooplastic Tissue, Open Approach | ||
02RG0KZ | Replacement of Mitral Valve with Nonautologous Tissue Substitute, Open Approach | ||
02RG37Z | Replacement of Mitral Valve with Autologous Tissue Substitute, Percutaneous Approach | ||
02RG38Z | Replacement of Mitral Valve with Zooplastic Tissue, Percutaneous Approach | ||
02RG3KZ | Replacement of Mitral Valve with Nonautologous Tissue Substitute, Percutaneous Approach | ||
02RG47Z | Replacement of Mitral Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RG48Z | Replacement of Mitral Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02RG4KZ | Replacement of Mitral Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
35.24 | Open and other replacement of mitral valve | 02RG0JZ | Replacement of Mitral Valve with Synthetic Substitute, Open Approach |
02RG3JZ | Replacement of Mitral Valve with Synthetic Substitute, Percutaneous Approach | ||
02RG4JZ | Replacement of Mitral Valve with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
35.26 | Open and other replacement of pulmonary valve | 02RH0JZ | Replacement of Pulmonary Valve with Synthetic Substitute, Open Approach |
02RH4JZ | Replacement of Pulmonary Valve with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
35.27 | Open and other replacement of tricuspid valve with tissue graft | 02RJ07Z | Replacement of Tricuspid Valve with Autologous Tissue Substitute, Open Approach |
02RJ08Z | Replacement of Tricuspid Valve with Zooplastic Tissue, Open Approach | ||
02RJ0KZ | Replacement of Tricuspid Valve with Nonautologous Tissue Substitute, Open Approach | ||
02RJ47Z | Replacement of Tricuspid Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RJ48Z | Replacement of Tricuspid Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02RJ4KZ | Replacement of Tricuspid Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
35.28 | Open and other replacement of tricuspid valve | 02RJ0JZ | Replacement of Tricuspid Valve with Synthetic Substitute, Open Approach |
02RJ4JZ | Replacement of Tricuspid Valve with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
35.33 | Annuloplasty | 02QF0ZZ | Repair Aortic Valve, Open Approach |
02QF3ZZ | Repair Aortic Valve, Percutaneous Approach | ||
02QF4ZZ | Repair Aortic Valve, Percutaneous Approach | ||
02QG0ZZ | Repair Mitral Valve, Open Approach | ||
02QG3ZZ | Repair Mitral Valve, Percutaneous Approach | ||
02QG4ZZ | Repair Mitral Valve, Percutaneous Endoscopic Approach | ||
02QH0ZZ | Repair Pulmonary Valve, Open Approach | ||
02QH3ZZ | Repair Pulmonary Valve, Percutaneous Approach | ||
02QH4ZZ | Repair Pulmonary Valve, Percutaneous Endoscopic Approach | ||
02QJ0ZZ | Repair Tricuspid Valve, Open Approach | ||
02QJ3ZZ | Repair Tricuspid Valve, Percutaneous Approach | ||
02QJ4ZZ | Repair Tricuspid Valve, Percutaneous Endoscopic Approach | ||
02UF07Z | Supplement Aortic Valve with Autologous Tissue Substitute, Open Approach | ||
02UF08Z | Supplement Aortic Valve with Zooplastic Tissue, Open Approach | ||
02UF0JZ | Supplement Aortic Valve with Synthetic Substitute, Open Approach | ||
02UF0KZ | Supplement Aortic Valve with Nonautologous Tissue Substitute, Open Approach | ||
02UF37Z | Supplement Aortic Valve with Autologous Tissue Substitute, Percutaneous Approach | ||
02UF38Z | Supplement Aortic Valve with Zooplastic Tissue, Percutaneous Approach | ||
02UF3JZ | Supplement Aortic Valve with Synthetic Substitute, Percutaneous Approach | ||
02UF3KZ | Supplement Aortic Valve with Nonautologous Tissue Substitute, Percutaneous Approach | ||
02UF47Z | Supplement Aortic Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02UF48Z | Supplement Aortic Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02UF4JZ | Supplement Aortic Valve with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02UF4KZ | Supplement Aortic Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02UG07Z | Supplement Mitral Valve with Autologous Tissue Substitute, Open Approach | ||
02UG08Z | Supplement Mitral Valve with Zooplastic Tissue, Open Approach | ||
02UG0JZ | Supplement Mitral Valve with Synthetic Substitute, Open Approach | ||
02UG0KZ | Supplement Mitral Valve with Nonautologous Tissue Substitute, Open Approach | ||
02UG37Z | Supplement Mitral Valve with Autologous Tissue Substitute, Percutaneous Approach | ||
02UG38Z | Supplement Mitral Valve with Zooplastic Tissue, Percutaneous Approach | ||
02UG3JZ | Supplement Mitral Valve with Synthetic Substitute, Percutaneous Approach | ||
02UG3KZ | Supplement Mitral Valve with Nonautologous Tissue Substitute, Percutaneous Approach | ||
02UG47Z | Supplement Mitral Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02UG48Z | Supplement Mitral Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02UG4JZ | Supplement Mitral Valve with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02UG4KZ | Supplement Mitral Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02UH07Z | Supplement Pulmonary Valve with Autologous Tissue Substitute, Open Approach | ||
02UH08Z | Supplement Pulmonary Valve with Zooplastic Tissue, Open Approach | ||
02UH0JZ | Supplement Pulmonary Valve with Synthetic Substitute, Open Approach | ||
02UH0KZ | Supplement Pulmonary Valve with Nonautologous Tissue Substitute, Open Approach | ||
02UH37Z | Supplement Pulmonary Valve with Autologous Tissue Substitute, Percutaneous Approach | ||
02UH38Z | Supplement Pulmonary Valve with Zooplastic Tissue, Percutaneous Approach | ||
02UH3JZ | Supplement Pulmonary Valve with Synthetic Substitute, Percutaneous Approach | ||
02UH3KZ | Supplement Pulmonary Valve with Nonautologous Tissue Substitute, Percutaneous Approach | ||
02UH47Z | Supplement Pulmonary Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02UH48Z | Supplement Pulmonary Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02UH4JZ | Supplement Pulmonary Valve with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02UH4KZ | Supplement Pulmonary Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02UJ07Z | Supplement Tricuspid Valve with Autologous Tissue Substitute, Open Approach | ||
02UJ08Z | Supplement Tricuspid Valve with Zooplastic Tissue, Open Approach | ||
02UJ0JZ | Supplement Tricuspid Valve with Synthetic Substitute, Open Approach | ||
02UJ0KZ | Supplement Tricuspid Valve with Nonautologous Tissue Substitute, Open Approach | ||
02UJ37Z | Supplement Tricuspid Valve with Autologous Tissue Substitute, Percutaneous Approach | ||
02UJ38Z | Supplement Tricuspid Valve with Zooplastic Tissue, Percutaneous Approach | ||
02UJ3JZ | Supplement Tricuspid Valve with Synthetic Substitute, Percutaneous Approach | ||
02UJ3KZ | Supplement Tricuspid Valve with Nonautologous Tissue Substitute, Percutaneous Approach | ||
02UJ47Z | Supplement Tricuspid Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02UJ48Z | Supplement Tricuspid Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02UJ4JZ | Supplement Tricuspid Valve with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02UJ4KZ | Supplement Tricuspid Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
35.99 | Other operations on valves of heart | 02CF0ZZ | Extirpation of Matter from Aortic Valve, Open Approach |
02CG0ZZ | Extirpation of Matter from Mitral Valve, Open Approach | ||
02CH0ZZ | Extirpation of Matter from Pulmonary Valve, Open Approach | ||
02CJ0ZZ | Extirpation of Matter from Tricuspid Valve, Open Approach | ||
02QF0ZZ | Repair Aortic Valve, Open Approach | ||
02QG0ZZ | Repair Mitral Valve, Open Approach | ||
02QH0ZZ | Repair Pulmonary Valve, Open Approach | ||
02QJ0ZZ | Repair Tricuspid Valve, Open Approach | ||
02TH0ZZ | Resection of Pulmonary Valve, Open Approach | ||
02TH3ZZ | Resection of Pulmonary Valve, Percutaneous Approach | ||
02TH4ZZ | Resection of Pulmonary Valve, Percutaneous Endoscopic Approach | ||
37.68 | Insertion of percutaneous external heart assist device | 02HA3RZ | Insertion of External Heart Assist System into Heart, Percutaneous Approach |
5A02116 | Assistance with Cardiac Output using Other Pump, Intermittent | ||
5A0211D | Assistance with Cardiac Output using Impeller Pump, Intermittent | ||
5A02216 | Assistance with Cardiac Output using Other Pump, Continuous | ||
5A0221D | Assistance with Cardiac Output using Impeller Pump, Continuous | ||
38.45 | Resection of vessel with replacement, thoracic vessels | 02RP07Z | Replacement of Pulmonary Trunk with Autologous Tissue Substitute, Open Approach |
02RP08Z | Replacement of Pulmonary Trunk with Zooplastic Tissue, Open Approach | ||
02RP0JZ | Replacement of Pulmonary Trunk with Synthetic Substitute, Open Approach | ||
02RP0KZ | Replacement of Pulmonary Trunk with Nonautologous Tissue Substitute, Open Approach | ||
02RP47Z | Replacement of Pulmonary Trunk with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RP48Z | Replacement of Pulmonary Trunk with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02RP4JZ | Replacement of Pulmonary Trunk with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02RP4KZ | Replacement of Pulmonary Trunk with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RQ07Z | Replacement of Right Pulmonary Artery with Autologous Tissue Substitute, Open Approach | ||
02RQ08Z | Replacement of Right Pulmonary Artery with Zooplastic Tissue, Open Approach | ||
02RQ0JZ | Replacement of Right Pulmonary Artery with Synthetic Substitute, Open Approach | ||
02RQ0KZ | Replacement of Right Pulmonary Artery with Nonautologous Tissue Substitute, Open Approach | ||
02RQ47Z | Replacement of Right Pulmonary Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RQ48Z | Replacement of Right Pulmonary Artery with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02RQ4JZ | Replacement of Right Pulmonary Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02RQ4KZ | Replacement of Right Pulmonary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RR07Z | Replacement of Left Pulmonary Artery with Autologous Tissue Substitute, Open Approach | ||
02RR08Z | Replacement of Left Pulmonary Artery with Zooplastic Tissue, Open Approach | ||
02RR0JZ | Replacement of Left Pulmonary Artery with Synthetic Substitute, Open Approach | ||
02RR0KZ | Replacement of Left Pulmonary Artery with Nonautologous Tissue Substitute, Open Approach | ||
02RR47Z | Replacement of Left Pulmonary Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RR48Z | Replacement of Left Pulmonary Artery with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02RR4JZ | Replacement of Left Pulmonary Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02RR4KZ | Replacement of Left Pulmonary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RS07Z | Replacement of Right Pulmonary Vein with Autologous Tissue Substitute, Open Approach | ||
02RS08Z | Replacement of Right Pulmonary Vein with Zooplastic Tissue, Open Approach | ||
02RS0JZ | Replacement of Right Pulmonary Vein with Synthetic Substitute, Open Approach | ||
02RS0KZ | Replacement of Right Pulmonary Vein with Nonautologous Tissue Substitute, Open Approach | ||
02RS47Z | Replacement of Right Pulmonary Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RS48Z | Replacement of Right Pulmonary Vein with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02RS4JZ | Replacement of Right Pulmonary Vein with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02RS4KZ | Replacement of Right Pulmonary Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RT07Z | Replacement of Left Pulmonary Vein with Autologous Tissue Substitute, Open Approach | ||
02RT08Z | Replacement of Left Pulmonary Vein with Zooplastic Tissue, Open Approach | ||
02RT0JZ | Replacement of Left Pulmonary Vein with Synthetic Substitute, Open Approach | ||
02RT0KZ | Replacement of Left Pulmonary Vein with Nonautologous Tissue Substitute, Open Approach | ||
02RT47Z | Replacement of Left Pulmonary Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RT48Z | Replacement of Left Pulmonary Vein with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02RT4JZ | Replacement of Left Pulmonary Vein with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02RT4KZ | Replacement of Left Pulmonary Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RV07Z | Replacement of Superior Vena Cava with Autologous Tissue Substitute, Open Approach | ||
02RV08Z | Replacement of Superior Vena Cava with Zooplastic Tissue, Open Approach | ||
02RV0JZ | Replacement of Superior Vena Cava with Synthetic Substitute, Open Approach | ||
02RV0KZ | Replacement of Superior Vena Cava with Nonautologous Tissue Substitute, Open Approach | ||
02RV47Z | Replacement of Superior Vena Cava with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RV48Z | Replacement of Superior Vena Cava with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02RV4JZ | Replacement of Superior Vena Cava with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02RV4KZ | Replacement of Superior Vena Cava with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02RW07Z | Replacement of Thoracic Aorta with Autologous Tissue Substitute, Open Approach | ||
02RW08Z | Replacement of Thoracic Aorta with Zooplastic Tissue, Open Approach | ||
02RW0JZ | Replacement of Thoracic Aorta with Synthetic Substitute, Open Approach | ||
02RW0KZ | Replacement of Thoracic Aorta with Nonautologous Tissue Substitute, Open Approach | ||
02RW48Z | Replacement of Thoracic Aorta with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02RW48Z | Replacement of Thoracic Aorta with Zooplastic Tissue, Percutaneous Endoscopic Approach | ||
02RW4JZ | Replacement of Thoracic Aorta with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02RW4KZ | Replacement of Thoracic Aorta with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03R007Z | Replacement of Right Internal Mammary Artery with Autologous Tissue Substitute, Open Approach | ||
03R00JZ | Replacement of Right Internal Mammary Artery with Synthetic Substitute, Open Approach | ||
03R00KZ | Replacement of Right Internal Mammary Artery with Nonautologous Tissue Substitute, Open Approach | ||
03R047Z | Replacement of Right Internal Mammary Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03R04JZ | Replacement of Right Internal Mammary Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
03R04KZ | Replacement of Right Internal Mammary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03R107Z | Replacement of Left Internal Mammary Artery with Autologous Tissue Substitute, Open Approach | ||
03R10JZ | Replacement of Left Internal Mammary Artery with Synthetic Substitute, Open Approach | ||
03R10KZ | Replacement of Left Internal Mammary Artery with Nonautologous Tissue Substitute, Open Approach | ||
03R147Z | Replacement of Left Internal Mammary Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03R14JZ | Replacement of Left Internal Mammary Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
03R14KZ | Replacement of Left Internal Mammary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03R207Z | Replacement of Innominate Artery with Autologous Tissue Substitute, Open Approach | ||
03R20JZ | Replacement of Innominate Artery with Synthetic Substitute, Open Approach | ||
03R20KZ | Replacement of Innominate Artery with Nonautologous Tissue Substitute, Open Approach | ||
03R247Z | Replacement of Innominate Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03R24JZ | Replacement of Innominate Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
03R24KZ | Replacement of Innominate Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03R307Z | Replacement of Right Subclavian Artery with Autologous Tissue Substitute, Open Approach | ||
03R30JZ | Replacement of Right Subclavian Artery with Synthetic Substitute, Open Approach | ||
03R30KZ | Replacement of Right Subclavian Artery with Nonautologous Tissue Substitute, Open Approach | ||
03R347Z | Replacement of Right Subclavian Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03R34JZ | Replacement of Right Subclavian Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
03R34KZ | Replacement of Right Subclavian Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03R407Z | Replacement of Left Subclavian Artery with Autologous Tissue Substitute, Open Approach | ||
03R40JZ | Replacement of Left Subclavian Artery with Synthetic Substitute, Open Approach | ||
03R40KZ | Replacement of Left Subclavian Artery with Nonautologous Tissue Substitute, Open Approach | ||
03R447Z | Replacement of Left Subclavian Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03R44JZ | Replacement of Left Subclavian Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
03R44KZ | Replacement of Left Subclavian Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05R007Z | Replacement of Azygos Vein with Autologous Tissue Substitute, Open Approach | ||
05R00JZ | Replacement of Azygos Vein with Synthetic Substitute, Open Approach | ||
05R00KZ | Replacement of Azygos Vein with Nonautologous Tissue Substitute, Open Approach | ||
05R047Z | Replacement of Azygos Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05R04JZ | Replacement of Azygos Vein with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
05R04KZ | Replacement of Azygos Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05R107Z | Replacement of Hemiazygos Vein with Autologous Tissue Substitute, Open Approach | ||
05R10JZ | Replacement of Hemiazygos Vein with Synthetic Substitute, Open Approach | ||
05R10KZ | Replacement of Hemiazygos Vein with Nonautologous Tissue Substitute, Open Approach | ||
05R147Z | Replacement of Hemiazygos Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05R14JZ | Replacement of Hemiazygos Vein with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
05R14KZ | Replacement of Hemiazygos Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05R307Z | Replacement of Right Innominate Vein with Autologous Tissue Substitute, Open Approach | ||
05R30JZ | Replacement of Right Innominate Vein with Synthetic Substitute, Open Approach | ||
05R30KZ | Replacement of Right Innominate Vein with Nonautologous Tissue Substitute, Open Approach | ||
05R347Z | Replacement of Right Innominate Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05R34JZ | Replacement of Right Innominate Vein with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
05R34KZ | Replacement of Right Innominate Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05R407Z | Replacement of Left Innominate Vein with Autologous Tissue Substitute, Open Approach | ||
05R407Z | Replacement of Left Innominate Vein with Autologous Tissue Substitute, Open Approach | ||
05R40JZ | Replacement of Left Innominate Vein with Synthetic Substitute, Open Approach | ||
05R40JZ | Replacement of Left Innominate Vein with Synthetic Substitute, Open Approach | ||
05R40KZ | Replacement of Left Innominate Vein with Nonautologous Tissue Substitute, Open Approach | ||
05R40KZ | Replacement of Left Innominate Vein with Nonautologous Tissue Substitute, Open Approach | ||
05R447Z | Replacement of Left Innominate Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05R447Z | Replacement of Left Innominate Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05R44JZ | Replacement of Left Innominate Vein with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
05R44JZ | Replacement of Left Innominate Vein with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
05R44KZ | Replacement of Left Innominate Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05R44KZ | Replacement of Left Innominate Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05R607Z | Replacement of Left Subclavian Vein with Autologous Tissue Substitute, Open Approach | ||
05R60JZ | Replacement of Left Subclavian Vein with Synthetic Substitute, Open Approach | ||
05R60KZ | Replacement of Left Subclavian Vein with Nonautologous Tissue Substitute, Open Approach | ||
05R647Z | Replacement of Left Subclavian Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05R64JZ | Replacement of Left Subclavian Vein with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
05R64KZ | Replacement of Left Subclavian Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
38.91 | Arterial catheterization | 02HP03Z | Insertion of Infusion Device into Pulmonary Trunk, Open Approach |
02HP33Z | Insertion of Infusion Device into Pulmonary Trunk, Percutaneous Approach | ||
02HP43Z | Insertion of Infusion Device into Pulmonary Trunk, Percutaneous Endoscopic Approach | ||
02HQ03Z | Insertion of Infusion Device into Right Pulmonary Artery, Open Approach | ||
02HQ33Z | Insertion of Infusion Device into Right Pulmonary Artery, Percutaneous Approach | ||
02HQ43Z | Insertion of Infusion Device into Right Pulmonary Artery, Percutaneous Endoscopic Approach | ||
02HR03Z | Insertion of Infusion Device into Left Pulmonary Artery, Open Approach | ||
02HR33Z | Insertion of Infusion Device into Left Pulmonary Artery, Percutaneous Approach | ||
02HR43Z | Insertion of Infusion Device into Left Pulmonary Artery, Percutaneous Endoscopic Approach | ||
02HW03Z | Insertion of Infusion Device into Thoracic Aorta, Open Approach | ||
02HW33Z | Insertion of Infusion Device into Thoracic Aorta, Percutaneous Approach | ||
02HW43Z | Insertion of Infusion Device into Thoracic Aorta, Percutaneous Endoscopic Approach | ||
03H003Z | Insertion of Infusion Device into Right Internal Mammary Artery, Open Approach | ||
03H033Z | Insertion of Infusion Device into Right Internal Mammary Artery, Percutaneous Approach | ||
03H043Z | Insertion of Infusion Device into Right Internal Mammary Artery, Percutaneous Endoscopic Approach | ||
03H103Z | Insertion of Infusion Device into Left Internal Mammary Artery, Open Approach | ||
03H133Z | Insertion of Infusion Device into Left Internal Mammary Artery, Percutaneous Approach | ||
03H143Z | Insertion of Infusion Device into Left Internal Mammary Artery, Percutaneous Endoscopic Approach | ||
03H203Z | Insertion of Infusion Device into Innominate Artery, Open Approach | ||
03H233Z | Insertion of Infusion Device into Innominate Artery, Percutaneous Approach | ||
03H243Z | Insertion of Infusion Device into Innominate Artery, Percutaneous Endoscopic Approach | ||
03H303Z | Insertion of Infusion Device into Right Subclavian Artery, Open Approach | ||
03H333Z | Insertion of Infusion Device into Right Subclavian Artery, Percutaneous Approach | ||
03H343Z | Insertion of Infusion Device into Right Subclavian Artery, Percutaneous Endoscopic Approach | ||
03H403Z | Insertion of Infusion Device into Left Subclavian Artery, Open Approach | ||
03H433Z | Insertion of Infusion Device into Left Subclavian Artery, Percutaneous Approach | ||
03H443Z | Insertion of Infusion Device into Left Subclavian Artery, Percutaneous Endoscopic Approach | ||
03H503Z | Insertion of Infusion Device into Right Axillary Artery, Open Approach | ||
03H533Z | Insertion of Infusion Device into Right Axillary Artery, Percutaneous Approach | ||
03H543Z | Insertion of Infusion Device into Right Axillary Artery, Percutaneous Endoscopic Approach | ||
03H603Z | Insertion of Infusion Device into Left Axillary Artery, Open Approach | ||
03H633Z | Insertion of Infusion Device into Left Axillary Artery, Percutaneous Approach | ||
03H643Z | Insertion of Infusion Device into Left Axillary Artery, Percutaneous Endoscopic Approach | ||
03H703Z | Insertion of Infusion Device into Right Brachial Artery, Open Approach | ||
03H733Z | Insertion of Infusion Device into Right Brachial Artery, Percutaneous Approach | ||
03H743Z | Insertion of Infusion Device into Right Brachial Artery, Percutaneous Endoscopic Approach | ||
03H803Z | Insertion of Infusion Device into Left Brachial Artery, Open Approach | ||
03H833Z | Insertion of Infusion Device into Left Brachial Artery, Percutaneous Approach | ||
03H843Z | Insertion of Infusion Device into Left Brachial Artery, Percutaneous Endoscopic Approach | ||
03H903Z | Insertion of Infusion Device into Right Ulnar Artery, Open Approach | ||
03H933Z | Insertion of Infusion Device into Right Ulnar Artery, Percutaneous Approach | ||
03H943Z | Insertion of Infusion Device into Right Ulnar Artery, Percutaneous Endoscopic Approach | ||
03HA03Z | Insertion of Infusion Device into Left Ulnar Artery, Open Approach | ||
03HA33Z | Insertion of Infusion Device into Left Ulnar Artery, Percutaneous Approach | ||
03HA43Z | Insertion of Infusion Device into Left Ulnar Artery, Percutaneous Endoscopic Approach | ||
03HB03Z | Insertion of Infusion Device into Right Radial Artery, Open Approach | ||
03HB33Z | Insertion of Infusion Device into Right Radial Artery, Percutaneous Approach | ||
03HB43Z | Insertion of Infusion Device into Right Radial Artery, Percutaneous Endoscopic Approach | ||
03HC03Z | Insertion of Infusion Device into Left Radial Artery, Open Approach | ||
03HC33Z | Insertion of Infusion Device into Left Radial Artery, Percutaneous Approach | ||
03HC43Z | Insertion of Infusion Device into Left Radial Artery, Percutaneous Endoscopic Approach | ||
03HD03Z | Insertion of Infusion Device into Right Hand Artery, Open Approach | ||
03HD33Z | Insertion of Infusion Device into Right Hand Artery, Percutaneous Approach | ||
03HD43Z | Insertion of Infusion Device into Right Hand Artery, Percutaneous Endoscopic Approach | ||
03HF03Z | Insertion of Infusion Device into Left Hand Artery, Open Approach | ||
03HF33Z | Insertion of Infusion Device into Left Hand Artery, Percutaneous Approach | ||
03HF43Z | Insertion of Infusion Device into Left Hand Artery, Percutaneous Endoscopic Approach | ||
03HG03Z | Insertion of Infusion Device into Intracranial Artery, Open Approach | ||
03HG33Z | Insertion of Infusion Device into Intracranial Artery, Percutaneous Approach | ||
03HG43Z | Insertion of Infusion Device into Intracranial Artery, Percutaneous Endoscopic Approach | ||
03HH03Z | Insertion of Infusion Device into Right Common Carotid Artery, Open Approach | ||
03HH33Z | Insertion of Infusion Device into Right Common Carotid Artery, Percutaneous Approach | ||
03HH43Z | Insertion of Infusion Device into Right Common Carotid Artery, Percutaneous Endoscopic Approach | ||
03HJ03Z | Insertion of Infusion Device into Left Common Carotid Artery, Open Approach | ||
03HJ33Z | Insertion of Infusion Device into Left Common Carotid Artery, Percutaneous Approach | ||
03HJ43Z | Insertion of Infusion Device into Left Common Carotid Artery, Percutaneous Endoscopic Approach | ||
03HK03Z | Insertion of Infusion Device into Right Internal Carotid Artery, Open Approach | ||
03HK33Z | Insertion of Infusion Device into Right Internal Carotid Artery, Percutaneous Approach | ||
03HK43Z | Insertion of Infusion Device into Right Internal Carotid Artery, Percutaneous Endoscopic Approach | ||
03HL03Z | Insertion of Infusion Device into Left Internal Carotid Artery, Open Approach | ||
03HL33Z | Insertion of Infusion Device into Left Internal Carotid Artery, Percutaneous Approach | ||
03HL43Z | Insertion of Infusion Device into Left Internal Carotid Artery, Percutaneous Endoscopic Approach | ||
03HM03Z | Insertion of Infusion Device into Right External Carotid Artery, Open Approach | ||
03HM33Z | Insertion of Infusion Device into Right External Carotid Artery, Percutaneous Approach | ||
03HM43Z | Insertion of Infusion Device into Right External Carotid Artery, Percutaneous Endoscopic Approach | ||
03HN03Z | Insertion of Infusion Device into Left External Carotid Artery, Open Approach | ||
03HN33Z | Insertion of Infusion Device into Left External Carotid Artery, Percutaneous Approach | ||
03HN43Z | Insertion of Infusion Device into Left External Carotid Artery, Percutaneous Endoscopic Approach | ||
03HP03Z | Insertion of Infusion Device into Right Vertebral Artery, Open Approach | ||
03HP33Z | Insertion of Infusion Device into Right Vertebral Artery, Percutaneous Approach | ||
03HP43Z | Insertion of Infusion Device into Right Vertebral Artery, Percutaneous Endoscopic Approach | ||
03HQ03Z | Insertion of Infusion Device into Left Vertebral Artery, Open Approach | ||
03HQ33Z | Insertion of Infusion Device into Left Vertebral Artery, Percutaneous Approach | ||
03HQ43Z | Insertion of Infusion Device into Left Vertebral Artery, Percutaneous Endoscopic Approach | ||
03HR03Z | Insertion of Infusion Device into Face Artery, Open Approach | ||
03HR33Z | Insertion of Infusion Device into Face Artery, Percutaneous Approach | ||
03HR43Z | Insertion of Infusion Device into Face Artery, Percutaneous Endoscopic Approach | ||
03HS03Z | Insertion of Infusion Device into Right Temporal Artery, Open Approach | ||
03HS33Z | Insertion of Infusion Device into Right Temporal Artery, Percutaneous Approach | ||
03HS43Z | Insertion of Infusion Device into Right Temporal Artery, Percutaneous Endoscopic Approach | ||
03HT03Z | Insertion of Infusion Device into Left Temporal Artery, Open Approach | ||
03HT33Z | Insertion of Infusion Device into Left Temporal Artery, Percutaneous Approach | ||
03HT43Z | Insertion of Infusion Device into Left Temporal Artery, Percutaneous Endoscopic Approach | ||
03HU03Z | Insertion of Infusion Device into Right Thyroid Artery, Open Approach | ||
03HU33Z | Insertion of Infusion Device into Right Thyroid Artery, Percutaneous Approach | ||
03HU43Z | Insertion of Infusion Device into Right Thyroid Artery, Percutaneous Endoscopic Approach | ||
03HV03Z | Insertion of Infusion Device into Left Thyroid Artery, Open Approach | ||
03HV33Z | Insertion of Infusion Device into Left Thyroid Artery, Percutaneous Approach | ||
03HV43Z | Insertion of Infusion Device into Left Thyroid Artery, Percutaneous Endoscopic Approach | ||
03HY03Z | Insertion of Infusion Device into Upper Artery, Open Approach | ||
03HY33Z | Insertion of Infusion Device into Upper Artery, Percutaneous Approach | ||
03HY43Z | Insertion of Infusion Device into Upper Artery, Percutaneous Endoscopic Approach | ||
04H003Z | Insertion of Infusion Device into Abdominal Aorta, Open Approach | ||
04H033Z | Insertion of Infusion Device into Abdominal Aorta, Percutaneous Approach | ||
04H043Z | Insertion of Infusion Device into Abdominal Aorta, Percutaneous Endoscopic Approach | ||
04H103Z | Insertion of Infusion Device into Celiac Artery, Open Approach | ||
04H133Z | Insertion of Infusion Device into Celiac Artery, Percutaneous Approach | ||
04H143Z | Insertion of Infusion Device into Celiac Artery, Percutaneous Endoscopic Approach | ||
04H203Z | Insertion of Infusion Device into Gastric Artery, Open Approach | ||
04H233Z | Insertion of Infusion Device into Gastric Artery, Percutaneous Approach | ||
04H243Z | Insertion of Infusion Device into Gastric Artery, Percutaneous Endoscopic Approach | ||
04H303Z | Insertion of Infusion Device into Hepatic Artery, Open Approach | ||
04H333Z | Insertion of Infusion Device into Hepatic Artery, Percutaneous Approach | ||
04H343Z | Insertion of Infusion Device into Hepatic Artery, Percutaneous Endoscopic Approach | ||
04H403Z | Insertion of Infusion Device into Splenic Artery, Open Approach | ||
04H433Z | Insertion of Infusion Device into Splenic Artery, Percutaneous Approach | ||
04H443Z | Insertion of Infusion Device into Splenic Artery, Percutaneous Endoscopic Approach | ||
04H503Z | Insertion of Infusion Device into Superior Mesenteric Artery, Open Approach | ||
04H533Z | Insertion of Infusion Device into Superior Mesenteric Artery, Percutaneous Approach | ||
04H543Z | Insertion of Infusion Device into Superior Mesenteric Artery, Percutaneous Endoscopic Approach | ||
04H603Z | Insertion of Infusion Device into Right Colic Artery, Open Approach | ||
04H633Z | Insertion of Infusion Device into Right Colic Artery, Percutaneous Approach | ||
04H643Z | Insertion of Infusion Device into Right Colic Artery, Percutaneous Endoscopic Approach | ||
04H703Z | Insertion of Infusion Device into Left Colic Artery, Open Approach | ||
04H733Z | Insertion of Infusion Device into Left Colic Artery, Percutaneous Approach | ||
04H743Z | Insertion of Infusion Device into Left Colic Artery, Percutaneous Endoscopic Approach | ||
04H803Z | Insertion of Infusion Device into Middle Colic Artery, Open Approach | ||
04H833Z | Insertion of Infusion Device into Middle Colic Artery, Percutaneous Approach | ||
04H843Z | Insertion of Infusion Device into Middle Colic Artery, Percutaneous Endoscopic Approach | ||
04H903Z | Insertion of Infusion Device into Right Renal Artery, Open Approach | ||
04H933Z | Insertion of Infusion Device into Right Renal Artery, Percutaneous Approach | ||
04H943Z | Insertion of Infusion Device into Right Renal Artery, Percutaneous Endoscopic Approach | ||
04HA33Z | Insertion of Infusion Device into Left Renal Artery, Open Approach | ||
02QJ4ZZ | Insertion of Infusion Device into Left Renal Artery, Percutaneous Approach | ||
04HA43Z | Insertion of Infusion Device into Left Renal Artery, Percutaneous Endoscopic Approach | ||
04HB03Z | Insertion of Infusion Device into Inferior Mesenteric Artery, Open Approach | ||
04HB33Z | Insertion of Infusion Device into Inferior Mesenteric Artery, Percutaneous Approach | ||
04HB43Z | Insertion of Infusion Device into Inferior Mesenteric Artery, Percutaneous Endoscopic Approach | ||
04HC03Z | Insertion of Infusion Device into Right Common Iliac Artery, Open Approach | ||
04HC33Z | Insertion of Infusion Device into Right Common Iliac Artery, Percutaneous Approach | ||
04HC43Z | Insertion of Infusion Device into Right Common Iliac Artery, Percutaneous Endoscopic Approach | ||
04HD03Z | Insertion of Infusion Device into Left Common Iliac Artery, Open Approach | ||
04HD33Z | Insertion of Infusion Device into Left Common Iliac Artery, Percutaneous Approach | ||
04HD43Z | Insertion of Infusion Device into Left Common Iliac Artery, Percutaneous Endoscopic Approach | ||
04HE03Z | Insertion of Infusion Device into Right Internal Iliac Artery, Open Approach | ||
04HE33Z | Insertion of Infusion Device into Right Internal Iliac Artery, Percutaneous Approach | ||
04HE43Z | Insertion of Infusion Device into Right Internal Iliac Artery, Percutaneous Endoscopic Approach | ||
04HF03Z | Insertion of Infusion Device into Left Internal Iliac Artery, Open Approach | ||
04HF33Z | Insertion of Infusion Device into Left Internal Iliac Artery, Percutaneous Approach | ||
04HF43Z | Insertion of Infusion Device into Left Internal Iliac Artery, Percutaneous Endoscopic Approach | ||
04HH03Z | Insertion of Infusion Device into Right External Iliac Artery, Open Approach | ||
04HH33Z | Insertion of Infusion Device into Right External Iliac Artery, Percutaneous Approach | ||
04HH43Z | Insertion of Infusion Device into Right External Iliac Artery, Percutaneous Endoscopic Approach | ||
04HJ03Z | Insertion of Infusion Device into Left External Iliac Artery, Open Approach | ||
04HJ33Z | Insertion of Infusion Device into Left External Iliac Artery, Percutaneous Approach | ||
04HJ43Z | Insertion of Infusion Device into Left External Iliac Artery, Percutaneous Endoscopic Approach | ||
04HK03Z | Insertion of Infusion Device into Right Femoral Artery, Open Approach | ||
04HK33Z | Insertion of Infusion Device into Right Femoral Artery, Percutaneous Approach | ||
04HK43Z | Insertion of Infusion Device into Right Femoral Artery, Percutaneous Endoscopic Approach | ||
04HL03Z | Insertion of Infusion Device into Left Femoral Artery, Open Approach | ||
04HL33Z | Insertion of Infusion Device into Left Femoral Artery, Percutaneous Approach | ||
04HL43Z | Insertion of Infusion Device into Left Femoral Artery, Percutaneous Endoscopic Approach | ||
04HM03Z | Insertion of Infusion Device into Right Popliteal Artery, Open Approach | ||
04HM33Z | Insertion of Infusion Device into Right Popliteal Artery, Percutaneous Approach | ||
04HM43Z | Insertion of Infusion Device into Right Popliteal Artery, Percutaneous Endoscopic Approach | ||
04HN03Z | Insertion of Infusion Device into Left Popliteal Artery, Open Approach | ||
04HN33Z | Insertion of Infusion Device into Left Popliteal Artery, Percutaneous Approach | ||
04HN43Z | Insertion of Infusion Device into Left Popliteal Artery, Percutaneous Endoscopic Approach | ||
04HP03Z | Insertion of Infusion Device into Right Anterior Tibial Artery, Open Approach | ||
04HP33Z | Insertion of Infusion Device into Right Anterior Tibial Artery, Percutaneous Approach | ||
04HP43Z | Insertion of Infusion Device into Right Anterior Tibial Artery, Percutaneous Endoscopic Approach | ||
04HQ03Z | Insertion of Infusion Device into Left Anterior Tibial Artery, Open Approach | ||
04HQ33Z | Insertion of Infusion Device into Left Anterior Tibial Artery, Percutaneous Approach | ||
04HQ43Z | Insertion of Infusion Device into Left Anterior Tibial Artery, Percutaneous Endoscopic Approach | ||
04HR03Z | Insertion of Infusion Device into Right Posterior Tibial Artery, Open Approach | ||
04HR33Z | Insertion of Infusion Device into Right Posterior Tibial Artery, Percutaneous Approach | ||
04HR43Z | Insertion of Infusion Device into Right Posterior Tibial Artery, Percutaneous Endoscopic Approach | ||
04HS03Z | Insertion of Infusion Device into Left Posterior Tibial Artery, Open Approach | ||
04HS33Z | Insertion of Infusion Device into Left Posterior Tibial Artery, Percutaneous Approach | ||
04HS43Z | Insertion of Infusion Device into Left Posterior Tibial Artery, Percutaneous Endoscopic Approach | ||
04HT03Z | Insertion of Infusion Device into Right Peroneal Artery, Open Approach | ||
04HT33Z | Insertion of Infusion Device into Right Peroneal Artery, Percutaneous Approach | ||
04HT43Z | Insertion of Infusion Device into Right Peroneal Artery, Percutaneous Endoscopic Approach | ||
04HU03Z | Insertion of Infusion Device into Left Peroneal Artery, Open Approach | ||
04HU33Z | Insertion of Infusion Device into Left Peroneal Artery, Percutaneous Approach | ||
04HU43Z | Insertion of Infusion Device into Left Peroneal Artery, Percutaneous Endoscopic Approach | ||
02NH3ZZ | Release Pulmonary Valve, Percutaneous Approach | ||
02NH4ZZ | Release Pulmonary Valve, Percutaneous Endoscopic Approach | ||
04HV03Z | Insertion of Infusion Device into Right Foot Artery, Open Approach | ||
04HV33Z | Insertion of Infusion Device into Right Foot Artery, Percutaneous Approach | ||
04HV43Z | Insertion of Infusion Device into Right Foot Artery, Percutaneous Endoscopic Approach | ||
04HW03Z | Insertion of Infusion Device into Left Foot Artery, Open Approach | ||
04HW33Z | Insertion of Infusion Device into Left Foot Artery, Percutaneous Approach | ||
04HW43Z | Insertion of Infusion Device into Left Foot Artery, Percutaneous Endoscopic Approach | ||
04HY03Z | Insertion of Infusion Device into Lower Artery, Open Approach | ||
04HY33Z | Insertion of Infusion Device into Lower Artery, Percutaneous Approach | ||
04HY43Z | Insertion of Infusion Device into Lower Artery, Percutaneous Endoscopic Approach | ||
39.73 | Endovascular implantation of graft in thoracic aorta | 02UW3JZ | Supplement Thoracic Aorta with Synthetic Substitute, Percutaneous Approach |
02UW4JZ | Supplement Thoracic Aorta with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02VW0DZ | Restriction of Thoracic Aorta with Intraluminal Device, Open Approach | ||
02VW3DZ | Restriction of Thoracic Aorta with Intraluminal Device, Percutaneous Approach | ||
02VW4DZ | Restriction of Thoracic Aorta with Intraluminal Device, Percutaneous Endoscopic Approach | ||
88.72 | Diagnostic ultrasound of heart | B240YZZ | Ultrasonography of Single Coronary Artery using Other Contrast |
B240ZZ4 | Ultrasonography of Single Coronary Artery, Transesophageal | ||
B240ZZZ | Ultrasonography of Single Coronary Artery | ||
B241YZZ | Ultrasonography of Multiple Coronary Arteries using Other Contrast | ||
B241ZZ4 | Ultrasonography of Multiple Coronary Arteries, Transesophageal | ||
B241ZZZ | Ultrasonography of Multiple Coronary Arteries | ||
B244YZZ | Ultrasonography of Right Heart using Other Contrast | ||
B244ZZ4 | Ultrasonography of Right Heart, Transesophageal | ||
B244ZZZ | Ultrasonography of Right Heart | ||
B245YZZ | Ultrasonography of Left Heart using Other Contrast | ||
B245ZZ4 | Ultrasonography of Left Heart, Transesophageal | ||
B245ZZZ | Ultrasonography of Left Heart | ||
B246YZZ | Ultrasonography of Right and Left Heart using Other Contrast | ||
B246ZZ4 | Ultrasonography of Right and Left Heart, Transesophageal | ||
B246ZZZ | Ultrasonography of Right and Left Heart | ||
B24BYZZ | Ultrasonography of Heart with Aorta using Other Contrast | ||
B24BZZ4 | Ultrasonography of Heart with Aorta, Transesophageal | ||
B24BZZZ | Ultrasonography of Heart with Aorta | ||
B24CYZZ | Ultrasonography of Pericardium using Other Contrast | ||
B24CZZ4 | Ultrasonography of Pericardium, Transesophageal | ||
B24CZZZ | Ultrasonography of Pericardium | ||
B24DYZZ | Ultrasonography of Pediatric Heart using Other Contrast | ||
B24DZZ4 | Ultrasonography of Pediatric Heart, Transesophageal | ||
B24DZZZ | Ultrasonography of Pediatric Heart | ||
ICD-9-CM Procedure Code | Description | ICD-10-PCS Procedure Code | Description |
---|---|---|---|
36.10 | Aortocoronary bypass for heart revascularization, not otherwise specified | 0210093 | Bypass Coronary Artery, One Site from Coronary Artery with Autologous Venous Tissue, Open Approach |
0210493 | Bypass Coronary Artery, One Site from Coronary Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
02100A3 | Bypass Coronary Artery, One Site from Coronary Artery with Autologous Arterial Tissue, Open Approach | ||
02100J3 | Bypass Coronary Artery, One Site from Coronary Artery with Synthetic Substitute, Open Approach | ||
02100K3 | Bypass Coronary Artery, One Site from Coronary Artery with Nonautologous Tissue Substitute, Open Approach | ||
02100Z3 | Bypass Coronary Artery, One Site from Coronary Artery, Open Approach | ||
02104A3 | Bypass Coronary Artery, One Site from Coronary Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02104J3 | Bypass Coronary Artery, One Site from Coronary Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02104K3 | Bypass Coronary Artery, One Site from Coronary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02104Z3 | Bypass Coronary Artery, One Site from Coronary Artery, Percutaneous Endoscopic Approach | ||
36.11 | (Aorto)coronary bypass of one coronary artery | 021009W | Bypass Coronary Artery, One Site from Aorta with Autologous Venous Tissue, Open Approach |
02100AW | Bypass Coronary Artery, One Site from Aorta with Autologous Arterial Tissue, Open Approach | ||
02100JW | Bypass Coronary Artery, One Site from Aorta with Synthetic Substitute, Open Approach | ||
02100KW | Bypass Coronary Artery, One Site from Aorta with Nonautologous Tissue Substitute, Open Approach | ||
021049W | Bypass Coronary Artery, One Site from Aorta with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
02104AW | Bypass Coronary Artery, One Site from Aorta with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02104JW | Bypass Coronary Artery, One Site from Aorta with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02104KW | Bypass Coronary Artery, One Site from Aorta with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
36.12 | (Aorto)coronary bypass of two coronary artery | 021109W | Bypass Coronary Artery, Two Sites from Aorta with Autologous Venous Tissue, Open Approach |
02110AW | Bypass Coronary Artery, Two Sites from Aorta with Autologous Arterial Tissue, Open Approach | ||
02110JW | Bypass Coronary Artery, Two Sites from Aorta with Synthetic Substitute, Open Approach | ||
02110KW | Bypass Coronary Artery, Two Sites from Aorta with Nonautologous Tissue Substitute, Open Approach | ||
021149W | Bypass Coronary Artery, Two Sites from Aorta with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
02114AW | Bypass Coronary Artery, Two Sites from Aorta with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02114JW | Bypass Coronary Artery, Two Sites from Aorta with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02114KW | Bypass Coronary Artery, Two Sites from Aorta with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
36.13 | (Aorto)coronary bypass of three coronary artery | 021209W | Bypass Coronary Artery, Three Sites from Aorta with Autologous Venous Tissue, Open Approach |
02120AW | Bypass Coronary Artery, Three Sites from Aorta with Autologous Arterial Tissue, Open Approach | ||
02120JW | Bypass Coronary Artery, Three Sites from Aorta with Synthetic Substitute, Open Approach | ||
02120KW | Bypass Coronary Artery, Three Sites from Aorta with Nonautologous Tissue Substitute, Open Approach | ||
021249W | Bypass Coronary Artery, Three Sites from Aorta with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
02124AW | Bypass Coronary Artery, Three Sites from Aorta with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02124JW | Bypass Coronary Artery, Three Sites from Aorta with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02124KW | Bypass Coronary Artery, Three Sites from Aorta with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
36.14 | (Aorto)coronary bypass of four or more coronary artery | 021309W | Bypass Coronary Artery, Four or More Sites from Aorta with Autologous Venous Tissue, Open Approach |
02130AW | Bypass Coronary Artery, Four or More Sites from Aorta with Autologous Arterial Tissue, Open Approach | ||
02130JW | Bypass Coronary Artery, Four or More Sites from Aorta with Synthetic Substitute, Open Approach | ||
02130KW | Bypass Coronary Artery, Four or More Sites from Aorta with Nonautologous Tissue Substitute, Open Approach | ||
021349W | Bypass Coronary Artery, Four or More Sites from Aorta with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
02134AW | Bypass Coronary Artery, Four or More Sites from Aorta with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02134JW | Bypass Coronary Artery, Four or More Sites from Aorta with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02134KW | Bypass Coronary Artery, Four or More Sites from Aorta with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
36.15 | Single internal mammary-coronary artery bypass | 0210098 | Bypass Coronary Artery, One Site from Right Internal Mammary with Autologous Venous Tissue, Open Approach |
0210099 | Bypass Coronary Artery, One Site from Left Internal Mammary with Autologous Venous Tissue, Open Approach | ||
0210498 | Bypass Coronary Artery, One Site from Right Internal Mammary with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
0210499 | Bypass Coronary Artery, One Site from Left Internal Mammary with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
021009C | Bypass Coronary Artery, One Site from Thoracic Artery with Autologous Venous Tissue, Open Approach | ||
02100A8 | Bypass Coronary Artery, One Site from Right Internal Mammary with Autologous Arterial Tissue, Open Approach | ||
02100A9 | Bypass Coronary Artery, One Site from Left Internal Mammary with Autologous Arterial Tissue, Open Approach | ||
02100AC | Bypass Coronary Artery, One Site from Thoracic Artery with Autologous Arterial Tissue, Open Approach | ||
02100J8 | Bypass Coronary Artery, One Site from Right Internal Mammary with Synthetic Substitute, Open Approach | ||
02100J9 | Bypass Coronary Artery, One Site from Left Internal Mammary with Synthetic Substitute, Open Approach | ||
02100JC | Bypass Coronary Artery, One Site from Thoracic Artery with Synthetic Substitute, Open Approach | ||
02100K8 | Bypass Coronary Artery, One Site from Right Internal Mammary with Nonautologous Tissue Substitute, Open Approach | ||
02100K9 | Bypass Coronary Artery, One Site from Left Internal Mammary with Nonautologous Tissue Substitute, Open Approach | ||
02100KC | Bypass Coronary Artery, One Site from Thoracic Artery with Nonautologous Tissue Substitute, Open Approach | ||
02100Z8 | Bypass Coronary Artery, One Site from Right Internal Mammary, Open Approach | ||
02100Z9 | Bypass Coronary Artery, One Site from Left Internal Mammary, Open Approach | ||
02100ZC | Bypass Coronary Artery, One Site from Thoracic Artery, Open Approach | ||
021049C | Bypass Coronary Artery, One Site from Thoracic Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
02104A8 | Bypass Coronary Artery, One Site from Right Internal Mammary with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02104A9 | Bypass Coronary Artery, One Site from Left Internal Mammary with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02104AC | Bypass Coronary Artery, One Site from Thoracic Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02104J8 | Bypass Coronary Artery, One Site from Right Internal Mammary with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02104J9 | Bypass Coronary Artery, One Site from Left Internal Mammary with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02104JC | Bypass Coronary Artery, One Site from Thoracic Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02104K8 | Bypass Coronary Artery, One Site from Right Internal Mammary with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02104K9 | Bypass Coronary Artery, One Site from Left Internal Mammary with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02104KC | Bypass Coronary Artery, One Site from Thoracic Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02104Z8 | Bypass Coronary Artery, One Site from Right Internal Mammary, Percutaneous Endoscopic Approach | ||
02104Z9 | Bypass Coronary Artery, One Site from Left Internal Mammary, Percutaneous Endoscopic Approach | ||
02104ZC | Bypass Coronary Artery, One Site from Thoracic Artery, Percutaneous Endoscopic Approach | ||
36.16 | Double internal mammary-coronary artery bypass | 0211098 | Bypass Coronary Artery, Two Sites from Right Internal Mammary with Autologous Venous Tissue, Open Approach |
0211099 | Bypass Coronary Artery, Two Sites from Left Internal Mammary with Autologous Venous Tissue, Open Approach | ||
0211498 | Bypass Coronary Artery, Two Sites from Right Internal Mammary with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
0211499 | Bypass Coronary Artery, Two Sites from Left Internal Mammary with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
0212098 | Bypass Coronary Artery, Three Sites from Right Internal Mammary with Autologous Venous Tissue, Open Approach | ||
0212099 | Bypass Coronary Artery, Three Sites from Left Internal Mammary with Autologous Venous Tissue, Open Approach | ||
0212498 | Bypass Coronary Artery, Three Sites from Right Internal Mammary with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
0212499 | Bypass Coronary Artery, Three Sites from Left Internal Mammary with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
0213098 | Bypass Coronary Artery, Four or More Sites from Right Internal Mammary with Autologous Venous Tissue, Open Approach | ||
0213099 | Bypass Coronary Artery, Four or More Sites from Left Internal Mammary with Autologous Venous Tissue, Open Approach | ||
0213498 | Bypass Coronary Artery, Four or More Sites from Right Internal Mammary with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
0213499 | Bypass Coronary Artery, Four or More Sites from Left Internal Mammary with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
021109C | Bypass Coronary Artery, Two Sites from Thoracic Artery with Autologous Venous Tissue, Open Approach | ||
02110A8 | Bypass Coronary Artery, Two Sites from Right Internal Mammary with Autologous Arterial Tissue, Open Approach | ||
02110A9 | Bypass Coronary Artery, Two Sites from Left Internal Mammary with Autologous Arterial Tissue, Open Approach | ||
02110AC | Bypass Coronary Artery, Two Sites from Thoracic Artery with Autologous Arterial Tissue, Open Approach | ||
02110J8 | Bypass Coronary Artery, Two Sites from Right Internal Mammary with Synthetic Substitute, Open Approach | ||
02110J9 | Bypass Coronary Artery, Two Sites from Left Internal Mammary with Synthetic Substitute, Open Approach | ||
02110JC | Bypass Coronary Artery, Two Sites from Thoracic Artery with Synthetic Substitute, Open Approach | ||
02110K8 | Bypass Coronary Artery, Two Sites from Right Internal Mammary with Nonautologous Tissue Substitute, Open Approach | ||
02110K9 | Bypass Coronary Artery, Two Sites from Left Internal Mammary with Nonautologous Tissue Substitute, Open Approach | ||
02110KC | Bypass Coronary Artery, Two Sites from Thoracic Artery with Nonautologous Tissue Substitute, Open Approach | ||
02110Z8 | Bypass Coronary Artery, Two Sites from Right Internal Mammary, Open Approach | ||
02110Z9 | Bypass Coronary Artery, Two Sites from Left Internal Mammary, Open Approach | ||
02110ZC | Bypass Coronary Artery, Two Sites from Thoracic Artery, Open Approach | ||
021149C | Bypass Coronary Artery, Two Sites from Thoracic Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
02114A8 | Bypass Coronary Artery, Two Sites from Right Internal Mammary with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02114A9 | Bypass Coronary Artery, Two Sites from Left Internal Mammary with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02114AC | Bypass Coronary Artery, Two Sites from Thoracic Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02114J8 | Bypass Coronary Artery, Two Sites from Right Internal Mammary with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02114J9 | Bypass Coronary Artery, Two Sites from Left Internal Mammary with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02114JC | Bypass Coronary Artery, Two Sites from Thoracic Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02114K8 | Bypass Coronary Artery, Two Sites from Right Internal Mammary with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02114K9 | Bypass Coronary Artery, Two Sites from Left Internal Mammary with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02114KC | Bypass Coronary Artery, Two Sites from Thoracic Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02114Z8 | Bypass Coronary Artery, Two Sites from Right Internal Mammary, Percutaneous Endoscopic Approach | ||
02114Z9 | Bypass Coronary Artery, Two Sites from Left Internal Mammary, Percutaneous Endoscopic Approach | ||
02114ZC | Bypass Coronary Artery, Two Sites from Thoracic Artery, Percutaneous Endoscopic Approach | ||
021209C | Bypass Coronary Artery, Three Sites from Thoracic Artery with Autologous Venous Tissue, Open Approach | ||
02120A8 | Bypass Coronary Artery, Three Sites from Right Internal Mammary with Autologous Arterial Tissue, Open Approach | ||
02120A9 | Bypass Coronary Artery, Three Sites from Left Internal Mammary with Autologous Arterial Tissue, Open Approach | ||
02120AC | Bypass Coronary Artery, Three Sites from Thoracic Artery with Autologous Arterial Tissue, Open Approach | ||
02120J8 | Bypass Coronary Artery, Three Sites from Right Internal Mammary with Synthetic Substitute, Open Approach | ||
02120J9 | Bypass Coronary Artery, Three Sites from Left Internal Mammary with Synthetic Substitute, Open Approach | ||
02120JC | Bypass Coronary Artery, Three Sites from Thoracic Artery with Synthetic Substitute, Open Approach | ||
02120K8 | Bypass Coronary Artery, Three Sites from Right Internal Mammary with Nonautologous Tissue Substitute, Open Approach | ||
02120K9 | Bypass Coronary Artery, Three Sites from Left Internal Mammary with Nonautologous Tissue Substitute, Open Approach | ||
02120KC | Bypass Coronary Artery, Three Sites from Thoracic Artery with Nonautologous Tissue Substitute, Open Approach | ||
02120Z8 | Bypass Coronary Artery, Three Sites from Right Internal Mammary, Open Approach | ||
02120Z9 | Bypass Coronary Artery, Three Sites from Left Internal Mammary, Open Approach | ||
02120ZC | Bypass Coronary Artery, Three Sites from Thoracic Artery, Open Approach | ||
021249C | Bypass Coronary Artery, Three Sites from Thoracic Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
02124A8 | Bypass Coronary Artery, Three Sites from Right Internal Mammary with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02124A9 | Bypass Coronary Artery, Three Sites from Left Internal Mammary with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02124AC | Bypass Coronary Artery, Three Sites from Thoracic Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02124J8 | Bypass Coronary Artery, Three Sites from Right Internal Mammary with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02124J9 | Bypass Coronary Artery, Three Sites from Left Internal Mammary with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02124JC | Bypass Coronary Artery, Three Sites from Thoracic Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02124K8 | Bypass Coronary Artery, Three Sites from Right Internal Mammary with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02124K9 | Bypass Coronary Artery, Three Sites from Left Internal Mammary with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02124KC | Bypass Coronary Artery, Three Sites from Thoracic Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02124Z8 | Bypass Coronary Artery, Three Sites from Right Internal Mammary, Percutaneous Endoscopic Approach | ||
02124Z9 | Bypass Coronary Artery, Three Sites from Left Internal Mammary, Percutaneous Endoscopic Approach | ||
02124ZC | Bypass Coronary Artery, Three Sites from Thoracic Artery, Percutaneous Endoscopic Approach | ||
021309C | Bypass Coronary Artery, Four or More Sites from Thoracic Artery with Autologous Venous Tissue, Open Approach | ||
02130A8 | Bypass Coronary Artery, Four or More Sites from Right Internal Mammary with Autologous Arterial Tissue, Open Approach | ||
02130A9 | Bypass Coronary Artery, Four or More Sites from Left Internal Mammary with Autologous Arterial Tissue, Open Approach | ||
02130AC | Bypass Coronary Artery, Four or More Sites from Thoracic Artery with Autologous Arterial Tissue, Open Approach | ||
02130J8 | Bypass Coronary Artery, Four or More Sites from Right Internal Mammary with Synthetic Substitute, Open Approach | ||
02130J9 | Bypass Coronary Artery, Four or More Sites from Left Internal Mammary with Synthetic Substitute, Open Approach | ||
02130JC | Bypass Coronary Artery, Four or More Sites from Thoracic Artery with Synthetic Substitute, Open Approach | ||
02130K8 | Bypass Coronary Artery, Four or More Sites from Right Internal Mammary with Nonautologous Tissue Substitute, Open Approach | ||
02130K9 | Bypass Coronary Artery, Four or More Sites from Left Internal Mammary with Nonautologous Tissue Substitute, Open Approach | ||
02130KC | Bypass Coronary Artery, Four or More Sites from Thoracic Artery with Nonautologous Tissue Substitute, Open Approach | ||
02130Z8 | Bypass Coronary Artery, Four or More Sites from Right Internal Mammary, Open Approach | ||
02130Z9 | Bypass Coronary Artery, Four or More Sites from Left Internal Mammary, Open Approach | ||
02130ZC | Bypass Coronary Artery, Four or More Sites from Thoracic Artery, Open Approach | ||
021349C | Bypass Coronary Artery, Four or More Sites from Thoracic Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
02134A8 | Bypass Coronary Artery, Four or More Sites from Right Internal Mammary with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02134A9 | Bypass Coronary Artery, Four or More Sites from Left Internal Mammary with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02134AC | Bypass Coronary Artery, Four or More Sites from Thoracic Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02134J8 | Bypass Coronary Artery, Four or More Sites from Right Internal Mammary with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02134J9 | Bypass Coronary Artery, Four or More Sites from Left Internal Mammary with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02134JC | Bypass Coronary Artery, Four or More Sites from Thoracic Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02134K8 | Bypass Coronary Artery, Four or More Sites from Right Internal Mammary with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02134K9 | Bypass Coronary Artery, Four or More Sites from Left Internal Mammary with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02134KC | Bypass Coronary Artery, Four or More Sites from Thoracic Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02134Z8 | Bypass Coronary Artery, Four or More Sites from Right Internal Mammary, Percutaneous Endoscopic Approach | ||
02134Z9 | Bypass Coronary Artery, Four or More Sites from Left Internal Mammary, Percutaneous Endoscopic Approach | ||
02134ZC | Bypass Coronary Artery, Four or More Sites from Thoracic Artery, Percutaneous Endoscopic Approach | ||
36.17 | Abdominal-coronary artery bypass | 021009F | Bypass Coronary Artery, One Site from Abdominal Artery with Autologous Venous Tissue, Open Approach |
02100AF | Bypass Coronary Artery, One Site from Abdominal Artery with Autologous Arterial Tissue, Open Approach | ||
02100JF | Bypass Coronary Artery, One Site from Abdominal Artery with Synthetic Substitute, Open Approach | ||
02100KF | Bypass Coronary Artery, One Site from Abdominal Artery with Nonautologous Tissue Substitute, Open Approach | ||
02100ZF | Bypass Coronary Artery, One Site from Abdominal Artery, Open Approach | ||
021049F | Bypass Coronary Artery, One Site from Abdominal Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
02104AF | Bypass Coronary Artery, One Site from Abdominal Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02104JF | Bypass Coronary Artery, One Site from Abdominal Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02104KF | Bypass Coronary Artery, One Site from Abdominal Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02104ZF | Bypass Coronary Artery, One Site from Abdominal Artery, Percutaneous Endoscopic Approach | ||
021109F | Bypass Coronary Artery, Two Sites from Abdominal Artery with Autologous Venous Tissue, Open Approach | ||
02110AF | Bypass Coronary Artery, Two Sites from Abdominal Artery with Autologous Arterial Tissue, Open Approach | ||
02110JF | Bypass Coronary Artery, Two Sites from Abdominal Artery with Synthetic Substitute, Open Approach | ||
02110KF | Bypass Coronary Artery, Two Sites from Abdominal Artery with Nonautologous Tissue Substitute, Open Approach | ||
02110ZF | Bypass Coronary Artery, Two Sites from Abdominal Artery, Open Approach | ||
021149F | Bypass Coronary Artery, Two Sites from Abdominal Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
02114AF | Bypass Coronary Artery, Two Sites from Abdominal Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02114JF | Bypass Coronary Artery, Two Sites from Abdominal Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02114KF | Bypass Coronary Artery, Two Sites from Abdominal Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02114ZF | Bypass Coronary Artery, Two Sites from Abdominal Artery, Percutaneous Endoscopic Approach | ||
021209F | Bypass Coronary Artery, Three Sites from Abdominal Artery with Autologous Venous Tissue, Open Approach | ||
02120AF | Bypass Coronary Artery, Three Sites from Abdominal Artery with Autologous Arterial Tissue, Open Approach | ||
02120JF | Bypass Coronary Artery, Three Sites from Abdominal Artery with Synthetic Substitute, Open Approach | ||
02120KF | Bypass Coronary Artery, Three Sites from Abdominal Artery with Nonautologous Tissue Substitute, Open Approach | ||
02120ZF | Bypass Coronary Artery, Three Sites from Abdominal Artery, Open Approach | ||
021249F | Bypass Coronary Artery, Three Sites from Abdominal Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
02124AF | Bypass Coronary Artery, Three Sites from Abdominal Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02124JF | Bypass Coronary Artery, Three Sites from Abdominal Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02124KF | Bypass Coronary Artery, Three Sites from Abdominal Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02124ZF | Bypass Coronary Artery, Three Sites from Abdominal Artery, Percutaneous Endoscopic Approach | ||
021309F | Bypass Coronary Artery, Four or More Sites from Abdominal Artery with Autologous Venous Tissue, Open Approach | ||
02130AF | Bypass Coronary Artery, Four or More Sites from Abdominal Artery with Autologous Arterial Tissue, Open Approach | ||
02130JF | Bypass Coronary Artery, Four or More Sites from Abdominal Artery with Synthetic Substitute, Open Approach | ||
02130KF | Bypass Coronary Artery, Four or More Sites from Abdominal Artery with Nonautologous Tissue Substitute, Open Approach | ||
02130ZF | Bypass Coronary Artery, Four or More Sites from Abdominal Artery, Open Approach | ||
021349F | Bypass Coronary Artery, Four or More Sites from Abdominal Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
02134AF | Bypass Coronary Artery, Four or More Sites from Abdominal Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02134JF | Bypass Coronary Artery, Four or More Sites from Abdominal Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02134KF | Bypass Coronary Artery, Four or More Sites from Abdominal Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02134ZF | Bypass Coronary Artery, Four or More Sites from Abdominal Artery, Percutaneous Endoscopic Approach | ||
36.19 | Other bypass anastomosis for heart revascularization | 0210093 | Bypass Coronary Artery, One Site from Coronary Artery with Autologous Venous Tissue, Open Approach |
0210493 | Bypass Coronary Artery, One Site from Coronary Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
0211093 | Bypass Coronary Artery, Two Sites from Coronary Artery with Autologous Venous Tissue, Open Approach | ||
0211493 | Bypass Coronary Artery, Two Sites from Coronary Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
0212093 | Bypass Coronary Artery, Three Sites from Coronary Artery with Autologous Venous Tissue, Open Approach | ||
0213493 | Bypass Coronary Artery, Four or More Sites from Coronary Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach | ||
02100A3 | Bypass Coronary Artery, One Site from Coronary Artery with Autologous Arterial Tissue, Open Approach | ||
02100J3 | Bypass Coronary Artery, One Site from Coronary Artery with Synthetic Substitute, Open Approach | ||
02100K3 | Bypass Coronary Artery, One Site from Coronary Artery with Nonautologous Tissue Substitute, Open Approach | ||
02100Z3 | Bypass Coronary Artery, One Site from Coronary Artery, Open Approach | ||
02104A3 | Bypass Coronary Artery, One Site from Coronary Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02104J3 | Bypass Coronary Artery, One Site from Coronary Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02104K3 | Bypass Coronary Artery, One Site from Coronary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02104Z3 | Bypass Coronary Artery, One Site from Coronary Artery, Percutaneous Endoscopic Approach | ||
02110A3 | Bypass Coronary Artery, Two Sites from Coronary Artery with Autologous Arterial Tissue, Open Approach | ||
02110J3 | Bypass Coronary Artery, Two Sites from Coronary Artery with Synthetic Substitute, Open Approach | ||
02110K3 | Bypass Coronary Artery, Two Sites from Coronary Artery with Nonautologous Tissue Substitute, Open Approach | ||
02110Z3 | Bypass Coronary Artery, Two Sites from Coronary Artery, Open Approach | ||
02114A3 | Bypass Coronary Artery, Two Sites from Coronary Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02114J3 | Bypass Coronary Artery, Two Sites from Coronary Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02114K3 | Bypass Coronary Artery, Two Sites from Coronary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02114Z3 | Bypass Coronary Artery, Two Sites from Coronary Artery, Percutaneous Endoscopic Approach | ||
02120A3 | Bypass Coronary Artery, Three Sites from Coronary Artery with Autologous Arterial Tissue, Open Approach | ||
02120J3 | Bypass Coronary Artery, Three Sites from Coronary Artery with Synthetic Substitute, Open Approach | ||
02120K3 | Bypass Coronary Artery, Three Sites from Coronary Artery with Nonautologous Tissue Substitute, Open Approach | ||
02120Z3 | Bypass Coronary Artery, Three Sites from Coronary Artery, Open Approach | ||
02124A3 | Bypass Coronary Artery, Three Sites from Coronary Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02124J3 | Bypass Coronary Artery, Three Sites from Coronary Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02124K3 | Bypass Coronary Artery, Three Sites from Coronary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02124Z3 | Bypass Coronary Artery, Three Sites from Coronary Artery, Percutaneous Endoscopic Approach | ||
02130A3 | Bypass Coronary Artery, Four or More Sites from Coronary Artery with Autologous Arterial Tissue, Open Approach | ||
02130J3 | Bypass Coronary Artery, Four or More Sites from Coronary Artery with Synthetic Substitute, Open Approach | ||
02130K3 | Bypass Coronary Artery, Four or More Sites from Coronary Artery with Nonautologous Tissue Substitute, Open Approach | ||
02130Z3 | Bypass Coronary Artery, Four or More Sites from Coronary Artery, Open Approach | ||
02134A3 | Bypass Coronary Artery, Four or More Sites from Coronary Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach | ||
02134J3 | Bypass Coronary Artery, Four or More Sites from Coronary Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
02134K3 | Bypass Coronary Artery, Four or More Sites from Coronary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
02134Z3 | Bypass Coronary Artery, Four or More Sites from Coronary Artery, Percutaneous Endoscopic Approach | ||
38.91 | Arterial catheterization | 02HP03Z | Insertion of Infusion Device into Pulmonary Trunk, Open Approach |
02HP33Z | Insertion of Infusion Device into Pulmonary Trunk, Percutaneous Approach | ||
02HP43Z | Insertion of Infusion Device into Pulmonary Trunk, Percutaneous Endoscopic Approach | ||
02HQ03Z | Insertion of Infusion Device into Right Pulmonary Artery, Open Approach | ||
02HQ33Z | Insertion of Infusion Device into Right Pulmonary Artery, Percutaneous Approach | ||
02HQ43Z | Insertion of Infusion Device into Right Pulmonary Artery, Percutaneous Endoscopic Approach | ||
02HR03Z | Insertion of Infusion Device into Left Pulmonary Artery, Open Approach | ||
02HR33Z | Insertion of Infusion Device into Left Pulmonary Artery, Percutaneous Approach | ||
02HR43Z | Insertion of Infusion Device into Left Pulmonary Artery, Percutaneous Endoscopic Approach | ||
02HW03Z | Insertion of Infusion Device into Thoracic Aorta, Open Approach | ||
02HW33Z | Insertion of Infusion Device into Thoracic Aorta, Percutaneous Approach | ||
02HW43Z | Insertion of Infusion Device into Thoracic Aorta, Percutaneous Endoscopic Approach | ||
03H003Z | Insertion of Infusion Device into Right Internal Mammary Artery, Open Approach | ||
03H033Z | Insertion of Infusion Device into Right Internal Mammary Artery, Percutaneous Approach | ||
03H043Z | Insertion of Infusion Device into Right Internal Mammary Artery, Percutaneous Endoscopic Approach | ||
03H103Z | Insertion of Infusion Device into Left Internal Mammary Artery, Open Approach | ||
03H133Z | Insertion of Infusion Device into Left Internal Mammary Artery, Percutaneous Approach | ||
03H143Z | Insertion of Infusion Device into Left Internal Mammary Artery, Percutaneous Endoscopic Approach | ||
03H203Z | Insertion of Infusion Device into Innominate Artery, Open Approach | ||
03H233Z | Insertion of Infusion Device into Innominate Artery, Percutaneous Approach | ||
03H243Z | Insertion of Infusion Device into Innominate Artery, Percutaneous Endoscopic Approach | ||
03H303Z | Insertion of Infusion Device into Right Subclavian Artery, Open Approach | ||
03H333Z | Insertion of Infusion Device into Right Subclavian Artery, Percutaneous Approach | ||
03H343Z | Insertion of Infusion Device into Right Subclavian Artery, Percutaneous Endoscopic Approach | ||
03H403Z | Insertion of Infusion Device into Left Subclavian Artery, Open Approach | ||
03H433Z | Insertion of Infusion Device into Left Subclavian Artery, Percutaneous Approach | ||
03H443Z | Insertion of Infusion Device into Left Subclavian Artery, Percutaneous Endoscopic Approach | ||
03H503Z | Insertion of Infusion Device into Right Axillary Artery, Open Approach | ||
03H533Z | Insertion of Infusion Device into Right Axillary Artery, Percutaneous Approach | ||
03H543Z | Insertion of Infusion Device into Right Axillary Artery, Percutaneous Endoscopic Approach | ||
03H603Z | Insertion of Infusion Device into Left Axillary Artery, Open Approach | ||
03H633Z | Insertion of Infusion Device into Left Axillary Artery, Percutaneous Approach | ||
03H643Z | Insertion of Infusion Device into Left Axillary Artery, Percutaneous Endoscopic Approach | ||
03H703Z | Insertion of Infusion Device into Right Brachial Artery, Open Approach | ||
03H733Z | Insertion of Infusion Device into Right Brachial Artery, Percutaneous Approach | ||
03H743Z | Insertion of Infusion Device into Right Brachial Artery, Percutaneous Endoscopic Approach | ||
03H803Z | Insertion of Infusion Device into Left Brachial Artery, Open Approach | ||
03H833Z | Insertion of Infusion Device into Left Brachial Artery, Percutaneous Approach | ||
03H843Z | Insertion of Infusion Device into Left Brachial Artery, Percutaneous Endoscopic Approach | ||
03H903Z | Insertion of Infusion Device into Right Ulnar Artery, Open Approach | ||
03H933Z | Insertion of Infusion Device into Right Ulnar Artery, Percutaneous Approach | ||
03H943Z | Insertion of Infusion Device into Right Ulnar Artery, Percutaneous Endoscopic Approach | ||
03HA03Z | Insertion of Infusion Device into Left Ulnar Artery, Open Approach | ||
03HA33Z | Insertion of Infusion Device into Left Ulnar Artery, Percutaneous Approach | ||
03HA43Z | Insertion of Infusion Device into Left Ulnar Artery, Percutaneous Endoscopic Approach | ||
03HB03Z | Insertion of Infusion Device into Right Radial Artery, Open Approach | ||
03HB33Z | Insertion of Infusion Device into Right Radial Artery, Percutaneous Approach | ||
03HB43Z | Insertion of Infusion Device into Right Radial Artery, Percutaneous Endoscopic Approach | ||
03HC03Z | Insertion of Infusion Device into Left Radial Artery, Open Approach | ||
03HC33Z | Insertion of Infusion Device into Left Radial Artery, Percutaneous Approach | ||
03HC43Z | Insertion of Infusion Device into Left Radial Artery, Percutaneous Endoscopic Approach | ||
03HD03Z | Insertion of Infusion Device into Right Hand Artery, Open Approach | ||
03HD33Z | Insertion of Infusion Device into Right Hand Artery, Percutaneous Approach | ||
03HD43Z | Insertion of Infusion Device into Right Hand Artery, Percutaneous Endoscopic Approach | ||
03HF03Z | Insertion of Infusion Device into Left Hand Artery, Open Approach | ||
03HF33Z | Insertion of Infusion Device into Left Hand Artery, Percutaneous Approach | ||
03HF43Z | Insertion of Infusion Device into Left Hand Artery, Percutaneous Endoscopic Approach | ||
03HG03Z | Insertion of Infusion Device into Intracranial Artery, Open Approach | ||
03HG33Z | Insertion of Infusion Device into Intracranial Artery, Percutaneous Approach | ||
03HG43Z | Insertion of Infusion Device into Intracranial Artery, Percutaneous Endoscopic Approach | ||
03HH03Z | Insertion of Infusion Device into Right Common Carotid Artery, Open Approach | ||
03HH33Z | Insertion of Infusion Device into Right Common Carotid Artery, Percutaneous Approach | ||
03HH43Z | Insertion of Infusion Device into Right Common Carotid Artery, Percutaneous Endoscopic Approach | ||
03HJ03Z | Insertion of Infusion Device into Left Common Carotid Artery, Open Approach | ||
03HJ33Z | Insertion of Infusion Device into Left Common Carotid Artery, Percutaneous Approach | ||
03HJ43Z | Insertion of Infusion Device into Left Common Carotid Artery, Percutaneous Endoscopic Approach | ||
03HK03Z | Insertion of Infusion Device into Right Internal Carotid Artery, Open Approach | ||
03HK33Z | Insertion of Infusion Device into Right Internal Carotid Artery, Percutaneous Approach | ||
03HK43Z | Insertion of Infusion Device into Right Internal Carotid Artery, Percutaneous Endoscopic Approach | ||
03HL03Z | Insertion of Infusion Device into Left Internal Carotid Artery, Open Approach | ||
03HL33Z | Insertion of Infusion Device into Left Internal Carotid Artery, Percutaneous Approach | ||
03HL43Z | Insertion of Infusion Device into Left Internal Carotid Artery, Percutaneous Endoscopic Approach | ||
03HM03Z | Insertion of Infusion Device into Right External Carotid Artery, Open Approach | ||
03HM33Z | Insertion of Infusion Device into Right External Carotid Artery, Percutaneous Approach | ||
03HM43Z | Insertion of Infusion Device into Right External Carotid Artery, Percutaneous Endoscopic Approach | ||
03HN03Z | Insertion of Infusion Device into Left External Carotid Artery, Open Approach | ||
03HN33Z | Insertion of Infusion Device into Left External Carotid Artery, Percutaneous Approach | ||
03HN43Z | Insertion of Infusion Device into Left External Carotid Artery, Percutaneous Endoscopic Approach | ||
03HP03Z | Insertion of Infusion Device into Right Vertebral Artery, Open Approach | ||
03HP33Z | Insertion of Infusion Device into Right Vertebral Artery, Percutaneous Approach | ||
03HP43Z | Insertion of Infusion Device into Right Vertebral Artery, Percutaneous Endoscopic Approach | ||
03HQ03Z | Insertion of Infusion Device into Left Vertebral Artery, Open Approach | ||
03HQ33Z | Insertion of Infusion Device into Left Vertebral Artery, Percutaneous Approach | ||
03HQ43Z | Insertion of Infusion Device into Left Vertebral Artery, Percutaneous Endoscopic Approach | ||
03HR03Z | Insertion of Infusion Device into Face Artery, Open Approach | ||
03HR33Z | Insertion of Infusion Device into Face Artery, Percutaneous Approach | ||
03HR43Z | Insertion of Infusion Device into Face Artery, Percutaneous Endoscopic Approach | ||
03HS03Z | Insertion of Infusion Device into Right Temporal Artery, Open Approach | ||
03HS33Z | Insertion of Infusion Device into Right Temporal Artery, Percutaneous Approach | ||
03HS43Z | Insertion of Infusion Device into Right Temporal Artery, Percutaneous Endoscopic Approach | ||
03HT03Z | Insertion of Infusion Device into Left Temporal Artery, Open Approach | ||
03HT33Z | Insertion of Infusion Device into Left Temporal Artery, Percutaneous Approach | ||
03HT43Z | Insertion of Infusion Device into Left Temporal Artery, Percutaneous Endoscopic Approach | ||
03HU03Z | Insertion of Infusion Device into Right Thyroid Artery, Open Approach | ||
03HU33Z | Insertion of Infusion Device into Right Thyroid Artery, Percutaneous Approach | ||
03HU43Z | Insertion of Infusion Device into Right Thyroid Artery, Percutaneous Endoscopic Approach | ||
03HV03Z | Insertion of Infusion Device into Left Thyroid Artery, Open Approach | ||
03HV33Z | Insertion of Infusion Device into Left Thyroid Artery, Percutaneous Approach | ||
03HV43Z | Insertion of Infusion Device into Left Thyroid Artery, Percutaneous Endoscopic Approach | ||
03HY03Z | Insertion of Infusion Device into Upper Artery, Open Approach | ||
03HY33Z | Insertion of Infusion Device into Upper Artery, Percutaneous Approach | ||
03HY43Z | Insertion of Infusion Device into Upper Artery, Percutaneous Endoscopic Approach | ||
04H003Z | Insertion of Infusion Device into Abdominal Aorta, Open Approach | ||
04H033Z | Insertion of Infusion Device into Abdominal Aorta, Percutaneous Approach | ||
04H043Z | Insertion of Infusion Device into Abdominal Aorta, Percutaneous Endoscopic Approach | ||
04H103Z | Insertion of Infusion Device into Celiac Artery, Open Approach | ||
04H133Z | Insertion of Infusion Device into Celiac Artery, Percutaneous Approach | ||
04H143Z | Insertion of Infusion Device into Celiac Artery, Percutaneous Endoscopic Approach | ||
04H203Z | Insertion of Infusion Device into Gastric Artery, Open Approach | ||
04H233Z | Insertion of Infusion Device into Gastric Artery, Percutaneous Approach | ||
04H243Z | Insertion of Infusion Device into Gastric Artery, Percutaneous Endoscopic Approach | ||
04H303Z | Insertion of Infusion Device into Hepatic Artery, Open Approach | ||
04H333Z | Insertion of Infusion Device into Hepatic Artery, Percutaneous Approach | ||
04H343Z | Insertion of Infusion Device into Hepatic Artery, Percutaneous Endoscopic Approach | ||
04H403Z | Insertion of Infusion Device into Splenic Artery, Open Approach | ||
04H433Z | Insertion of Infusion Device into Splenic Artery, Percutaneous Approach | ||
04H443Z | Insertion of Infusion Device into Splenic Artery, Percutaneous Endoscopic Approach | ||
04H503Z | Insertion of Infusion Device into Superior Mesenteric Artery, Open Approach | ||
04H533Z | Insertion of Infusion Device into Superior Mesenteric Artery, Percutaneous Approach | ||
04H543Z | Insertion of Infusion Device into Superior Mesenteric Artery, Percutaneous Endoscopic Approach | ||
04H603Z | Insertion of Infusion Device into Right Colic Artery, Open Approach | ||
04H633Z | Insertion of Infusion Device into Right Colic Artery, Percutaneous Approach | ||
04H643Z | Insertion of Infusion Device into Right Colic Artery, Percutaneous Endoscopic Approach | ||
04H703Z | Insertion of Infusion Device into Left Colic Artery, Open Approach | ||
04H733Z | Insertion of Infusion Device into Left Colic Artery, Percutaneous Approach | ||
04H743Z | Insertion of Infusion Device into Left Colic Artery, Percutaneous Endoscopic Approach | ||
04H803Z | Insertion of Infusion Device into Middle Colic Artery, Open Approach | ||
04H833Z | Insertion of Infusion Device into Middle Colic Artery, Percutaneous Approach | ||
04H843Z | Insertion of Infusion Device into Middle Colic Artery, Percutaneous Endoscopic Approach | ||
04H903Z | Insertion of Infusion Device into Right Renal Artery, Open Approach | ||
04H933Z | Insertion of Infusion Device into Right Renal Artery, Percutaneous Approach | ||
04H943Z | Insertion of Infusion Device into Right Renal Artery, Percutaneous Endoscopic Approach | ||
04HA33Z | Insertion of Infusion Device into Left Renal Artery, Open Approach | ||
02QJ4ZZ | Insertion of Infusion Device into Left Renal Artery, Percutaneous Approach | ||
04HA43Z | Insertion of Infusion Device into Left Renal Artery, Percutaneous Endoscopic Approach | ||
04HB03Z | Insertion of Infusion Device into Inferior Mesenteric Artery, Open Approach | ||
04HB33Z | Insertion of Infusion Device into Inferior Mesenteric Artery, Percutaneous Approach | ||
04HB43Z | Insertion of Infusion Device into Inferior Mesenteric Artery, Percutaneous Endoscopic Approach | ||
04HC03Z | Insertion of Infusion Device into Right Common Iliac Artery, Open Approach | ||
04HC33Z | Insertion of Infusion Device into Right Common Iliac Artery, Percutaneous Approach | ||
04HC43Z | Insertion of Infusion Device into Right Common Iliac Artery, Percutaneous Endoscopic Approach | ||
04HD03Z | Insertion of Infusion Device into Left Common Iliac Artery, Open Approach | ||
04HD33Z | Insertion of Infusion Device into Left Common Iliac Artery, Percutaneous Approach | ||
04HD43Z | Insertion of Infusion Device into Left Common Iliac Artery, Percutaneous Endoscopic Approach | ||
04HE03Z | Insertion of Infusion Device into Right Internal Iliac Artery, Open Approach | ||
04HE33Z | Insertion of Infusion Device into Right Internal Iliac Artery, Percutaneous Approach | ||
04HE43Z | Insertion of Infusion Device into Right Internal Iliac Artery, Percutaneous Endoscopic Approach | ||
04HF03Z | Insertion of Infusion Device into Left Internal Iliac Artery, Open Approach | ||
04HF33Z | Insertion of Infusion Device into Left Internal Iliac Artery, Percutaneous Approach | ||
04HF43Z | Insertion of Infusion Device into Left Internal Iliac Artery, Percutaneous Endoscopic Approach | ||
04HH03Z | Insertion of Infusion Device into Right External Iliac Artery, Open Approach | ||
04HH33Z | Insertion of Infusion Device into Right External Iliac Artery, Percutaneous Approach | ||
04HH43Z | Insertion of Infusion Device into Right External Iliac Artery, Percutaneous Endoscopic Approach | ||
04HJ03Z | Insertion of Infusion Device into Left External Iliac Artery, Open Approach | ||
04HJ33Z | Insertion of Infusion Device into Left External Iliac Artery, Percutaneous Approach | ||
04HJ43Z | Insertion of Infusion Device into Left External Iliac Artery, Percutaneous Endoscopic Approach | ||
04HK03Z | Insertion of Infusion Device into Right Femoral Artery, Open Approach | ||
04HK33Z | Insertion of Infusion Device into Right Femoral Artery, Percutaneous Approach | ||
04HK43Z | Insertion of Infusion Device into Right Femoral Artery, Percutaneous Endoscopic Approach | ||
04HL03Z | Insertion of Infusion Device into Left Femoral Artery, Open Approach | ||
04HL33Z | Insertion of Infusion Device into Left Femoral Artery, Percutaneous Approach | ||
04HL43Z | Insertion of Infusion Device into Left Femoral Artery, Percutaneous Endoscopic Approach | ||
04HM03Z | Insertion of Infusion Device into Right Popliteal Artery, Open Approach | ||
04HM33Z | Insertion of Infusion Device into Right Popliteal Artery, Percutaneous Approach | ||
04HM43Z | Insertion of Infusion Device into Right Popliteal Artery, Percutaneous Endoscopic Approach | ||
04HN03Z | Insertion of Infusion Device into Left Popliteal Artery, Open Approach | ||
04HN33Z | Insertion of Infusion Device into Left Popliteal Artery, Percutaneous Approach | ||
04HN43Z | Insertion of Infusion Device into Left Popliteal Artery, Percutaneous Endoscopic Approach | ||
04HP03Z | Insertion of Infusion Device into Right Anterior Tibial Artery, Open Approach | ||
04HP33Z | Insertion of Infusion Device into Right Anterior Tibial Artery, Percutaneous Approach | ||
04HP43Z | Insertion of Infusion Device into Right Anterior Tibial Artery, Percutaneous Endoscopic Approach | ||
04HQ03Z | Insertion of Infusion Device into Left Anterior Tibial Artery, Open Approach | ||
04HQ33Z | Insertion of Infusion Device into Left Anterior Tibial Artery, Percutaneous Approach | ||
04HQ43Z | Insertion of Infusion Device into Left Anterior Tibial Artery, Percutaneous Endoscopic Approach | ||
04HR03Z | Insertion of Infusion Device into Right Posterior Tibial Artery, Open Approach | ||
04HR33Z | Insertion of Infusion Device into Right Posterior Tibial Artery, Percutaneous Approach | ||
04HR43Z | Insertion of Infusion Device into Right Posterior Tibial Artery, Percutaneous Endoscopic Approach | ||
04HS03Z | Insertion of Infusion Device into Left Posterior Tibial Artery, Open Approach | ||
04HS33Z | Insertion of Infusion Device into Left Posterior Tibial Artery, Percutaneous Approach | ||
04HS43Z | Insertion of Infusion Device into Left Posterior Tibial Artery, Percutaneous Endoscopic Approach | ||
04HT03Z | Insertion of Infusion Device into Right Peroneal Artery, Open Approach | ||
04HT33Z | Insertion of Infusion Device into Right Peroneal Artery, Percutaneous Approach | ||
04HT43Z | Insertion of Infusion Device into Right Peroneal Artery, Percutaneous Endoscopic Approach | ||
04HU03Z | Insertion of Infusion Device into Left Peroneal Artery, Open Approach | ||
04HU33Z | Insertion of Infusion Device into Left Peroneal Artery, Percutaneous Approach | ||
04HU43Z | Insertion of Infusion Device into Left Peroneal Artery, Percutaneous Endoscopic Approach | ||
02NH3ZZ | Release Pulmonary Valve, Percutaneous Approach | ||
02NH4ZZ | Release Pulmonary Valve, Percutaneous Endoscopic Approach | ||
04HV03Z | Insertion of Infusion Device into Right Foot Artery, Open Approach | ||
04HV33Z | Insertion of Infusion Device into Right Foot Artery, Percutaneous Approach | ||
04HV43Z | Insertion of Infusion Device into Right Foot Artery, Percutaneous Endoscopic Approach | ||
04HW03Z | Insertion of Infusion Device into Left Foot Artery, Open Approach | ||
04HW33Z | Insertion of Infusion Device into Left Foot Artery, Percutaneous Approach | ||
04HW43Z | Insertion of Infusion Device into Left Foot Artery, Percutaneous Endoscopic Approach | ||
04HY03Z | Insertion of Infusion Device into Lower Artery, Open Approach | ||
04HY33Z | Insertion of Infusion Device into Lower Artery, Percutaneous Approach | ||
04HY43Z | Insertion of Infusion Device into Lower Artery, Percutaneous Endoscopic Approach | ||
39.61 | Extracorporeal circulation auxiliary to open heart surgery | 5A1221Z | Performance of Cardiac Output, Continuous |
Reimbursement information provided by Edwards Lifesciences is gathered from third-party sources and is presented for informational purposes only. Edwards makes no representation, warranty or guarantee as to the timeliness, accuracy or completeness of the information and such information is not, and should not be construed as reimbursement, coding or legal advice. Any and all references to reimbursement codes are provided as examples only and are not intended to be a recommendation or advice as to the appropriate code for a particular patient, diagnosis, product or procedure or a guarantee or promise of coverage or payment, nor does Edwards Lifesciences warranty that codes listed are appropriate in all related clinical scenarios. It is the responsibility of the provider to determine if coverage exists and what requirements are necessary for submitting a proper claim for reimbursement to a health plan or payer, including the appropriate code(s) for products provided or services rendered. Laws, regulations, and payer policies concerning reimbursement are complex and change frequently; service providers are responsible for all decisions relating to coding and reimbursement submissions. Medicare’s Correct Coding Initiative and commercial payer policies are reviewed and updated several times each year. Accordingly, Edwards strongly recommends consultation with payers, reimbursement specialists and/or legal counsel regarding appropriate product or procedure codes, coverage, and reimbursement matters.
References- Current Procedure Terminology (CPT) copyright 2015, American Medical Association (AMA). All rights reserved. CPT is a registered trademark of the AMA. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. Applicable FARS/DFARS restrictions apply to government use.
- Not all codes provided are applicable for the clinical scenarios in which Edwards Lifesciences’ Heart Valve technologies are used. The provider is responsible for selecting the most appropriate code(s) for the patient’s clinical presentation. When diagnostic services are performed, it may be appropriate to add applicable codes according to the service provided following the correct coding guidelines. Services that are considered a component of another procedure may not always be coded and billed separately.
- For all Medicare payments for physician, hospital outpatient, and ASC services, the multiple procedure reduction rule may apply. Consult with coding and billing staff, and payer policy for further guidance. National average Medicare payment is calculated using the Conversion Factor of $35.8279 per the Medicare Physician Fee Schedule for Calendar Year 2016 Final Rule issued October 30, 2015. National average is based on factors such as geography, teaching vs. non-teaching hospital, rural vs. urban area, etc. and your payment may be different based on these factors. This payment will differ for commercial payers. Payments are effective January 1, 2016 through December 31, 2016.
- For Minimal Incision Valve Surgery procedures, multiple catheters and/or cannulae are typically used; therefore, the use of modifier -59 may be required. Check with internal billing staff and payer policies for clarification.
- Diagnostic procedures performed in the facility setting may require the use of modifier -26 to reflect the professional component of the service only. Check with internal billing staff and payer policies for clarification. Intraoperative Transesophageal echocardiography (TEE) is a non-covered service for many payers. Providers may wish to review Medicare’s Correct Coding Initiative when providing anesthesia services in conjunction with TEE. Consult payer policies and contracts for clarification.
- Centers for Medicare & Medicaid Services. FY 2016 Inpatient Prospective Payment System Final Rule.
- National Uniform Billing Committee, American Hospital Association
- Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Rules and Regulations: This final rule adopts modifications to two of the code set standards adopted in the Transactions and Code Sets final rule published in the Federal Register pursuant to certain provisions of the Administrative Simplification subtitle of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Specifically, this final rule modifies the standard medical data code sets (hereinafter ‘‘code sets’’) for coding diagnoses and inpatient hospital procedures by concurrently adopting the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) for diagnosis coding, including the Official ICD-10-CM Guidelines for Coding and Reporting, as maintained and distributed by the U.S. Department of Health and Human Services (HHS), hereinafter referred to as ICD-10-CM, and the International Classification of Diseases, 10th Revision, Procedure Coding System (ICD-10-PCS) for inpatient hospital procedure coding, including the Official ICD-10-PCS Guidelines for Coding and Reporting, as maintained and distributed by the HHS, hereinafter referred to as ICD-10-PCS. These new codes replace the International Classification of Diseases, 9th Revision, Clinical Modification, Volumes 1 and 2, including the Official ICD-9-CM Guidelines for Coding and Reporting, hereinafter referred to as ICD-9-CM Volumes 1 and 2, and the International Classification of Diseases, 9th Revision, Clinical Modification, Volume 3, including the Official ICD-9-CM Guidelines for Coding and Reporting, hereinafter referred to as ICD-9-CM Volume 3, for diagnosis and procedure codes, respectively. DATES: The effective date of this regulation is March 17, 2009. The effective date is the date that the policies herein take effect, and new policies are considered to be officially adopted. The compliance date, which is different than the effective date, is the date on which entities are required to have implemented the policies adopted in this rule. The compliance date for this regulation is October 1, 2015.
- International Classification of Diseases, 9th Revision, Clinical Modification 2015 ICD-9-CM for hospitals, volume 1, 2, & 3.
- International Classification of Diseases, 10th Revision, Procedure Coding System 2015 Draft.
2016 Facility and Physician Billing Guide
Clinicians use Current Procedural Terminology (CPT)1 codes to bill for procedures and services. Each CPT code is assigned unique relative value units (RVUs), which are used to determine payment by the Centers for Medicare & Medicaid Services (CMS). Some commonly billed CPT codes used to describe procedures related to Edwards Lifesciences’ Critical Care technologies (e.g. Swan-Ganz catheter, FloTrac sensor, PreSep and PediaSat and PediaSat oximetry catheters) are listed below.2 This list may not be comprehensive or complete. These procedures may be subject to the CMS multiple procedure reduction rule. When applicable, a payment reduction of 50% is applied to all payment amounts except the procedure with the greatest RVUs, which is paid at 100% unless exempt by CPT instructions or payer policy.
CPT Code | Description | Medicare National Average Physician Payment3 |
36555 | Insertion of non-tunneled centrally inserted central venous catheter; younger than 5 years of age | $124 |
36556 | Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older | $126 |
36620 | Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous | $53 |
93503 | Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes) | $135 |
99221 | Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of low severity. Typically, 30 minutes are spent at the bedside and on the patient's hospital floor or unit. | $102 |
99222 | Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of moderate severity. Typically, 50 minutes are spent at the bedside and on the patient's hospital floor or unit. | $138 |
99223 | Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of high severity. Typically, 70 minutes are spent at the bedside and on the patient's hospital floor or unit. | $204 |
99231 | Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is stable, recovering or improving. Typically, 15 minutes are spent at the bedside and on the patient's hospital floor or unit. | $40 |
99232 | Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is responding inadequately to therapy or has developed a minor complication. Typically, 25 minutes are spent at the bedside and on the patient's hospital floor or unit. | $73 |
99233 | Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is unstable or has developed a significant complication or a significant new problem. Typically, 35 minutes are spent at the bedside and on the patient's hospital floor or unit. | $105 |
99291 | Critical Care Evaluation and Management of the critically ill or critically injured, first 30-74 minutes | $226 |
99292 | Critical Care Evaluation and Management of the critically ill or critically injured, each additional 30 minutes (List separately in addition to code for primary service) | $113 |
REVENUE CODES4 AND HCPCS CODES
Revenue codes help hospitals categorize services provided by revenue center. Medicare utilizes revenue codes for cost reporting purposes. It may be appropriate for hospitals to capture the cost for some of Edwards Lifesciences’ Critical Care technologies for payer reporting or cost accounting purposes as expenses within Revenue Code 0278 (Medical/Surgical – Other Implants) on the hospital’s UB-04 billing form. C codes do not apply to inpatient surgical procedures, but should be added to the hospital’s chargemaster to report device costs used in the outpatient setting. Medicare created C codes to track device cost information for future APC rate-setting purposes. No additional facility payment is associated with these codes. CMS may reject hospital claims if the appropriate code is not identified on the claim. C codes may not be recognized by commercial payers.
C Code | Description |
C1751 | Catheter, infusion, inserted peripherally, centrally or midline, other than hemodialysis |
C1769 | Guide wire |
C1894 | Sheath introducer, other than guiding, other than Intracardiac electrophysiological, non-laser |
Medicare inpatient hospital reimbursement is based upon the Medicare Severity-Diagnosis Related Group (MS-DRG) classification system, which assigns MS-DRGs based on ICD-9-CM diagnosis and procedure codes. Although the compliance date for mandatory use of ICD-10 codes is October 1, 20155, this guide is intended to provide the cross-over codes for testing purposes only. Given Medicare and other payers are encouraging the provider community to perform parallel coding and test the claims systems, this guide will provide the necessary conversion from ICD-9 codes to the appropriate ICD-10 codes.
ICD-9-CM Procedure Code6 | Description | ICD-10-CM Procedure Code7 | Description |
---|---|---|---|
38.91 | Arterial catheterization | 02HP03Z | Insertion of Infusion Device into Pulmonary Trunk, Open Approach |
02HP33Z | Insertion of Infusion Device into Pulmonary Trunk, Percutaneous Approach | ||
02HP43Z | Insertion of Infusion Device into Pulmonary Trunk, Percutaneous Endoscopic Approach | ||
02HQ03Z | Insertion of Infusion Device into Right Pulmonary Artery, Open Approach | ||
02HQ33Z | Insertion of Infusion Device into Right Pulmonary Artery, Percutaneous Approach | ||
02HQ43Z | Insertion of Infusion Device into Right Pulmonary Artery, Percutaneous Endoscopic Approach | ||
02HR03Z | Insertion of Infusion Device into Left Pulmonary Artery, Open Approach | ||
02HR33Z | Insertion of Infusion Device into Left Pulmonary Artery, Percutaneous Approach | ||
02HR43Z | Insertion of Infusion Device into Left Pulmonary Artery, Percutaneous Endoscopic Approach | ||
02HW03Z | Insertion of Infusion Device into Thoracic Aorta, Open Approach | ||
02HW33Z | Insertion of Infusion Device into Thoracic Aorta, Percutaneous Approach | ||
02HW43Z | Insertion of Infusion Device into Thoracic Aorta, Percutaneous Endoscopic Approach | ||
03H003Z | Insertion of Infusion Device into Right Internal Mammary Artery, Open Approach | ||
03H033Z | Insertion of Infusion Device into Right Internal Mammary Artery, Percutaneous Approach | ||
03H043Z | Insertion of Infusion Device into Right Internal Mammary Artery, Percutaneous Endoscopic Approach | ||
03H103Z | Insertion of Infusion Device into Left Internal Mammary Artery, Open Approach | ||
03H133Z | Insertion of Infusion Device into Left Internal Mammary Artery, Percutaneous Approach | ||
03H143Z | Insertion of Infusion Device into Left Internal Mammary Artery, Percutaneous Endoscopic Approach | ||
03H203Z | Insertion of Infusion Device into Innominate Artery, Open Approach | ||
03H233Z | Insertion of Infusion Device into Innominate Artery, Percutaneous Approach | ||
03H243Z | Insertion of Infusion Device into Innominate Artery, Percutaneous Endoscopic Approach | ||
03H303Z | Insertion of Infusion Device into Right Subclavian Artery, Open Approach | ||
03H333Z | Insertion of Infusion Device into Right Subclavian Artery, Percutaneous Approach | ||
03H343Z | Insertion of Infusion Device into Right Subclavian Artery, Percutaneous Endoscopic Approach | ||
03H403Z | Insertion of Infusion Device into Left Subclavian Artery, Open Approach | ||
03H433Z | Insertion of Infusion Device into Left Subclavian Artery, Percutaneous Approach | ||
03H443Z | Insertion of Infusion Device into Left Subclavian Artery, Percutaneous Endoscopic Approach | ||
03H503Z | Insertion of Infusion Device into Right Axillary Artery, Open Approach | ||
03H533Z | Insertion of Infusion Device into Right Axillary Artery, Percutaneous Approach | ||
03H543Z | Insertion of Infusion Device into Right Axillary Artery, Percutaneous Endoscopic Approach | ||
03H603Z | Insertion of Infusion Device into Left Axillary Artery, Open Approach | ||
03H633Z | Insertion of Infusion Device into Left Axillary Artery, Percutaneous Approach | ||
03H643Z | Insertion of Infusion Device into Left Axillary Artery, Percutaneous Endoscopic Approach | ||
03H703Z | Insertion of Infusion Device into Right Brachial Artery, Open Approach | ||
03H733Z | Insertion of Infusion Device into Right Brachial Artery, Percutaneous Approach | ||
03H743Z | Insertion of Infusion Device into Right Brachial Artery, Percutaneous Endoscopic Approach | ||
03H803Z | Insertion of Infusion Device into Left Brachial Artery, Open Approach | ||
03H833Z | Insertion of Infusion Device into Left Brachial Artery, Percutaneous Approach | ||
03H843Z | Insertion of Infusion Device into Left Brachial Artery, Percutaneous Endoscopic Approach | ||
03H903Z | Insertion of Infusion Device into Right Ulnar Artery, Open Approach | ||
03H933Z | Insertion of Infusion Device into Right Ulnar Artery, Percutaneous Approach | ||
03H943Z | Insertion of Infusion Device into Right Ulnar Artery, Percutaneous Endoscopic Approach | ||
03HA03Z | Insertion of Infusion Device into Left Ulnar Artery, Open Approach | ||
03HA33Z | Insertion of Infusion Device into Left Ulnar Artery, Percutaneous Approach | ||
03HA43Z | Insertion of Infusion Device into Left Ulnar Artery, Percutaneous Endoscopic Approach | ||
03HB03Z | Insertion of Infusion Device into Right Radial Artery, Open Approach | ||
03HB33Z | Insertion of Infusion Device into Right Radial Artery, Percutaneous Approach | ||
03HB43Z | Insertion of Infusion Device into Right Radial Artery, Percutaneous Endoscopic Approach | ||
03HC03Z | Insertion of Infusion Device into Left Radial Artery, Open Approach | ||
03HC33Z | Insertion of Infusion Device into Left Radial Artery, Percutaneous Approach | ||
03HC43Z | Insertion of Infusion Device into Left Radial Artery, Percutaneous Endoscopic Approach | ||
03HD03Z | Insertion of Infusion Device into Right Hand Artery, Open Approach | ||
03HD33Z | Insertion of Infusion Device into Right Hand Artery, Percutaneous Approach | ||
03HD43Z | Insertion of Infusion Device into Right Hand Artery, Percutaneous Endoscopic Approach | ||
03HF03Z | Insertion of Infusion Device into Left Hand Artery, Open Approach | ||
03HF33Z | Insertion of Infusion Device into Left Hand Artery, Percutaneous Approach | ||
03HF43Z | Insertion of Infusion Device into Left Hand Artery, Percutaneous Endoscopic Approach | ||
03HG03Z | Insertion of Infusion Device into Intracranial Artery, Open Approach | ||
03HG33Z | Insertion of Infusion Device into Intracranial Artery, Percutaneous Approach | ||
03HG43Z | Insertion of Infusion Device into Intracranial Artery, Percutaneous Endoscopic Approach | ||
03HH03Z | Insertion of Infusion Device into Right Common Carotid Artery, Open Approach | ||
03HH33Z | Insertion of Infusion Device into Right Common Carotid Artery, Percutaneous Approach | ||
03HH43Z | Insertion of Infusion Device into Right Common Carotid Artery, Percutaneous Endoscopic Approach | ||
03HJ03Z | Insertion of Infusion Device into Left Common Carotid Artery, Open Approach | ||
03HJ33Z | Insertion of Infusion Device into Left Common Carotid Artery, Percutaneous Approach | ||
03HJ43Z | Insertion of Infusion Device into Left Common Carotid Artery, Percutaneous Endoscopic Approach | ||
03HK03Z | Insertion of Infusion Device into Right Internal Carotid Artery, Open Approach | ||
03HK33Z | Insertion of Infusion Device into Right Internal Carotid Artery, Percutaneous Approach | ||
03HK43Z | Insertion of Infusion Device into Right Internal Carotid Artery, Percutaneous Endoscopic Approach | ||
03HL03Z | Insertion of Infusion Device into Left Internal Carotid Artery, Open Approach | ||
03HL33Z | Insertion of Infusion Device into Left Internal Carotid Artery, Percutaneous Approach | ||
03HL43Z | Insertion of Infusion Device into Left Internal Carotid Artery, Percutaneous Endoscopic Approach | ||
03HM03Z | Insertion of Infusion Device into Right External Carotid Artery, Open Approach | ||
03HM33Z | Insertion of Infusion Device into Right External Carotid Artery, Percutaneous Approach | ||
03HM43Z | Insertion of Infusion Device into Right External Carotid Artery, Percutaneous Endoscopic Approach | ||
03HN03Z | Insertion of Infusion Device into Left External Carotid Artery, Open Approach | ||
03HN33Z | Insertion of Infusion Device into Left External Carotid Artery, Percutaneous Approach | ||
03HN43Z | Insertion of Infusion Device into Left External Carotid Artery, Percutaneous Endoscopic Approach | ||
03HP03Z | Insertion of Infusion Device into Right Vertebral Artery, Open Approach | ||
03HP33Z | Insertion of Infusion Device into Right Vertebral Artery, Percutaneous Approach | ||
03HP43Z | Insertion of Infusion Device into Right Vertebral Artery, Percutaneous Endoscopic Approach | ||
03HQ03Z | Insertion of Infusion Device into Left Vertebral Artery, Open Approach | ||
03HQ33Z | Insertion of Infusion Device into Left Vertebral Artery, Percutaneous Approach | ||
03HQ43Z | Insertion of Infusion Device into Left Vertebral Artery, Percutaneous Endoscopic Approach | ||
03HR03Z | Insertion of Infusion Device into Face Artery, Open Approach | ||
03HR33Z | Insertion of Infusion Device into Face Artery, Percutaneous Approach | ||
03HR43Z | Insertion of Infusion Device into Face Artery, Percutaneous Endoscopic Approach | ||
03HS03Z | Insertion of Infusion Device into Right Temporal Artery, Open Approach | ||
03HS33Z | Insertion of Infusion Device into Right Temporal Artery, Percutaneous Approach | ||
03HS43Z | Insertion of Infusion Device into Right Temporal Artery, Percutaneous Endoscopic Approach | ||
03HT03Z | Insertion of Infusion Device into Left Temporal Artery, Open Approach | ||
03HT33Z | Insertion of Infusion Device into Left Temporal Artery, Percutaneous Approach | ||
03HT43Z | Insertion of Infusion Device into Left Temporal Artery, Percutaneous Endoscopic Approach | ||
03HU03Z | Insertion of Infusion Device into Right Thyroid Artery, Open Approach | ||
03HU33Z | Insertion of Infusion Device into Right Thyroid Artery, Percutaneous Approach | ||
03HU43Z | Insertion of Infusion Device into Right Thyroid Artery, Percutaneous Endoscopic Approach | ||
03HV03Z | Insertion of Infusion Device into Left Thyroid Artery, Open Approach | ||
03HV33Z | Insertion of Infusion Device into Left Thyroid Artery, Percutaneous Approach | ||
03HV43Z | Insertion of Infusion Device into Left Thyroid Artery, Percutaneous Endoscopic Approach | ||
03HY03Z | Insertion of Infusion Device into Upper Artery, Open Approach | ||
03HY33Z | Insertion of Infusion Device into Upper Artery, Percutaneous Approach | ||
03HY43Z | Insertion of Infusion Device into Upper Artery, Percutaneous Endoscopic Approach | ||
04H003Z | Insertion of Infusion Device into Abdominal Aorta, Open Approach | ||
04H033Z | Insertion of Infusion Device into Abdominal Aorta, Percutaneous Approach | ||
04H043Z | Insertion of Infusion Device into Abdominal Aorta, Percutaneous Endoscopic Approach | ||
04H103Z | Insertion of Infusion Device into Celiac Artery, Open Approach | ||
04H133Z | Insertion of Infusion Device into Celiac Artery, Percutaneous Approach | ||
04H143Z | Insertion of Infusion Device into Celiac Artery, Percutaneous Endoscopic Approach | ||
04H203Z | Insertion of Infusion Device into Gastric Artery, Open Approach | ||
04H233Z | Insertion of Infusion Device into Gastric Artery, Percutaneous Approach | ||
04H243Z | Insertion of Infusion Device into Gastric Artery, Percutaneous Endoscopic Approach | ||
04H303Z | Insertion of Infusion Device into Hepatic Artery, Open Approach | ||
04H333Z | Insertion of Infusion Device into Hepatic Artery, Percutaneous Approach | ||
04H343Z | Insertion of Infusion Device into Hepatic Artery, Percutaneous Endoscopic Approach | ||
04H403Z | Insertion of Infusion Device into Splenic Artery, Open Approach | ||
04H433Z | Insertion of Infusion Device into Splenic Artery, Percutaneous Approach | ||
04H443Z | Insertion of Infusion Device into Splenic Artery, Percutaneous Endoscopic Approach | ||
04H503Z | Insertion of Infusion Device into Superior Mesenteric Artery, Open Approach | ||
04H533Z | Insertion of Infusion Device into Superior Mesenteric Artery, Percutaneous Approach | ||
04H543Z | Insertion of Infusion Device into Superior Mesenteric Artery, Percutaneous Endoscopic Approach | ||
04H603Z | Insertion of Infusion Device into Right Colic Artery, Open Approach | ||
04H633Z | Insertion of Infusion Device into Right Colic Artery, Percutaneous Approach | ||
04H643Z | Insertion of Infusion Device into Right Colic Artery, Percutaneous Endoscopic Approach | ||
04H703Z | Insertion of Infusion Device into Left Colic Artery, Open Approach | ||
04H733Z | Insertion of Infusion Device into Left Colic Artery, Percutaneous Approach | ||
04H743Z | Insertion of Infusion Device into Left Colic Artery, Percutaneous Endoscopic Approach | ||
04H803Z | Insertion of Infusion Device into Middle Colic Artery, Open Approach | ||
04H833Z | Insertion of Infusion Device into Middle Colic Artery, Percutaneous Approach | ||
04H843Z | Insertion of Infusion Device into Middle Colic Artery, Percutaneous Endoscopic Approach | ||
04H903Z | Insertion of Infusion Device into Right Renal Artery, Open Approach | ||
04H933Z | Insertion of Infusion Device into Right Renal Artery, Percutaneous Approach | ||
04H943Z | Insertion of Infusion Device into Right Renal Artery, Percutaneous Endoscopic Approach | ||
04HA33Z | Insertion of Infusion Device into Left Renal Artery, Open Approach | ||
02QJ4ZZ | Insertion of Infusion Device into Left Renal Artery, Percutaneous Approach | ||
04HA43Z | Insertion of Infusion Device into Left Renal Artery, Percutaneous Endoscopic Approach | ||
04HB03Z | Insertion of Infusion Device into Inferior Mesenteric Artery, Open Approach | ||
04HB33Z | Insertion of Infusion Device into Inferior Mesenteric Artery, Percutaneous Approach | ||
04HB43Z | Insertion of Infusion Device into Inferior Mesenteric Artery, Percutaneous Endoscopic Approach | ||
04HC03Z | Insertion of Infusion Device into Right Common Iliac Artery, Open Approach | ||
04HC33Z | Insertion of Infusion Device into Right Common Iliac Artery, Percutaneous Approach | ||
04HC43Z | Insertion of Infusion Device into Right Common Iliac Artery, Percutaneous Endoscopic Approach | ||
04HD03Z | Insertion of Infusion Device into Left Common Iliac Artery, Open Approach | ||
04HD33Z | Insertion of Infusion Device into Left Common Iliac Artery, Percutaneous Approach | ||
04HD43Z | Insertion of Infusion Device into Left Common Iliac Artery, Percutaneous Endoscopic Approach | ||
04HE03Z | Insertion of Infusion Device into Right Internal Iliac Artery, Open Approach | ||
04HE33Z | Insertion of Infusion Device into Right Internal Iliac Artery, Percutaneous Approach | ||
04HE43Z | Insertion of Infusion Device into Right Internal Iliac Artery, Percutaneous Endoscopic Approach | ||
04HF03Z | Insertion of Infusion Device into Left Internal Iliac Artery, Open Approach | ||
04HF33Z | Insertion of Infusion Device into Left Internal Iliac Artery, Percutaneous Approach | ||
04HF43Z | Insertion of Infusion Device into Left Internal Iliac Artery, Percutaneous Endoscopic Approach | ||
04HH03Z | Insertion of Infusion Device into Right External Iliac Artery, Open Approach | ||
04HH33Z | Insertion of Infusion Device into Right External Iliac Artery, Percutaneous Approach | ||
04HH43Z | Insertion of Infusion Device into Right External Iliac Artery, Percutaneous Endoscopic Approach | ||
04HJ03Z | Insertion of Infusion Device into Left External Iliac Artery, Open Approach | ||
04HJ33Z | Insertion of Infusion Device into Left External Iliac Artery, Percutaneous Approach | ||
04HJ43Z | Insertion of Infusion Device into Left External Iliac Artery, Percutaneous Endoscopic Approach | ||
04HK03Z | Insertion of Infusion Device into Right Femoral Artery, Open Approach | ||
04HK33Z | Insertion of Infusion Device into Right Femoral Artery, Percutaneous Approach | ||
04HK43Z | Insertion of Infusion Device into Right Femoral Artery, Percutaneous Endoscopic Approach | ||
04HL03Z | Insertion of Infusion Device into Left Femoral Artery, Open Approach | ||
04HL33Z | Insertion of Infusion Device into Left Femoral Artery, Percutaneous Approach | ||
04HL43Z | Insertion of Infusion Device into Left Femoral Artery, Percutaneous Endoscopic Approach | ||
04HM03Z | Insertion of Infusion Device into Right Popliteal Artery, Open Approach | ||
04HM33Z | Insertion of Infusion Device into Right Popliteal Artery, Percutaneous Approach | ||
04HM43Z | Insertion of Infusion Device into Right Popliteal Artery, Percutaneous Endoscopic Approach | ||
04HN03Z | Insertion of Infusion Device into Left Popliteal Artery, Open Approach | ||
04HN33Z | Insertion of Infusion Device into Left Popliteal Artery, Percutaneous Approach | ||
04HN43Z | Insertion of Infusion Device into Left Popliteal Artery, Percutaneous Endoscopic Approach | ||
04HP03Z | Insertion of Infusion Device into Right Anterior Tibial Artery, Open Approach | ||
04HP33Z | Insertion of Infusion Device into Right Anterior Tibial Artery, Percutaneous Approach | ||
04HP43Z | Insertion of Infusion Device into Right Anterior Tibial Artery, Percutaneous Endoscopic Approach | ||
04HQ03Z | Insertion of Infusion Device into Left Anterior Tibial Artery, Open Approach | ||
04HQ33Z | Insertion of Infusion Device into Left Anterior Tibial Artery, Percutaneous Approach | ||
04HQ43Z | Insertion of Infusion Device into Left Anterior Tibial Artery, Percutaneous Endoscopic Approach | ||
04HR03Z | Insertion of Infusion Device into Right Posterior Tibial Artery, Open Approach | ||
04HR33Z | Insertion of Infusion Device into Right Posterior Tibial Artery, Percutaneous Approach | ||
04HR43Z | Insertion of Infusion Device into Right Posterior Tibial Artery, Percutaneous Endoscopic Approach | ||
04HS03Z | Insertion of Infusion Device into Left Posterior Tibial Artery, Open Approach | ||
04HS33Z | Insertion of Infusion Device into Left Posterior Tibial Artery, Percutaneous Approach | ||
04HS43Z | Insertion of Infusion Device into Left Posterior Tibial Artery, Percutaneous Endoscopic Approach | ||
04HT03Z | Insertion of Infusion Device into Right Peroneal Artery, Open Approach | ||
04HT33Z | Insertion of Infusion Device into Right Peroneal Artery, Percutaneous Approach | ||
04HT43Z | Insertion of Infusion Device into Right Peroneal Artery, Percutaneous Endoscopic Approach | ||
04HU03Z | Insertion of Infusion Device into Left Peroneal Artery, Open Approach | ||
04HU33Z | Insertion of Infusion Device into Left Peroneal Artery, Percutaneous Approach | ||
04HU43Z | Insertion of Infusion Device into Left Peroneal Artery, Percutaneous Endoscopic Approach | ||
02NH3ZZ | Release Pulmonary Valve, Percutaneous Approach | ||
02NH4ZZ | Release Pulmonary Valve, Percutaneous Endoscopic Approach | ||
04HV03Z | Insertion of Infusion Device into Right Foot Artery, Open Approach | ||
04HV33Z | Insertion of Infusion Device into Right Foot Artery, Percutaneous Approach | ||
04HV43Z | Insertion of Infusion Device into Right Foot Artery, Percutaneous Endoscopic Approach | ||
04HW03Z | Insertion of Infusion Device into Left Foot Artery, Open Approach | ||
04HW33Z | Insertion of Infusion Device into Left Foot Artery, Percutaneous Approach | ||
04HW43Z | Insertion of Infusion Device into Left Foot Artery, Percutaneous Endoscopic Approach | ||
04HY03Z | Insertion of Infusion Device into Lower Artery, Open Approach | ||
04HY33Z | Insertion of Infusion Device into Lower Artery, Percutaneous Approach | ||
04HY43Z | Insertion of Infusion Device into Lower Artery, Percutaneous Endoscopic Approach | ||
38.93 | Venous catheterization, not elsewhere classified | 02H633Z | Insertion of Infusion Device into Right Atrium, Percutaneous Approach |
02HK33Z | Insertion of Infusion Device into Right Ventricle, Percutaneous Approach | ||
02HS03Z | Insertion of Infusion Device into Right Pulmonary Vein, Open Approach | ||
02HS33Z | Insertion of Infusion Device into Right Pulmonary Vein, Percutaneous Approach | ||
02HS43Z | Insertion of Infusion Device into Right Pulmonary Vein, Percutaneous Endoscopic Approach | ||
02HT03Z | Insertion of Infusion Device into Left Pulmonary Vein, Open Approach | ||
02HT33Z | Insertion of Infusion Device into Left Pulmonary Vein, Percutaneous Approach | ||
02HT43Z | Insertion of Infusion Device into Left Pulmonary Vein, Percutaneous Endoscopic Approach | ||
02HV03Z | Insertion of Infusion Device into Superior Vena Cava, Open Approach | ||
02HV33Z | Insertion of Infusion Device into Superior Vena Cava, Percutaneous Approach | ||
02HV43Z | Insertion of Infusion Device into Superior Vena Cava, Percutaneous Endoscopic Approach | ||
05H003Z | Insertion of Infusion Device into Azygos Vein, Open Approach | ||
05H033Z | Insertion of Infusion Device into Azygos Vein, Percutaneous Approach | ||
05H043Z | Insertion of Infusion Device into Azygos Vein, Percutaneous Endoscopic Approach | ||
05H103Z | Insertion of Infusion Device into Hemiazygos Vein, Open Approach | ||
05H133Z | Insertion of Infusion Device into Hemiazygos Vein, Percutaneous Approach | ||
05H143Z | Insertion of Infusion Device into Hemiazygos Vein, Percutaneous Endoscopic Approach | ||
05H303Z | Insertion of Infusion Device into Right Innominate Vein, Open Approach | ||
05H333Z | Insertion of Infusion Device into Right Innominate Vein, Percutaneous Approach | ||
05H343Z | Insertion of Infusion Device into Right Innominate Vein, Percutaneous Endoscopic Approach | ||
05H403Z | Insertion of Infusion Device into Left Innominate Vein, Open Approach | ||
05H433Z | Insertion of Infusion Device into Left Innominate Vein, Percutaneous Approach | ||
05H443Z | Insertion of Infusion Device into Left Innominate Vein, Percutaneous Endoscopic Approach | ||
05H503Z | Insertion of Infusion Device into Right Subclavian Vein, Open Approach | ||
05H533Z | Insertion of Infusion Device into Right Subclavian Vein, Percutaneous Approach | ||
05H543Z | Insertion of Infusion Device into Right Subclavian Vein, Percutaneous Endoscopic Approach | ||
05H603Z | Insertion of Infusion Device into Left Subclavian Vein, Open Approach | ||
05H633Z | Insertion of Infusion Device into Left Subclavian Vein, Percutaneous Approach | ||
05H643Z | Insertion of Infusion Device into Left Subclavian Vein, Percutaneous Endoscopic Approach | ||
05H703Z | Insertion of Infusion Device into Right Axillary Vein, Open Approach | ||
05H733Z | Insertion of Infusion Device into Right Axillary Vein, Percutaneous Approach | ||
05H743Z | Insertion of Infusion Device into Right Axillary Vein, Percutaneous Endoscopic Approach | ||
05H803Z | Insertion of Infusion Device into Left Axillary Vein, Open Approach | ||
05H833Z | Insertion of Infusion Device into Left Axillary Vein, Percutaneous Approach | ||
05H843Z | Insertion of Infusion Device into Left Axillary Vein, Percutaneous Endoscopic Approach | ||
05H903Z | Insertion of Infusion Device into Right Brachial Vein, Open Approach | ||
05H933Z | Insertion of Infusion Device into Right Brachial Vein, Percutaneous Approach | ||
05H943Z | Insertion of Infusion Device into Right Brachial Vein, Percutaneous Endoscopic Approach | ||
05HA03Z | Insertion of Infusion Device into Left Brachial Vein, Open Approach | ||
05HA33Z | Insertion of Infusion Device into Left Brachial Vein, Percutaneous Approach | ||
05HA43Z | Insertion of Infusion Device into Left Brachial Vein, Percutaneous Endoscopic Approach | ||
05HB03Z | Insertion of Infusion Device into Right Basilic Vein, Open Approach | ||
05HB33Z | Insertion of Infusion Device into Right Basilic Vein, Percutaneous Approach | ||
05HB43Z | Insertion of Infusion Device into Right Basilic Vein, Percutaneous Endoscopic Approach | ||
05HC03Z | Insertion of Infusion Device into Left Basilic Vein, Open Approach | ||
05HC33Z | Insertion of Infusion Device into Left Basilic Vein, Percutaneous Approach | ||
05HC43Z | Insertion of Infusion Device into Left Basilic Vein, Percutaneous Endoscopic Approach | ||
05HD03Z | Insertion of Infusion Device into Right Cephalic Vein, Open Approach | ||
05HD33Z | Insertion of Infusion Device into Right Cephalic Vein, Percutaneous Approach | ||
05HD43Z | Insertion of Infusion Device into Right Cephalic Vein, Percutaneous Endoscopic Approach | ||
05HF03Z | Insertion of Infusion Device into Left Cephalic Vein, Open Approach | ||
05HF33Z | Insertion of Infusion Device into Left Cephalic Vein, Percutaneous Approach | ||
05HF43Z | Insertion of Infusion Device into Left Cephalic Vein, Percutaneous Endoscopic Approach | ||
05HG03Z | Insertion of Infusion Device into Right Hand Vein, Open Approach | ||
05HG33Z | Insertion of Infusion Device into Right Hand Vein, Percutaneous Approach | ||
05HG43Z | Insertion of Infusion Device into Right Hand Vein, Percutaneous Endoscopic Approach | ||
05HH03Z | Insertion of Infusion Device into Left Hand Vein, Open Approach | ||
05HH33Z | Insertion of Infusion Device into Left Hand Vein, Percutaneous Approach | ||
05HH43Z | Insertion of Infusion Device into Left Hand Vein, Percutaneous Endoscopic Approach | ||
05HL03Z | Insertion of Infusion Device into Intracranial Vein, Open Approach | ||
05HL33Z | Insertion of Infusion Device into Intracranial Vein, Percutaneous Approach | ||
05HL43Z | Insertion of Infusion Device into Intracranial Vein, Percutaneous Endoscopic Approach | ||
05HM03Z | Insertion of Infusion Device into Right Internal Jugular Vein, Open Approach | ||
05HM33Z | Insertion of Infusion Device into Right Internal Jugular Vein, Percutaneous Approach | ||
05HM43Z | Insertion of Infusion Device into Right Internal Jugular Vein, Percutaneous Endoscopic Approach | ||
05HN03Z | Insertion of Infusion Device into Left Internal Jugular Vein, Open Approach | ||
05HN33Z | Insertion of Infusion Device into Left Internal Jugular Vein, Percutaneous Approach | ||
05HN43Z | Insertion of Infusion Device into Left Internal Jugular Vein, Percutaneous Endoscopic Approach | ||
05HP03Z | Insertion of Infusion Device into Right External Jugular Vein, Open Approach | ||
05HP33Z | Insertion of Infusion Device into Right External Jugular Vein, Percutaneous Approach | ||
05HP43Z | Insertion of Infusion Device into Right External Jugular Vein, Percutaneous Endoscopic Approach | ||
05HQ03Z | Insertion of Infusion Device into Left External Jugular Vein, Open Approach | ||
05HQ33Z | Insertion of Infusion Device into Left External Jugular Vein, Percutaneous Approach | ||
05HQ43Z | Insertion of Infusion Device into Left External Jugular Vein, Percutaneous Endoscopic Approach | ||
05HR03Z | Insertion of Infusion Device into Right Vertebral Vein, Open Approach | ||
05HR33Z | Insertion of Infusion Device into Right Vertebral Vein, Percutaneous Approach | ||
05HR43Z | Insertion of Infusion Device into Right Vertebral Vein, Percutaneous Endoscopic Approach | ||
05HS03Z | Insertion of Infusion Device into Left Vertebral Vein, Open Approach | ||
05HS33Z | Insertion of Infusion Device into Left Vertebral Vein, Percutaneous Approach | ||
05HS43Z | Insertion of Infusion Device into Left Vertebral Vein, Percutaneous Endoscopic Approach | ||
05HT03Z | Insertion of Infusion Device into Right Face Vein, Open Approach | ||
05HT33Z | Insertion of Infusion Device into Right Face Vein, Percutaneous Approach | ||
05HT43Z | Insertion of Infusion Device into Right Face Vein, Percutaneous Endoscopic Approach | ||
05HV03Z | Insertion of Infusion Device into Left Face Vein, Open Approach | ||
05HV33Z | Insertion of Infusion Device into Left Face Vein, Percutaneous Approach | ||
05HV43Z | Insertion of Infusion Device into Left Face Vein, Percutaneous Endoscopic Approach | ||
05HY03Z | Insertion of Infusion Device into Upper Vein, Open Approach | ||
05HY33Z | Insertion of Infusion Device into Upper Vein, Percutaneous Approach | ||
05HY43Z | Insertion of Infusion Device into Upper Vein, Percutaneous Endoscopic Approach | ||
06H003Z | Insertion of Infusion Device into Inferior Vena Cava, Open Approach | ||
06H033Z | Insertion of Infusion Device into Inferior Vena Cava, Percutaneous Approach | ||
06H043Z | Insertion of Infusion Device into Inferior Vena Cava, Percutaneous Endoscopic Approach | ||
06H103Z | Insertion of Infusion Device into Splenic Vein, Open Approach | ||
06H133Z | Insertion of Infusion Device into Splenic Vein, Percutaneous Approach | ||
06H143Z | Insertion of Infusion Device into Splenic Vein, Percutaneous Endoscopic Approach | ||
06H203Z | Insertion of Infusion Device into Gastric Vein, Open Approach | ||
06H233Z | Insertion of Infusion Device into Gastric Vein, Percutaneous Approach | ||
06H243Z | Insertion of Infusion Device into Gastric Vein, Percutaneous Endoscopic Approach | ||
06H303Z | Insertion of Infusion Device into Esophageal Vein, Open Approach | ||
06H333Z | Insertion of Infusion Device into Esophageal Vein, Percutaneous Approach | ||
06H343Z | Insertion of Infusion Device into Esophageal Vein, Percutaneous Endoscopic Approach | ||
06H403Z | Insertion of Infusion Device into Hepatic Vein, Open Approach | ||
06H433Z | Insertion of Infusion Device into Hepatic Vein, Percutaneous Approach | ||
06H443Z | Insertion of Infusion Device into Hepatic Vein, Percutaneous Endoscopic Approach | ||
06H503Z | Insertion of Infusion Device into Superior Mesenteric Vein, Open Approach | ||
06H533Z | Insertion of Infusion Device into Superior Mesenteric Vein, Percutaneous Approach | ||
06H543Z | Insertion of Infusion Device into Superior Mesenteric Vein, Percutaneous Endoscopic Approach | ||
06H603Z | Insertion of Infusion Device into Inferior Mesenteric Vein, Open Approach | ||
06H633Z | Insertion of Infusion Device into Inferior Mesenteric Vein, Percutaneous Approach | ||
06H643Z | Insertion of Infusion Device into Inferior Mesenteric Vein, Percutaneous Endoscopic Approach | ||
06H703Z | Insertion of Infusion Device into Colic Vein, Open Approach | ||
06H733Z | Insertion of Infusion Device into Colic Vein, Percutaneous Approach | ||
06H743Z | Insertion of Infusion Device into Colic Vein, Percutaneous Endoscopic Approach | ||
06H803Z | Insertion of Infusion Device into Portal Vein, Open Approach | ||
06H833Z | Insertion of Infusion Device into Portal Vein, Percutaneous Approach | ||
06H843Z | Insertion of Infusion Device into Portal Vein, Percutaneous Endoscopic Approach | ||
06H903Z | Insertion of Infusion Device into Right Renal Vein, Open Approach | ||
06H933Z | Insertion of Infusion Device into Right Renal Vein, Percutaneous Approach | ||
06H943Z | Insertion of Infusion Device into Right Renal Vein, Percutaneous Endoscopic Approach | ||
06HB03Z | Insertion of Infusion Device into Left Renal Vein, Open Approach | ||
06HB33Z | Insertion of Infusion Device into Left Renal Vein, Percutaneous Approach | ||
06HB43Z | Insertion of Infusion Device into Left Renal Vein, Percutaneous Endoscopic Approach | ||
06HC03Z | Insertion of Infusion Device into Right Common Iliac Vein, Open Approach | ||
06HC33Z | Insertion of Infusion Device into Right Common Iliac Vein, Percutaneous Approach | ||
06HC43Z | Insertion of Infusion Device into Right Common Iliac Vein, Percutaneous Endoscopic Approach | ||
06HD03Z | Insertion of Infusion Device into Left Common Iliac Vein, Open Approach | ||
06HD33Z | Insertion of Infusion Device into Left Common Iliac Vein, Percutaneous Approach | ||
06HD43Z | Insertion of Infusion Device into Left Common Iliac Vein, Percutaneous Endoscopic Approach | ||
06HF03Z | Insertion of Infusion Device into Right External Iliac Vein, Open Approach | ||
06HF33Z | Insertion of Infusion Device into Right External Iliac Vein, Percutaneous Approach | ||
06HF43Z | Insertion of Infusion Device into Right External Iliac Vein, Percutaneous Endoscopic Approach | ||
06HG03Z | Insertion of Infusion Device into Left External Iliac Vein, Open Approach | ||
06HG33Z | Insertion of Infusion Device into Left External Iliac Vein, Percutaneous Approach | ||
06HG43Z | Insertion of Infusion Device into Left External Iliac Vein, Percutaneous Endoscopic Approach | ||
06HH03Z | Insertion of Infusion Device into Right Hypogastric Vein, Open Approach | ||
06HH33Z | Insertion of Infusion Device into Right Hypogastric Vein, Percutaneous Approach | ||
06HH43Z | Insertion of Infusion Device into Right Hypogastric Vein, Percutaneous Endoscopic Approach | ||
06HJ03Z | Insertion of Infusion Device into Left Hypogastric Vein, Open Approach | ||
06HJ33Z | Insertion of Infusion Device into Left Hypogastric Vein, Percutaneous Approach | ||
06HJ43Z | Insertion of Infusion Device into Left Hypogastric Vein, Percutaneous Endoscopic Approach | ||
06HM03Z | Insertion of Infusion Device into Right Femoral Vein, Open Approach | ||
06HM33Z | Insertion of Infusion Device into Right Femoral Vein, Percutaneous Approach | ||
06HM43Z | Insertion of Infusion Device into Right Femoral Vein, Percutaneous Endoscopic Approach | ||
06HN03Z | Insertion of Infusion Device into Left Femoral Vein, Open Approach | ||
06HN33Z | Insertion of Infusion Device into Left Femoral Vein, Percutaneous Approach | ||
06HN43Z | Insertion of Infusion Device into Left Femoral Vein, Percutaneous Endoscopic Approach | ||
06HP03Z | Insertion of Infusion Device into Right Greater Saphenous Vein, Open Approach | ||
06HP33Z | Insertion of Infusion Device into Right Greater Saphenous Vein, Percutaneous Approach | ||
06HP43Z | Insertion of Infusion Device into Right Greater Saphenous Vein, Percutaneous Endoscopic Approach | ||
06HQ03Z | Insertion of Infusion Device into Left Greater Saphenous Vein, Open Approach | ||
06HQ33Z | Insertion of Infusion Device into Left Greater Saphenous Vein, Percutaneous Approach | ||
06HQ43Z | Insertion of Infusion Device into Left Greater Saphenous Vein, Percutaneous Endoscopic Approach | ||
06HR03Z | Insertion of Infusion Device into Right Lesser Saphenous Vein, Open Approach | ||
06HR33Z | Insertion of Infusion Device into Right Lesser Saphenous Vein, Percutaneous Approach | ||
06HR43Z | Insertion of Infusion Device into Right Lesser Saphenous Vein, Percutaneous Endoscopic Approach | ||
06HS03Z | Insertion of Infusion Device into Left Lesser Saphenous Vein, Open Approach | ||
06HS33Z | Insertion of Infusion Device into Left Lesser Saphenous Vein, Percutaneous Approach | ||
06HS43Z | Insertion of Infusion Device into Left Lesser Saphenous Vein, Percutaneous Endoscopic Approach | ||
06HT03Z | Insertion of Infusion Device into Right Foot Vein, Open Approach | ||
06HT33Z | Insertion of Infusion Device into Right Foot Vein, Percutaneous Approach | ||
06HT43Z | Supplement Pulmonary Valve with Synthetic Substitute, Percutaneous Approach | ||
06HV03Z | Insertion of Infusion Device into Right Foot Vein, Percutaneous Endoscopic Approach | ||
02UH47Z | Insertion of Infusion Device into Left Foot Vein, Open Approach | ||
06HV33Z | Insertion of Infusion Device into Left Foot Vein, Percutaneous Approach | ||
06HV43Z | Insertion of Infusion Device into Left Foot Vein, Percutaneous Endoscopic Approach | ||
06HY03Z | Insertion of Infusion Device into Lower Vein, Open Approach | ||
06HY33Z | Insertion of Infusion Device into Lower Vein, Percutaneous Approach | ||
06HY43Z | Insertion of Infusion Device into Lower Vein, Percutaneous Endoscopic Approach | ||
0JH60XZ | Insertion of Vascular Access Device into Chest Subcutaneous Tissue and Fascia, Open Approach | ||
0JH63XZ | Insertion of Vascular Access Device into Chest Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
0JH80XZ | Insertion of Vascular Access Device into Abdomen Subcutaneous Tissue and Fascia, Open Approach | ||
0JH83XZ | Insertion of Vascular Access Device into Abdomen Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
0JHD0XZ | Insertion of Vascular Access Device into Right Upper Arm Subcutaneous Tissue and Fascia, Open Approach | ||
0JHD3XZ | Insertion of Vascular Access Device into Right Upper Arm Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
0JHF0XZ | Insertion of Vascular Access Device into Left Upper Arm Subcutaneous Tissue and Fascia, Open Approach | ||
0JHF3XZ | Insertion of Vascular Access Device into Left Upper Arm Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
0JHG0XZ | Insertion of Vascular Access Device into Right Lower Arm Subcutaneous Tissue and Fascia, Open Approach | ||
0JHG3XZ | Insertion of Vascular Access Device into Right Lower Arm Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
0JHH0XZ | Insertion of Vascular Access Device into Left Lower Arm Subcutaneous Tissue and Fascia, Open Approach | ||
0JHH3XZ | Insertion of Vascular Access Device into Left Lower Arm Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
0JHL0XZ | Insertion of Vascular Access Device into Right Upper Leg Subcutaneous Tissue and Fascia, Open Approach | ||
0JHL3XZ | Insertion of Vascular Access Device into Right Upper Leg Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
0JHM0XZ | Insertion of Vascular Access Device into Left Upper Leg Subcutaneous Tissue and Fascia, Open Approach | ||
0JHM3XZ | Insertion of Vascular Access Device into Left Upper Leg Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
0JHN0XZ | Insertion of Vascular Access Device into Right Lower Leg Subcutaneous Tissue and Fascia, Open Approach | ||
0JHN3XZ | Insertion of Vascular Access Device into Right Lower Leg Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
0JHP0XZ | Insertion of Vascular Access Device into Left Lower Leg Subcutaneous Tissue and Fascia, Open Approach | ||
0JHP3XZ | Insertion of Vascular Access Device into Left Lower Leg Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
89.62 | Central venous pressure monitoring | 4A04XB1 | Measurement of Venous Pressure, Peripheral, External Approach |
4A14XB1 | Monitoring of Venous Pressure, Peripheral, External Approach | ||
89.64 | Pulmonary artery wedge monitoring | 02HP00Z | Insertion of Pressure Sensor Monitoring Device into Pulmonary Trunk, Open Approach |
02HP02Z | Insertion of Monitoring Device into Pulmonary Trunk, Open Approach | ||
02HP30Z | Insertion of Pressure Sensor Monitoring Device into Pulmonary Trunk, Percutaneous Approach | ||
02HP32Z | Insertion of Monitoring Device into Pulmonary Trunk, Percutaneous Approach | ||
02HP40Z | Insertion of Pressure Sensor Monitoring Device into Pulmonary Trunk, Percutaneous Endoscopic Approach | ||
02HP42Z | Insertion of Monitoring Device into Pulmonary Trunk, Percutaneous Endoscopic Approach | ||
02HQ00Z | Insertion of Pressure Sensor Monitoring Device into Right Pulmonary Artery, Open Approach | ||
02HQ02Z | Insertion of Monitoring Device into Right Pulmonary Artery, Open Approach | ||
02HQ30Z | Insertion of Pressure Sensor Monitoring Device into Right Pulmonary Artery, Percutaneous Approach | ||
02HQ32Z | Insertion of Monitoring Device into Right Pulmonary Artery, Percutaneous Approach | ||
02HQ40Z | Insertion of Pressure Sensor Monitoring Device into Right Pulmonary Artery, Percutaneous Endoscopic Approach | ||
02HQ42Z | Insertion of Monitoring Device into Right Pulmonary Artery, Percutaneous Endoscopic Approach | ||
02HR00Z | Insertion of Pressure Sensor Monitoring Device into Left Pulmonary Artery, Open Approach | ||
02HR02Z | Insertion of Monitoring Device into Left Pulmonary Artery, Open Approach | ||
02HR30Z | Insertion of Pressure Sensor Monitoring Device into Left Pulmonary Artery, Percutaneous Approach | ||
02HR32Z | Insertion of Monitoring Device into Left Pulmonary Artery, Percutaneous Approach | ||
02HR40Z | Insertion of Pressure Sensor Monitoring Device into Left Pulmonary Artery, Percutaneous Endoscopic Approach | ||
02HR42Z | Insertion of Monitoring Device into Left Pulmonary Artery, Percutaneous Endoscopic Approach | ||
4A0239Z | Measurement of Cardiac Output, Percutaneous Approach | ||
4A1239Z | Monitoring of Cardiac Output, Percutaneous Approach | ||
89.68 | Monitoring of cardiac output by other technique | 4A030JC | Measurement of Arterial Pulse, Coronary, Open Approach |
4A033JC | Measurement of Arterial Pulse, Coronary, Percutaneous Approach | ||
4A1209Z | Monitoring of Cardiac Output, Open Approach | ||
4A12X9Z | Monitoring of Cardiac Output, External Approach | ||
4A030JC | Measurement of Arterial Pulse, Coronary, Open Approach | ||
4A033JC | Measurement of Arterial Pulse, Coronary, Percutaneous Approach | ||
4A1209Z | Monitoring of Cardiac Output, Open Approach | ||
4A12X9Z | Monitoring of Cardiac Output, External Approach | ||
Reimbursement information provided by Edwards Lifesciences is gathered from third-party sources and is presented for informational purposes only. Edwards makes no representation, warranty or guarantee as to the timeliness, accuracy or completeness of the information and such information is not, and should not be construed as reimbursement, coding or legal advice. Any and all references to reimbursement codes are provided as examples only and are not intended to be a recommendation or advice as to the appropriate code for the a particular patient, diagnosis, product or procedure or a guarantee or promise of coverage or payment, nor does Edwards Lifesciences warranty that codes listed are appropriate in all related clinical scenarios. It is the responsibility of the provider to determine if coverage exists and what requirements are necessary for submitting a proper claim for reimbursement to a health plan or payer, including the appropriate code(s) for products provided or services rendered. Laws, regulations, and payer policies concerning reimbursement are complex and change frequently; service providers are responsible for all decisions relating to coding and reimbursement submissions. Medicare’s Correct Coding Initiative and commercial payer policies are reviewed and updated several times each year. Accordingly, Edwards strongly recommends consultation with payers, reimbursement specialists and/or legal counsel regarding appropriate product or procedure codes, coverage, and reimbursement matters.
References- Current Procedural Terminology (CPT) copyright 2015, American Medical Association (AMA). All rights reserved. CPT is a registered trademark of the AMA. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. Applicable FARS/DFARS restrictions apply to government use.
- Not all codes provided are applicable for the clinical scenarios in which Edwards Lifesciences’ Critical Care technologies are used. The provider is responsible for selecting the most appropriate code(s) for the patient’s clinical presentation. When radiologic guidance is used for catheter placement, it may be appropriate to add applicable codes according to the service provided following correct coding guidelines. Services that are considered a component of another procedure may not always be coded and billed separately.
- For all Medicare payments for physician, hospital outpatient, and ASC services, the multiple procedure reduction rule may apply. Consult with coding and billing staff, and payer policy for further guidance. National average Medicare payment is calculated using the Conversion Factor of $35.8279 per the Medicare Physician Fee Schedule for Calendar Year 2016 Final Rule issued October 30, 2015. National average is based on factors such as geography, teaching vs. non-teaching hospital, rural vs. urban area, etc. and your payment may be different based on these factors. This payment will differ for commercial payers. Payments are effective January 1, 2016 through December 31, 2016.
- National Uniform Billing Committee, American Hospital Association.
- Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Rules and Regulations: This final rule adopts modifications to two of the code set standards adopted in the Transactions and Code Sets final rule published in the Federal Register pursuant to certain provisions of the Administrative Simplification subtitle of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Specifically, this final rule modifies the standard medical data code sets (hereinafter ‘‘code sets’’) for coding diagnoses and inpatient hospital procedures by concurrently adopting the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) for diagnosis coding, including the Official ICD-10-CM Guidelines for Coding and Reporting, as maintained and distributed by the U.S. Department of Health and Human Services (HHS), hereinafter referred to as ICD-10-CM, and the International Classification of Diseases, 10th Revision, Procedure Coding System (ICD-10-PCS) for inpatient hospital procedure coding, including the Official ICD-10-PCS Guidelines for Coding and Reporting, as maintained and distributed by the HHS, hereinafter referred to as ICD-10-PCS. These new codes replace the International Classification of Diseases, 9th Revision, Clinical Modification, Volumes 1 and 2, including the Official ICD-9-CM Guidelines for Coding and Reporting, hereinafter referred to as ICD-9-CM Volumes 1 and 2, and the International Classification of Diseases, 9th Revision, Clinical Modification, Volume 3, including the Official ICD-9-CM Guidelines for Coding and Reporting, hereinafter referred to as ICD-9-CM Volume 3, for diagnosis and procedure codes, respectively. DATES: The effective date of this regulation is March 17, 2009. The effective date is the date that the policies herein take effect, and new policies are considered to be officially adopted. The compliance date, which is different than the effective date, is the date on which entities are required to have implemented the policies adopted in this rule. The compliance date for this regulation is October 1, 2015.
- International Classification of Diseases, 9th Revision, Clinical Modification 2015 ICD-9-CM for hospitals, volume 1, 2, & 3.
- International Classification of Diseases, 10th Revision, Procedure Coding System 2015 Draft.
2016 Facility and Physician Billing Guide
Clinicians and outpatient facilities use Current Procedural Terminology (CPT1) codes to bill for procedures and services. Each CPT code is assigned unique relative value units (RVUs), which are used to determine payment by the Centers for Medicare & Medicaid Services (CMS). Some commonly billed CPT codes used to describe procedures related to Edwards Lifesciences’ Vascular technologies (e.g. Fogarty catheters) are listed below.2 This list may not be comprehensive or complete. These procedures may be subject to the CMS multiple procedure reduction rule. When applicable, a payment reduction of 50% is applied to all payment amounts except the procedure with the greatest RVUs, which is paid at 100% unless exempt by CPT instructions or payer policy. This rule does not normally apply to radiologic procedures.
Procedures related to the use of Edwards Lifesciences’ technologies (e.g. Fogarty catheters) are often performed in a facility setting, including an outpatient hospital department (OPPS, Place of Service (POS) code 22), Ambulatory Surgery Center (ASC, POS code 24), or a Vascular Access Center (which can be licensed as POS 11, 22, or 24). Reimbursement is determined based upon services rendered and varies by place of service. The following are commonly billed codes and associated national average Medicare payment amounts. This list may not be comprehensive and complete.
Interventional Procedures3 |
Medicare National Average Physician Payment4 |
Medicare National Average Facility Payment |
||||
CPT Code | Description | Facility Setting (Various POSs) | Non-Facility Setting (Including POS 11) | Outpatient Hospital5 (POS 22) | ASC (POS 24) | |
35301 | Thromboendarterectomy, including patch graft, if performed; carotid, vertebral, subclavian, by neck incision | $1,198 | Facility Only | n/a | n/a | n/a |
35390 | Reoperation, carotid, thromboendarterectomy, more than 1 month after original operation (list separately in addition to code for primary procedure) | $167 | Facility Only | n/a | n/a | n/a |
361476 | Introduction of needle and/or catheter, arteriovenous shunt created for dialysis (graft/fistula); initial access with complete radiological evaluation of dialysis access, including fluoroscopy, image documentation and report (includes access of shunt, injection(s) of contrast, and all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava) | $194 | $853 | APC 0668 |
$863 | $482 |
361487 | Introduction of needle and/or catheter, arteriovenous shunt created for dialysis (graft/fistula); additional access for therapeutic intervention (List separately in addition to code for primary procedure) | $51 | $267 | n/a | n/a | n/a |
36831 | Thrombectomy, open, arteriovenous fistula without revision, autogenous or non-autogenous dialysis graft (separate procedure) | $654 | Facility Only | APC 5182 |
$2,247 | $1,257 |
36833 | Revision, open, arteriovenous fistula; with thrombectomy, autogenous or non-autogenous dialysis graft (separate procedure) | $858 | Facility Only | APC 5183 |
$3,795 | $2,122 |
36870 | Thrombectomy, percutaneous, arteriovenous fistula; autogenous or nonautogenous graft (includes mechanical thrombus extraction and intra-graft thrombolysis) | $312 | $1,867 | APC 5191 |
$4,592 | $2,288 |
37211 | Transcatheter therapy, arterial infusion for thrombolysis other than coronary, any method, including radiological supervision and interpretation, initial treatment day | $419 | Facility Only | APC 5183 |
$3,795 | $2,122 |
37212 | Transcatheter therapy, venous infusion for thrombolysis, any method, including radiological supervision and interpretation, initial treatment day | $368 | Facility Only | APC 5181 |
$862 | $482 |
37213 | Transcatheter therapy, arterial or venous infusion for thrombolysis other than coronary, any method, including radiological supervision and interpretation, continued treatment on subsequent day during course of thrombolytic therapy, including follow-up catheter contrast injection, position change, or exchange, when performed | $259 | Facility Only | APC 5182 |
$2,247 | n/a |
37214 | Transcatheter therapy, arterial or venous infusion for thrombolysis other than coronary, any method, including radiological supervision and interpretation, continued treatment on subsequent day during course of thrombolytic therapy, including follow-up catheter contrast injection, position change, or exchange, when performed; cessation of thrombolysis including removal of catheter and vessel closure by any method | $142 | Facility Only | APC 5182 |
$2,247 | n/a |
REVENUE CODES 8 AND HCPCS CODES
Revenue codes help hospitals categorize services provided by revenue center. Medicare utilizes revenue codes for cost reporting purposes. It may be appropriate for hospitals to capture the cost of products used for these procedures for payer reporting or cost accounting purposes as expenses within Revenue Code 0278 (Medical/Surgical Supply – Other Implants) on the hospital UB-04 billing form. CMS uses C-codes under the Outpatient Prospective Payment System (OPPS) to track device cost information for future APC rate-setting purposes. No additional facility payment is associated with these codes. CMS may reject hospital claims if the appropriate C codes used to report device costs are not identified on the claim. Edwards Lifesciences’ Vascular technologies can be used in both the inpatient and outpatient setting. C codes which may apply to the use of these products in the outpatient setting are listed below. Procedure codes associated with these products are not necessarily included within this document.
C Code | Description | Edwards Product Examples |
---|---|---|
C1757 | Thrombectomy/ Embolectomy Catheter | Fogarty and Fogarty Fortis thrombectomy and embolectomy catheters: 120403F-120807F, 12A0403F-12A1004F, NL2EMB40-NL7EMB80, 12TLW403F-12TLW807F, 140806-1408010, 160245F, 160245F, 160246F, 320806F-32080810F |
C2628 | Catheter, occlusion | 620403F, 620404F, 620405F, 62080814F, 62080822F |
Medicare inpatient hospital reimbursement is based upon the Medicare Severity-Diagnostic Related Group (MS-DRG) classification system, which assigns MS-DRGs based on ICD-9-CM diagnosis and procedure codes. Although the compliance date for mandatory use of ICD-10 codes is October 1, 20159, this guide is intended to provide the cross-over codes for testing purposes only. Given Medicare and other payers are encouraging the provider community to perform parallel coding and test the claims systems, this guide will provide the necessary conversion from ICD-9 codes to the appropriate ICD-10 codes.
ICD-9-CM Procedure Code10 | Description | ICD-10-CM Procedure Code11 | Description |
---|---|---|---|
38.12 | Endarterectomy, other vessels of head and neck | 03CH0ZZ | Extirpation of Matter from Right Common Carotid Artery, Open Approach |
03CH4ZZ | Extirpation of Matter from Right Common Carotid Artery, Percutaneous Endoscopic Approach | ||
03CJ0ZZ | Extirpation of Matter from Left Common Carotid Artery, Open Approach | ||
03CJ4ZZ | Extirpation of Matter from Left Common Carotid Artery, Percutaneous Endoscopic Approach | ||
03CK0ZZ | Extirpation of Matter from Right Internal Carotid Artery, Open Approach | ||
03CK4ZZ | Extirpation of Matter from Right Internal Carotid Artery, Percutaneous Endoscopic Approach | ||
03CL0ZZ | Extirpation of Matter from Left Internal Carotid Artery, Open Approach | ||
03CL4ZZ | Extirpation of Matter from Left Internal Carotid Artery, Percutaneous Endoscopic Approach | ||
03CM0ZZ | Extirpation of Matter from Right External Carotid Artery, Open Approach | ||
03CM4ZZ | Extirpation of Matter from Right External Carotid Artery, Percutaneous Endoscopic Approach | ||
03CN0ZZ | Extirpation of Matter from Left External Carotid Artery, Open Approach | ||
03CN4ZZ | Extirpation of Matter from Left External Carotid Artery, Percutaneous Endoscopic Approach | ||
03CP0ZZ | Extirpation of Matter from Right Vertebral Artery, Open Approach | ||
03CP4ZZ | Extirpation of Matter from Right Vertebral Artery, Percutaneous Endoscopic Approach | ||
03CQ0ZZ | Extirpation of Matter from Left Vertebral Artery, Open Approach | ||
03CQ4ZZ | Extirpation of Matter from Left Vertebral Artery, Percutaneous Endoscopic Approach | ||
03CR0ZZ | Extirpation of Matter from Face Artery, Open Approach | ||
03CR3ZZ | Extirpation of Matter from Face Artery, Percutaneous Approach | ||
03CR4ZZ | Extirpation of Matter from Face Artery, Percutaneous Endoscopic Approach | ||
03CS0ZZ | Extirpation of Matter from Right Temporal Artery, Open Approach | ||
03CS3ZZ | Extirpation of Matter from Right Temporal Artery, Percutaneous Approach | ||
03CS4ZZ | Extirpation of Matter from Right Temporal Artery, Percutaneous Endoscopic Approach | ||
03CT0ZZ | Extirpation of Matter from Left Temporal Artery, Open Approach | ||
03CT3ZZ | Extirpation of Matter from Left Temporal Artery, Percutaneous Approach | ||
03CT4ZZ | Extirpation of Matter from Left Temporal Artery, Percutaneous Endoscopic Approach | ||
03CU0ZZ | Extirpation of Matter from Right Thyroid Artery, Open Approach | ||
03CU3ZZ | Extirpation of Matter from Right Thyroid Artery, Percutaneous Approach | ||
03CU4ZZ | Extirpation of Matter from Right Thyroid Artery, Percutaneous Endoscopic Approach | ||
03CV0ZZ | Extirpation of Matter from Left Thyroid Artery, Open Approach | ||
03CV3ZZ | Extirpation of Matter from Left Thyroid Artery, Percutaneous Approach | ||
03CV4ZZ | Extirpation of Matter from Left Thyroid Artery, Percutaneous Endoscopic Approach | ||
38.32 | Resection of other vessels of head and neck with anastomosis | 03BH0ZZ | Excision of Right Common Carotid Artery, Open Approach |
03BH4ZZ | Excision of Right Common Carotid Artery, Percutaneous Endoscopic Approach | ||
03BJ0ZZ | Excision of Left Common Carotid Artery, Open Approach | ||
03BJ4ZZ | Excision of Left Common Carotid Artery, Percutaneous Endoscopic Approach | ||
03BK0ZZ | Excision of Right Internal Carotid Artery, Open Approach | ||
03BK4ZZ | Excision of Right Internal Carotid Artery, Percutaneous Endoscopic Approach | ||
03BL0ZZ | Excision of Left Internal Carotid Artery, Open Approach | ||
03BL4ZZ | Excision of Left Internal Carotid Artery, Percutaneous Endoscopic Approach | ||
03BM0ZZ | Excision of Right External Carotid Artery, Open Approach | ||
03BM4ZZ | Excision of Right External Carotid Artery, Percutaneous Endoscopic Approach | ||
03BN0ZZ | Excision of Left External Carotid Artery, Open Approach | ||
03BN4ZZ | Excision of Left External Carotid Artery, Percutaneous Endoscopic Approach | ||
03BP0ZZ | Excision of Right Vertebral Artery, Open Approach | ||
03BP4ZZ | Excision of Right Vertebral Artery, Percutaneous Endoscopic Approach | ||
03BQ0ZZ | Excision of Left Vertebral Artery, Open Approach | ||
03BQ4ZZ | Excision of Left Vertebral Artery, Percutaneous Endoscopic Approach | ||
03BR0ZZ | Excision of Face Artery, Open Approach | ||
03BR4ZZ | Excision of Face Artery, Percutaneous Endoscopic Approach | ||
03BS0ZZ | Excision of Right Temporal Artery, Open Approach | ||
03BS4ZZ | Excision of Right Temporal Artery, Percutaneous Endoscopic Approach | ||
03BT0ZZ | Excision of Left Temporal Artery, Open Approach | ||
03BT4ZZ | Excision of Left Temporal Artery, Percutaneous Endoscopic Approach | ||
03BU0ZZ | Excision of Right Thyroid Artery, Open Approach | ||
03BU4ZZ | Excision of Right Thyroid Artery, Percutaneous Endoscopic Approach | ||
03BV0ZZ | Excision of Left Thyroid Artery, Open Approach | ||
03BV4ZZ | Excision of Left Thyroid Artery, Percutaneous Endoscopic Approach | ||
05BM0ZZ | Excision of Right Internal Jugular Vein, Open Approach | ||
05BM4ZZ | Excision of Right Internal Jugular Vein, Percutaneous Endoscopic Approach | ||
05BN0ZZ | Excision of Left Internal Jugular Vein, Open Approach | ||
05BN4ZZ | Excision of Left Internal Jugular Vein, Percutaneous Endoscopic Approach | ||
05BP0ZZ | Excision of Right External Jugular Vein, Open Approach | ||
05BP4ZZ | Excision of Right External Jugular Vein, Percutaneous Endoscopic Approach | ||
05BQ0ZZ | Excision of Left External Jugular Vein, Open Approach | ||
05BQ4ZZ | Excision of Left External Jugular Vein, Percutaneous Endoscopic Approach | ||
05BR0ZZ | Excision of Right Vertebral Vein, Open Approach | ||
05BR4ZZ | Excision of Right Vertebral Vein, Percutaneous Endoscopic Approach | ||
05BS0ZZ | Excision of Left Vertebral Vein, Open Approach | ||
05BS4ZZ | Excision of Left Vertebral Vein, Percutaneous Endoscopic Approach | ||
05BT0ZZ | Excision of Right Face Vein, Open Approach | ||
05BT4ZZ | Excision of Right Face Vein, Percutaneous Endoscopic Approach | ||
05BV0ZZ | Excision of Left Face Vein, Open Approach | ||
05BV4ZZ | Excision of Left Face Vein, Percutaneous Endoscopic Approach | ||
38.42 | Resection of other vessel of head and neck replacement; carotid artery (common) (external) (internal), jugular vein (external) (internal) | 03RH07Z | Replacement of Right Common Carotid Artery with Autologous Tissue Substitute, Open Approach |
03RH0JZ | Replacement of Right Common Carotid Artery with Synthetic Substitute, Open Approach | ||
03RH0KZ | Replacement of Right Common Carotid Artery with Nonautologous Tissue Substitute, Open Approach | ||
03RH47Z | Replacement of Right Common Carotid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RH4JZ | Replacement of Right Common Carotid Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
03RH4KZ | Replacement of Right Common Carotid Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RJ07Z | Replacement of Left Common Carotid Artery with Autologous Tissue Substitute, Open Approach | ||
03RJ0JZ | Replacement of Left Common Carotid Artery with Synthetic Substitute, Open Approach | ||
03RJ0KZ | Replacement of Left Common Carotid Artery with Nonautologous Tissue Substitute, Open Approach | ||
03RJ47Z | Replacement of Left Common Carotid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RJ4JZ | Replacement of Left Common Carotid Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
03RJ4KZ | Replacement of Left Common Carotid Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RK07Z | Replacement of Right Internal Carotid Artery with Autologous Tissue Substitute, Open Approach | ||
03RK0JZ | Replacement of Right Internal Carotid Artery with Synthetic Substitute, Open Approach | ||
03RK0KZ | Replacement of Right Internal Carotid Artery with Nonautologous Tissue Substitute, Open Approach | ||
03RK47Z | Replacement of Right Internal Carotid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RK4JZ | Replacement of Right Internal Carotid Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
03RK4KZ | Replacement of Right Internal Carotid Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RL07Z | Replacement of Left Internal Carotid Artery with Autologous Tissue Substitute, Open Approach | ||
03RL0JZ | Replacement of Left Internal Carotid Artery with Synthetic Substitute, Open Approach | ||
03RL0KZ | Replacement of Left Internal Carotid Artery with Nonautologous Tissue Substitute, Open Approach | ||
03RL47Z | Replacement of Left Internal Carotid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RL4JZ | Replacement of Left Internal Carotid Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
03RL4KZ | Replacement of Left Internal Carotid Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RM07Z | Replacement of Right External Carotid Artery with Autologous Tissue Substitute, Open Approach | ||
03RM0JZ | Replacement of Right External Carotid Artery with Synthetic Substitute, Open Approach | ||
03RM0KZ | Replacement of Right External Carotid Artery with Nonautologous Tissue Substitute, Open Approach | ||
03RM47Z | Replacement of Right External Carotid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RM4JZ | Replacement of Right External Carotid Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
03RM4KZ | Replacement of Right External Carotid Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RN07Z | Replacement of Left External Carotid Artery with Autologous Tissue Substitute, Open Approach | ||
03RN0JZ | Replacement of Left External Carotid Artery with Synthetic Substitute, Open Approach | ||
03RN0KZ | Replacement of Left External Carotid Artery with Nonautologous Tissue Substitute, Open Approach | ||
03RN47Z | Replacement of Left External Carotid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RN4JZ | Replacement of Left External Carotid Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
03RN4KZ | Replacement of Left External Carotid Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RP07Z | Replacement of Right Vertebral Artery with Autologous Tissue Substitute, Open Approach | ||
03RP0JZ | Replacement of Right Vertebral Artery with Synthetic Substitute, Open Approach | ||
03RP0KZ | Replacement of Right Vertebral Artery with Nonautologous Tissue Substitute, Open Approach | ||
03RP47Z | Replacement of Right Vertebral Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RP4JZ | Replacement of Right Vertebral Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
03RP4KZ | Replacement of Right Vertebral Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RQ07Z | Replacement of Left Vertebral Artery with Autologous Tissue Substitute, Open Approach | ||
03RQ0JZ | Replacement of Left Vertebral Artery with Synthetic Substitute, Open Approach | ||
03RQ0KZ | Replacement of Left Vertebral Artery with Nonautologous Tissue Substitute, Open Approach | ||
03RQ47Z | Replacement of Left Vertebral Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RQ4JZ | Replacement of Left Vertebral Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
03RQ4KZ | Replacement of Left Vertebral Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RR07Z | Replacement of Face Artery with Autologous Tissue Substitute, Open Approach | ||
03RR0JZ | Replacement of Face Artery with Synthetic Substitute, Open Approach | ||
03RR0KZ | Replacement of Face Artery with Nonautologous Tissue Substitute, Open Approach | ||
03RR47Z | Replacement of Face Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RR4JZ | Replacement of Face Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
03RR4KZ | Replacement of Face Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RS07Z | Replacement of Right Temporal Artery with Autologous Tissue Substitute, Open Approach | ||
03RS0JZ | Replacement of Right Temporal Artery with Synthetic Substitute, Open Approach | ||
03RS0KZ | Replacement of Right Temporal Artery with Nonautologous Tissue Substitute, Open Approach | ||
03RS47Z | Replacement of Right Temporal Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RS4JZ | Replacement of Right Temporal Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
03RS4KZ | Replacement of Right Temporal Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RT07Z | Replacement of Left Temporal Artery with Autologous Tissue Substitute, Open Approach | ||
03RT0JZ | Replacement of Left Temporal Artery with Synthetic Substitute, Open Approach | ||
03RT0KZ | Replacement of Left Temporal Artery with Nonautologous Tissue Substitute, Open Approach | ||
03RT47Z | Replacement of Left Temporal Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RT4JZ | Replacement of Left Temporal Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
03RT4KZ | Replacement of Left Temporal Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RU07Z | Replacement of Right Thyroid Artery with Autologous Tissue Substitute, Open Approach | ||
03RU0JZ | Replacement of Right Thyroid Artery with Synthetic Substitute, Open Approach | ||
03RU0KZ | Replacement of Right Thyroid Artery with Nonautologous Tissue Substitute, Open Approach | ||
03RU47Z | Replacement of Right Thyroid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RU4JZ | Replacement of Right Thyroid Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
03RU4KZ | Replacement of Right Thyroid Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RV07Z | Replacement of Left Thyroid Artery with Autologous Tissue Substitute, Open Approach | ||
03RV0JZ | Replacement of Left Thyroid Artery with Synthetic Substitute, Open Approach | ||
03RV0KZ | Replacement of Left Thyroid Artery with Nonautologous Tissue Substitute, Open Approach | ||
03RV47Z | Replacement of Left Thyroid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
03RV4JZ | Replacement of Left Thyroid Artery with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
03RV4KZ | Replacement of Left Thyroid Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05RM07Z | Replacement of Right Internal Jugular Vein with Autologous Tissue Substitute, Open Approach | ||
05RM0JZ | Replacement of Right Internal Jugular Vein with Synthetic Substitute, Open Approach | ||
05RM0KZ | Replacement of Right Internal Jugular Vein with Nonautologous Tissue Substitute, Open Approach | ||
05RM47Z | Replacement of Right Internal Jugular Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05RM4JZ | Replacement of Right Internal Jugular Vein with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
05RM4KZ | Replacement of Right Internal Jugular Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05RN07Z | Replacement of Left Internal Jugular Vein with Autologous Tissue Substitute, Open Approach | ||
05RN0JZ | Replacement of Left Internal Jugular Vein with Synthetic Substitute, Open Approach | ||
05RN0KZ | Replacement of Left Internal Jugular Vein with Nonautologous Tissue Substitute, Open Approach | ||
05RN47Z | Replacement of Left Internal Jugular Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05RN4JZ | Replacement of Left Internal Jugular Vein with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
05RN4KZ | Replacement of Left Internal Jugular Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05RP07Z | Replacement of Right External Jugular Vein with Autologous Tissue Substitute, Open Approach | ||
05RP0JZ | Replacement of Right External Jugular Vein with Synthetic Substitute, Open Approach | ||
05RP0KZ | Replacement of Right External Jugular Vein with Nonautologous Tissue Substitute, Open Approach | ||
05RP47Z | Replacement of Right External Jugular Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05RP4JZ | Replacement of Right External Jugular Vein with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
05RP4KZ | Replacement of Right External Jugular Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05RQ07Z | Replacement of Left External Jugular Vein with Autologous Tissue Substitute, Open Approach | ||
05RQ0JZ | Replacement of Left External Jugular Vein with Synthetic Substitute, Open Approach | ||
05RQ0KZ | Replacement of Left External Jugular Vein with Nonautologous Tissue Substitute, Open Approach | ||
05RQ47Z | Replacement of Left External Jugular Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05RQ4JZ | Replacement of Left External Jugular Vein with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
05RQ4KZ | Replacement of Left External Jugular Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05RR07Z | Replacement of Right Vertebral Vein with Autologous Tissue Substitute, Open Approach | ||
05RR0JZ | Replacement of Right Vertebral Vein with Synthetic Substitute, Open Approach | ||
05RR0KZ | Replacement of Right Vertebral Vein with Nonautologous Tissue Substitute, Open Approach | ||
05RR47Z | Replacement of Right Vertebral Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05RR4JZ | Replacement of Right Vertebral Vein with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
05RR4KZ | Replacement of Right Vertebral Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05RS07Z | Replacement of Left Vertebral Vein with Autologous Tissue Substitute, Open Approach | ||
05RS0JZ | Replacement of Left Vertebral Vein with Synthetic Substitute, Open Approach | ||
05RS0KZ | Replacement of Left Vertebral Vein with Nonautologous Tissue Substitute, Open Approach | ||
05RS47Z | Replacement of Left Vertebral Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05RS4JZ | Replacement of Left Vertebral Vein with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
05RS4KZ | Replacement of Left Vertebral Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05RT07Z | Replacement of Right Face Vein with Autologous Tissue Substitute, Open Approach | ||
05RT0JZ | Replacement of Right Face Vein with Synthetic Substitute, Open Approach | ||
05RT0KZ | Replacement of Right Face Vein with Nonautologous Tissue Substitute, Open Approach | ||
05RT47Z | Replacement of Right Face Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05RT4JZ | Replacement of Right Face Vein with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
05RT4KZ | Replacement of Right Face Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05RV07Z | Replacement of Left Face Vein with Autologous Tissue Substitute, Open Approach | ||
05RV0JZ | Replacement of Left Face Vein with Synthetic Substitute, Open Approach | ||
05RV0KZ | Replacement of Left Face Vein with Nonautologous Tissue Substitute, Open Approach | ||
05RV47Z | Replacement of Left Face Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
05RV4JZ | Replacement of Left Face Vein with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
05RV4KZ | Replacement of Left Face Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
06R307Z | Replacement of Esophageal Vein with Autologous Tissue Substitute, Open Approach | ||
06R30JZ | Replacement of Esophageal Vein with Synthetic Substitute, Open Approach | ||
06R30KZ | Replacement of Esophageal Vein with Nonautologous Tissue Substitute, Open Approach | ||
06R347Z | Replacement of Esophageal Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
06R34JZ | Replacement of Esophageal Vein with Synthetic Substitute, Percutaneous Endoscopic Approach | ||
06R34KZ | Replacement of Esophageal Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach | ||
38.91 | Arterial catheterization | 02HP03Z | Insertion of Infusion Device into Pulmonary Trunk, Open Approach |
02HP33Z | Insertion of Infusion Device into Pulmonary Trunk, Percutaneous Approach | ||
02HP43Z | Insertion of Infusion Device into Pulmonary Trunk, Percutaneous Endoscopic Approach | ||
02HQ03Z | Insertion of Infusion Device into Right Pulmonary Artery, Open Approach | ||
02HQ33Z | Insertion of Infusion Device into Right Pulmonary Artery, Percutaneous Approach | ||
02HQ43Z | Insertion of Infusion Device into Right Pulmonary Artery, Percutaneous Endoscopic Approach | ||
02HR03Z | Insertion of Infusion Device into Left Pulmonary Artery, Open Approach | ||
02HR33Z | Insertion of Infusion Device into Left Pulmonary Artery, Percutaneous Approach | ||
02HR43Z | Insertion of Infusion Device into Left Pulmonary Artery, Percutaneous Endoscopic Approach | ||
02HW03Z | Insertion of Infusion Device into Thoracic Aorta, Open Approach | ||
02HW33Z | Insertion of Infusion Device into Thoracic Aorta, Percutaneous Approach | ||
02HW43Z | Insertion of Infusion Device into Thoracic Aorta, Percutaneous Endoscopic Approach | ||
03H003Z | Insertion of Infusion Device into Right Internal Mammary Artery, Open Approach | ||
03H033Z | Insertion of Infusion Device into Right Internal Mammary Artery, Percutaneous Approach | ||
03H043Z | Insertion of Infusion Device into Right Internal Mammary Artery, Percutaneous Endoscopic Approach | ||
03H103Z | Insertion of Infusion Device into Left Internal Mammary Artery, Open Approach | ||
03H133Z | Insertion of Infusion Device into Left Internal Mammary Artery, Percutaneous Approach | ||
03H143Z | Insertion of Infusion Device into Left Internal Mammary Artery, Percutaneous Endoscopic Approach | ||
03H203Z | Insertion of Infusion Device into Innominate Artery, Open Approach | ||
03H233Z | Insertion of Infusion Device into Innominate Artery, Percutaneous Approach | ||
03H243Z | Insertion of Infusion Device into Innominate Artery, Percutaneous Endoscopic Approach | ||
03H303Z | Insertion of Infusion Device into Right Subclavian Artery, Open Approach | ||
03H333Z | Insertion of Infusion Device into Right Subclavian Artery, Percutaneous Approach | ||
03H343Z | Insertion of Infusion Device into Right Subclavian Artery, Percutaneous Endoscopic Approach | ||
03H403Z | Insertion of Infusion Device into Left Subclavian Artery, Open Approach | ||
03H433Z | Insertion of Infusion Device into Left Subclavian Artery, Percutaneous Approach | ||
03H443Z | Insertion of Infusion Device into Left Subclavian Artery, Percutaneous Endoscopic Approach | ||
03H503Z | Insertion of Infusion Device into Right Axillary Artery, Open Approach | ||
03H533Z | Insertion of Infusion Device into Right Axillary Artery, Percutaneous Approach | ||
03H543Z | Insertion of Infusion Device into Right Axillary Artery, Percutaneous Endoscopic Approach | ||
03H603Z | Insertion of Infusion Device into Left Axillary Artery, Open Approach | ||
03H633Z | Insertion of Infusion Device into Left Axillary Artery, Percutaneous Approach | ||
03H643Z | Insertion of Infusion Device into Left Axillary Artery, Percutaneous Endoscopic Approach | ||
03H703Z | Insertion of Infusion Device into Right Brachial Artery, Open Approach | ||
03H733Z | Insertion of Infusion Device into Right Brachial Artery, Percutaneous Approach | ||
03H743Z | Insertion of Infusion Device into Right Brachial Artery, Percutaneous Endoscopic Approach | ||
03H803Z | Insertion of Infusion Device into Left Brachial Artery, Open Approach | ||
03H833Z | Insertion of Infusion Device into Left Brachial Artery, Percutaneous Approach | ||
03H843Z | Insertion of Infusion Device into Left Brachial Artery, Percutaneous Endoscopic Approach | ||
03H903Z | Insertion of Infusion Device into Right Ulnar Artery, Open Approach | ||
03H933Z | Insertion of Infusion Device into Right Ulnar Artery, Percutaneous Approach | ||
03H943Z | Insertion of Infusion Device into Right Ulnar Artery, Percutaneous Endoscopic Approach | ||
03HA03Z | Insertion of Infusion Device into Left Ulnar Artery, Open Approach | ||
03HA33Z | Insertion of Infusion Device into Left Ulnar Artery, Percutaneous Approach | ||
03HA43Z | Insertion of Infusion Device into Left Ulnar Artery, Percutaneous Endoscopic Approach | ||
03HB03Z | Insertion of Infusion Device into Right Radial Artery, Open Approach | ||
03HB33Z | Insertion of Infusion Device into Right Radial Artery, Percutaneous Approach | ||
03HB43Z | Insertion of Infusion Device into Right Radial Artery, Percutaneous Endoscopic Approach | ||
03HC03Z | Insertion of Infusion Device into Left Radial Artery, Open Approach | ||
03HC33Z | Insertion of Infusion Device into Left Radial Artery, Percutaneous Approach | ||
03HC43Z | Insertion of Infusion Device into Left Radial Artery, Percutaneous Endoscopic Approach | ||
03HD03Z | Insertion of Infusion Device into Right Hand Artery, Open Approach | ||
03HD33Z | Insertion of Infusion Device into Right Hand Artery, Percutaneous Approach | ||
03HD43Z | Insertion of Infusion Device into Right Hand Artery, Percutaneous Endoscopic Approach | ||
03HF03Z | Insertion of Infusion Device into Left Hand Artery, Open Approach | ||
03HF33Z | Insertion of Infusion Device into Left Hand Artery, Percutaneous Approach | ||
03HF43Z | Insertion of Infusion Device into Left Hand Artery, Percutaneous Endoscopic Approach | ||
03HG03Z | Insertion of Infusion Device into Intracranial Artery, Open Approach | ||
03HG33Z | Insertion of Infusion Device into Intracranial Artery, Percutaneous Approach | ||
03HG43Z | Insertion of Infusion Device into Intracranial Artery, Percutaneous Endoscopic Approach | ||
03HH03Z | Insertion of Infusion Device into Right Common Carotid Artery, Open Approach | ||
03HH33Z | Insertion of Infusion Device into Right Common Carotid Artery, Percutaneous Approach | ||
03HH43Z | Insertion of Infusion Device into Right Common Carotid Artery, Percutaneous Endoscopic Approach | ||
03HJ03Z | Insertion of Infusion Device into Left Common Carotid Artery, Open Approach | ||
03HJ33Z | Insertion of Infusion Device into Left Common Carotid Artery, Percutaneous Approach | ||
03HJ43Z | Insertion of Infusion Device into Left Common Carotid Artery, Percutaneous Endoscopic Approach | ||
03HK03Z | Insertion of Infusion Device into Right Internal Carotid Artery, Open Approach | ||
03HK33Z | Insertion of Infusion Device into Right Internal Carotid Artery, Percutaneous Approach | ||
03HK43Z | Insertion of Infusion Device into Right Internal Carotid Artery, Percutaneous Endoscopic Approach | ||
03HL03Z | Insertion of Infusion Device into Left Internal Carotid Artery, Open Approach | ||
03HL33Z | Insertion of Infusion Device into Left Internal Carotid Artery, Percutaneous Approach | ||
03HL43Z | Insertion of Infusion Device into Left Internal Carotid Artery, Percutaneous Endoscopic Approach | ||
03HM03Z | Insertion of Infusion Device into Right External Carotid Artery, Open Approach | ||
03HM33Z | Insertion of Infusion Device into Right External Carotid Artery, Percutaneous Approach | ||
03HM43Z | Insertion of Infusion Device into Right External Carotid Artery, Percutaneous Endoscopic Approach | ||
03HN03Z | Insertion of Infusion Device into Left External Carotid Artery, Open Approach | ||
03HN33Z | Insertion of Infusion Device into Left External Carotid Artery, Percutaneous Approach | ||
03HN43Z | Insertion of Infusion Device into Left External Carotid Artery, Percutaneous Endoscopic Approach | ||
03HP03Z | Insertion of Infusion Device into Right Vertebral Artery, Open Approach | ||
03HP33Z | Insertion of Infusion Device into Right Vertebral Artery, Percutaneous Approach | ||
03HP43Z | Insertion of Infusion Device into Right Vertebral Artery, Percutaneous Endoscopic Approach | ||
03HQ03Z | Insertion of Infusion Device into Left Vertebral Artery, Open Approach | ||
03HQ33Z | Insertion of Infusion Device into Left Vertebral Artery, Percutaneous Approach | ||
03HQ43Z | Insertion of Infusion Device into Left Vertebral Artery, Percutaneous Endoscopic Approach | ||
03HR03Z | Insertion of Infusion Device into Face Artery, Open Approach | ||
03HR33Z | Insertion of Infusion Device into Face Artery, Percutaneous Approach | ||
03HR43Z | Insertion of Infusion Device into Face Artery, Percutaneous Endoscopic Approach | ||
03HS03Z | Insertion of Infusion Device into Right Temporal Artery, Open Approach | ||
03HS33Z | Insertion of Infusion Device into Right Temporal Artery, Percutaneous Approach | ||
03HS43Z | Insertion of Infusion Device into Right Temporal Artery, Percutaneous Endoscopic Approach | ||
03HT03Z | Insertion of Infusion Device into Left Temporal Artery, Open Approach | ||
03HT33Z | Insertion of Infusion Device into Left Temporal Artery, Percutaneous Approach | ||
03HT43Z | Insertion of Infusion Device into Left Temporal Artery, Percutaneous Endoscopic Approach | ||
03HU03Z | Insertion of Infusion Device into Right Thyroid Artery, Open Approach | ||
03HU33Z | Insertion of Infusion Device into Right Thyroid Artery, Percutaneous Approach | ||
03HU43Z | Insertion of Infusion Device into Right Thyroid Artery, Percutaneous Endoscopic Approach | ||
03HV03Z | Insertion of Infusion Device into Left Thyroid Artery, Open Approach | ||
03HV33Z | Insertion of Infusion Device into Left Thyroid Artery, Percutaneous Approach | ||
03HV43Z | Insertion of Infusion Device into Left Thyroid Artery, Percutaneous Endoscopic Approach | ||
03HY03Z | Insertion of Infusion Device into Upper Artery, Open Approach | ||
03HY33Z | Insertion of Infusion Device into Upper Artery, Percutaneous Approach | ||
03HY43Z | Insertion of Infusion Device into Upper Artery, Percutaneous Endoscopic Approach | ||
04H003Z | Insertion of Infusion Device into Abdominal Aorta, Open Approach | ||
04H033Z | Insertion of Infusion Device into Abdominal Aorta, Percutaneous Approach | ||
04H043Z | Insertion of Infusion Device into Abdominal Aorta, Percutaneous Endoscopic Approach | ||
04H103Z | Insertion of Infusion Device into Celiac Artery, Open Approach | ||
04H133Z | Insertion of Infusion Device into Celiac Artery, Percutaneous Approach | ||
04H143Z | Insertion of Infusion Device into Celiac Artery, Percutaneous Endoscopic Approach | ||
04H203Z | Insertion of Infusion Device into Gastric Artery, Open Approach | ||
04H233Z | Insertion of Infusion Device into Gastric Artery, Percutaneous Approach | ||
04H243Z | Insertion of Infusion Device into Gastric Artery, Percutaneous Endoscopic Approach | ||
04H303Z | Insertion of Infusion Device into Hepatic Artery, Open Approach | ||
04H333Z | Insertion of Infusion Device into Hepatic Artery, Percutaneous Approach | ||
04H343Z | Insertion of Infusion Device into Hepatic Artery, Percutaneous Endoscopic Approach | ||
04H403Z | Insertion of Infusion Device into Splenic Artery, Open Approach | ||
04H433Z | Insertion of Infusion Device into Splenic Artery, Percutaneous Approach | ||
04H443Z | Insertion of Infusion Device into Splenic Artery, Percutaneous Endoscopic Approach | ||
04H503Z | Insertion of Infusion Device into Superior Mesenteric Artery, Open Approach | ||
04H533Z | Insertion of Infusion Device into Superior Mesenteric Artery, Percutaneous Approach | ||
04H543Z | Insertion of Infusion Device into Superior Mesenteric Artery, Percutaneous Endoscopic Approach | ||
04H603Z | Insertion of Infusion Device into Right Colic Artery, Open Approach | ||
04H633Z | Insertion of Infusion Device into Right Colic Artery, Percutaneous Approach | ||
04H643Z | Insertion of Infusion Device into Right Colic Artery, Percutaneous Endoscopic Approach | ||
04H703Z | Insertion of Infusion Device into Left Colic Artery, Open Approach | ||
04H733Z | Insertion of Infusion Device into Left Colic Artery, Percutaneous Approach | ||
04H743Z | Insertion of Infusion Device into Left Colic Artery, Percutaneous Endoscopic Approach | ||
04H803Z | Insertion of Infusion Device into Middle Colic Artery, Open Approach | ||
04H833Z | Insertion of Infusion Device into Middle Colic Artery, Percutaneous Approach | ||
04H843Z | Insertion of Infusion Device into Middle Colic Artery, Percutaneous Endoscopic Approach | ||
04H903Z | Insertion of Infusion Device into Right Renal Artery, Open Approach | ||
04H933Z | Insertion of Infusion Device into Right Renal Artery, Percutaneous Approach | ||
04H943Z | Insertion of Infusion Device into Right Renal Artery, Percutaneous Endoscopic Approach | ||
04HA33Z | Insertion of Infusion Device into Left Renal Artery, Open Approach | ||
02QJ4ZZ | Insertion of Infusion Device into Left Renal Artery, Percutaneous Approach | ||
04HA43Z | Insertion of Infusion Device into Left Renal Artery, Percutaneous Endoscopic Approach | ||
04HB03Z | Insertion of Infusion Device into Inferior Mesenteric Artery, Open Approach | ||
04HB33Z | Insertion of Infusion Device into Inferior Mesenteric Artery, Percutaneous Approach | ||
04HB43Z | Insertion of Infusion Device into Inferior Mesenteric Artery, Percutaneous Endoscopic Approach | ||
04HC03Z | Insertion of Infusion Device into Right Common Iliac Artery, Open Approach | ||
04HC33Z | Insertion of Infusion Device into Right Common Iliac Artery, Percutaneous Approach | ||
04HC43Z | Insertion of Infusion Device into Right Common Iliac Artery, Percutaneous Endoscopic Approach | ||
04HD03Z | Insertion of Infusion Device into Left Common Iliac Artery, Open Approach | ||
04HD33Z | Insertion of Infusion Device into Left Common Iliac Artery, Percutaneous Approach | ||
04HD43Z | Insertion of Infusion Device into Left Common Iliac Artery, Percutaneous Endoscopic Approach | ||
04HE03Z | Insertion of Infusion Device into Right Internal Iliac Artery, Open Approach | ||
04HE33Z | Insertion of Infusion Device into Right Internal Iliac Artery, Percutaneous Approach | ||
04HE43Z | Insertion of Infusion Device into Right Internal Iliac Artery, Percutaneous Endoscopic Approach | ||
04HF03Z | Insertion of Infusion Device into Left Internal Iliac Artery, Open Approach | ||
04HF33Z | Insertion of Infusion Device into Left Internal Iliac Artery, Percutaneous Approach | ||
04HF43Z | Insertion of Infusion Device into Left Internal Iliac Artery, Percutaneous Endoscopic Approach | ||
04HH03Z | Insertion of Infusion Device into Right External Iliac Artery, Open Approach | ||
04HH33Z | Insertion of Infusion Device into Right External Iliac Artery, Percutaneous Approach | ||
04HH43Z | Insertion of Infusion Device into Right External Iliac Artery, Percutaneous Endoscopic Approach | ||
04HJ03Z | Insertion of Infusion Device into Left External Iliac Artery, Open Approach | ||
04HJ33Z | Insertion of Infusion Device into Left External Iliac Artery, Percutaneous Approach | ||
04HJ43Z | Insertion of Infusion Device into Left External Iliac Artery, Percutaneous Endoscopic Approach | ||
04HK03Z | Insertion of Infusion Device into Right Femoral Artery, Open Approach | ||
04HK33Z | Insertion of Infusion Device into Right Femoral Artery, Percutaneous Approach | ||
04HK43Z | Insertion of Infusion Device into Right Femoral Artery, Percutaneous Endoscopic Approach | ||
04HL03Z | Insertion of Infusion Device into Left Femoral Artery, Open Approach | ||
04HL33Z | Insertion of Infusion Device into Left Femoral Artery, Percutaneous Approach | ||
04HL43Z | Insertion of Infusion Device into Left Femoral Artery, Percutaneous Endoscopic Approach | ||
04HM03Z | Insertion of Infusion Device into Right Popliteal Artery, Open Approach | ||
04HM33Z | Insertion of Infusion Device into Right Popliteal Artery, Percutaneous Approach | ||
04HM43Z | Insertion of Infusion Device into Right Popliteal Artery, Percutaneous Endoscopic Approach | ||
04HN03Z | Insertion of Infusion Device into Left Popliteal Artery, Open Approach | ||
04HN33Z | Insertion of Infusion Device into Left Popliteal Artery, Percutaneous Approach | ||
04HN43Z | Insertion of Infusion Device into Left Popliteal Artery, Percutaneous Endoscopic Approach | ||
04HP03Z | Insertion of Infusion Device into Right Anterior Tibial Artery, Open Approach | ||
04HP33Z | Insertion of Infusion Device into Right Anterior Tibial Artery, Percutaneous Approach | ||
04HP43Z | Insertion of Infusion Device into Right Anterior Tibial Artery, Percutaneous Endoscopic Approach | ||
04HQ03Z | Insertion of Infusion Device into Left Anterior Tibial Artery, Open Approach | ||
04HQ33Z | Insertion of Infusion Device into Left Anterior Tibial Artery, Percutaneous Approach | ||
04HQ43Z | Insertion of Infusion Device into Left Anterior Tibial Artery, Percutaneous Endoscopic Approach | ||
04HR03Z | Insertion of Infusion Device into Right Posterior Tibial Artery, Open Approach | ||
04HR33Z | Insertion of Infusion Device into Right Posterior Tibial Artery, Percutaneous Approach | ||
04HR43Z | Insertion of Infusion Device into Right Posterior Tibial Artery, Percutaneous Endoscopic Approach | ||
04HS03Z | Insertion of Infusion Device into Left Posterior Tibial Artery, Open Approach | ||
04HS33Z | Insertion of Infusion Device into Left Posterior Tibial Artery, Percutaneous Approach | ||
04HS43Z | Insertion of Infusion Device into Left Posterior Tibial Artery, Percutaneous Endoscopic Approach | ||
04HT03Z | Insertion of Infusion Device into Right Peroneal Artery, Open Approach | ||
04HT33Z | Insertion of Infusion Device into Right Peroneal Artery, Percutaneous Approach | ||
04HT43Z | Insertion of Infusion Device into Right Peroneal Artery, Percutaneous Endoscopic Approach | ||
04HU03Z | Insertion of Infusion Device into Left Peroneal Artery, Open Approach | ||
04HU33Z | Insertion of Infusion Device into Left Peroneal Artery, Percutaneous Approach | ||
04HU43Z | Insertion of Infusion Device into Left Peroneal Artery, Percutaneous Endoscopic Approach | ||
02NH3ZZ | Release Pulmonary Valve, Percutaneous Approach | ||
02NH4ZZ | Release Pulmonary Valve, Percutaneous Endoscopic Approach | ||
04HV03Z | Insertion of Infusion Device into Right Foot Artery, Open Approach | ||
04HV33Z | Insertion of Infusion Device into Right Foot Artery, Percutaneous Approach | ||
04HV43Z | Insertion of Infusion Device into Right Foot Artery, Percutaneous Endoscopic Approach | ||
04HW03Z | Insertion of Infusion Device into Left Foot Artery, Open Approach | ||
04HW33Z | Insertion of Infusion Device into Left Foot Artery, Percutaneous Approach | ||
04HW43Z | Insertion of Infusion Device into Left Foot Artery, Percutaneous Endoscopic Approach | ||
04HY03Z | Insertion of Infusion Device into Lower Artery, Open Approach | ||
04HY33Z | Insertion of Infusion Device into Lower Artery, Percutaneous Approach | ||
04HY43Z | Insertion of Infusion Device into Lower Artery, Percutaneous Endoscopic Approach | ||
38.93 | Venous catheterization, not elsewhere classified | 02H633Z | Insertion of Infusion Device into Right Atrium, Percutaneous Approach |
02HK33Z | Insertion of Infusion Device into Right Ventricle, Percutaneous Approach | ||
02HS03Z | Insertion of Infusion Device into Right Pulmonary Vein, Open Approach | ||
02HS33Z | Insertion of Infusion Device into Right Pulmonary Vein, Percutaneous Approach | ||
02HS43Z | Insertion of Infusion Device into Right Pulmonary Vein, Percutaneous Endoscopic Approach | ||
02HT03Z | Insertion of Infusion Device into Left Pulmonary Vein, Open Approach | ||
02HT33Z | Insertion of Infusion Device into Left Pulmonary Vein, Percutaneous Approach | ||
02HT43Z | Insertion of Infusion Device into Left Pulmonary Vein, Percutaneous Endoscopic Approach | ||
02HV03Z | Insertion of Infusion Device into Superior Vena Cava, Open Approach | ||
02HV33Z | Insertion of Infusion Device into Superior Vena Cava, Percutaneous Approach | ||
02HV43Z | Insertion of Infusion Device into Superior Vena Cava, Percutaneous Endoscopic Approach | ||
05H003Z | Insertion of Infusion Device into Azygos Vein, Open Approach | ||
05H033Z | Insertion of Infusion Device into Azygos Vein, Percutaneous Approach | ||
05H043Z | Insertion of Infusion Device into Azygos Vein, Percutaneous Endoscopic Approach | ||
05H103Z | Insertion of Infusion Device into Hemiazygos Vein, Open Approach | ||
05H133Z | Insertion of Infusion Device into Hemiazygos Vein, Percutaneous Approach | ||
05H143Z | Insertion of Infusion Device into Hemiazygos Vein, Percutaneous Endoscopic Approach | ||
05H303Z | Insertion of Infusion Device into Right Innominate Vein, Open Approach | ||
05H333Z | Insertion of Infusion Device into Right Innominate Vein, Percutaneous Approach | ||
05H343Z | Insertion of Infusion Device into Right Innominate Vein, Percutaneous Endoscopic Approach | ||
05H403Z | Insertion of Infusion Device into Left Innominate Vein, Open Approach | ||
05H433Z | Insertion of Infusion Device into Left Innominate Vein, Percutaneous Approach | ||
05H443Z | Insertion of Infusion Device into Left Innominate Vein, Percutaneous Endoscopic Approach | ||
05H503Z | Insertion of Infusion Device into Right Subclavian Vein, Open Approach | ||
05H533Z | Insertion of Infusion Device into Right Subclavian Vein, Percutaneous Approach | ||
05H543Z | Insertion of Infusion Device into Right Subclavian Vein, Percutaneous Endoscopic Approach | ||
05H603Z | Insertion of Infusion Device into Left Subclavian Vein, Open Approach | ||
05H633Z | Insertion of Infusion Device into Left Subclavian Vein, Percutaneous Approach | ||
05H643Z | Insertion of Infusion Device into Left Subclavian Vein, Percutaneous Endoscopic Approach | ||
05H703Z | Insertion of Infusion Device into Right Axillary Vein, Open Approach | ||
05H733Z | Insertion of Infusion Device into Right Axillary Vein, Percutaneous Approach | ||
05H743Z | Insertion of Infusion Device into Right Axillary Vein, Percutaneous Endoscopic Approach | ||
05H803Z | Insertion of Infusion Device into Left Axillary Vein, Open Approach | ||
05H833Z | Insertion of Infusion Device into Left Axillary Vein, Percutaneous Approach | ||
05H843Z | Insertion of Infusion Device into Left Axillary Vein, Percutaneous Endoscopic Approach | ||
05H903Z | Insertion of Infusion Device into Right Brachial Vein, Open Approach | ||
05H933Z | Insertion of Infusion Device into Right Brachial Vein, Percutaneous Approach | ||
05H943Z | Insertion of Infusion Device into Right Brachial Vein, Percutaneous Endoscopic Approach | ||
05HA03Z | Insertion of Infusion Device into Left Brachial Vein, Open Approach | ||
05HA33Z | Insertion of Infusion Device into Left Brachial Vein, Percutaneous Approach | ||
05HA43Z | Insertion of Infusion Device into Left Brachial Vein, Percutaneous Endoscopic Approach | ||
05HB03Z | Insertion of Infusion Device into Right Basilic Vein, Open Approach | ||
05HB33Z | Insertion of Infusion Device into Right Basilic Vein, Percutaneous Approach | ||
05HB43Z | Insertion of Infusion Device into Right Basilic Vein, Percutaneous Endoscopic Approach | ||
05HC03Z | Insertion of Infusion Device into Left Basilic Vein, Open Approach | ||
05HC33Z | Insertion of Infusion Device into Left Basilic Vein, Percutaneous Approach | ||
05HC43Z | Insertion of Infusion Device into Left Basilic Vein, Percutaneous Endoscopic Approach | ||
05HD03Z | Insertion of Infusion Device into Right Cephalic Vein, Open Approach | ||
05HD33Z | Insertion of Infusion Device into Right Cephalic Vein, Percutaneous Approach | ||
05HD43Z | Insertion of Infusion Device into Right Cephalic Vein, Percutaneous Endoscopic Approach | ||
05HF03Z | Insertion of Infusion Device into Left Cephalic Vein, Open Approach | ||
05HF33Z | Insertion of Infusion Device into Left Cephalic Vein, Percutaneous Approach | ||
05HF43Z | Insertion of Infusion Device into Left Cephalic Vein, Percutaneous Endoscopic Approach | ||
05HG03Z | Insertion of Infusion Device into Right Hand Vein, Open Approach | ||
05HG33Z | Insertion of Infusion Device into Right Hand Vein, Percutaneous Approach | ||
05HG43Z | Insertion of Infusion Device into Right Hand Vein, Percutaneous Endoscopic Approach | ||
05HH03Z | Insertion of Infusion Device into Left Hand Vein, Open Approach | ||
05HH33Z | Insertion of Infusion Device into Left Hand Vein, Percutaneous Approach | ||
05HH43Z | Insertion of Infusion Device into Left Hand Vein, Percutaneous Endoscopic Approach | ||
05HL03Z | Insertion of Infusion Device into Intracranial Vein, Open Approach | ||
05HL33Z | Insertion of Infusion Device into Intracranial Vein, Percutaneous Approach | ||
05HL43Z | Insertion of Infusion Device into Intracranial Vein, Percutaneous Endoscopic Approach | ||
05HM03Z | Insertion of Infusion Device into Right Internal Jugular Vein, Open Approach | ||
05HM33Z | Insertion of Infusion Device into Right Internal Jugular Vein, Percutaneous Approach | ||
05HM43Z | Insertion of Infusion Device into Right Internal Jugular Vein, Percutaneous Endoscopic Approach | ||
05HN03Z | Insertion of Infusion Device into Left Internal Jugular Vein, Open Approach | ||
05HN33Z | Insertion of Infusion Device into Left Internal Jugular Vein, Percutaneous Approach | ||
05HN43Z | Insertion of Infusion Device into Left Internal Jugular Vein, Percutaneous Endoscopic Approach | ||
05HP03Z | Insertion of Infusion Device into Right External Jugular Vein, Open Approach | ||
05HP33Z | Insertion of Infusion Device into Right External Jugular Vein, Percutaneous Approach | ||
05HP43Z | Insertion of Infusion Device into Right External Jugular Vein, Percutaneous Endoscopic Approach | ||
05HQ03Z | Insertion of Infusion Device into Left External Jugular Vein, Open Approach | ||
05HQ33Z | Insertion of Infusion Device into Left External Jugular Vein, Percutaneous Approach | ||
05HQ43Z | Insertion of Infusion Device into Left External Jugular Vein, Percutaneous Endoscopic Approach | ||
05HR03Z | Insertion of Infusion Device into Right Vertebral Vein, Open Approach | ||
05HR33Z | Insertion of Infusion Device into Right Vertebral Vein, Percutaneous Approach | ||
05HR43Z | Insertion of Infusion Device into Right Vertebral Vein, Percutaneous Endoscopic Approach | ||
05HS03Z | Insertion of Infusion Device into Left Vertebral Vein, Open Approach | ||
05HS33Z | Insertion of Infusion Device into Left Vertebral Vein, Percutaneous Approach | ||
05HS43Z | Insertion of Infusion Device into Left Vertebral Vein, Percutaneous Endoscopic Approach | ||
05HT03Z | Insertion of Infusion Device into Right Face Vein, Open Approach | ||
05HT33Z | Insertion of Infusion Device into Right Face Vein, Percutaneous Approach | ||
05HT43Z | Insertion of Infusion Device into Right Face Vein, Percutaneous Endoscopic Approach | ||
05HV03Z | Insertion of Infusion Device into Left Face Vein, Open Approach | ||
05HV33Z | Insertion of Infusion Device into Left Face Vein, Percutaneous Approach | ||
05HV43Z | Insertion of Infusion Device into Left Face Vein, Percutaneous Endoscopic Approach | ||
05HY03Z | Insertion of Infusion Device into Upper Vein, Open Approach | ||
05HY33Z | Insertion of Infusion Device into Upper Vein, Percutaneous Approach | ||
05HY43Z | Insertion of Infusion Device into Upper Vein, Percutaneous Endoscopic Approach | ||
06H003Z | Insertion of Infusion Device into Inferior Vena Cava, Open Approach | ||
06H033Z | Insertion of Infusion Device into Inferior Vena Cava, Percutaneous Approach | ||
06H043Z | Insertion of Infusion Device into Inferior Vena Cava, Percutaneous Endoscopic Approach | ||
06H103Z | Insertion of Infusion Device into Splenic Vein, Open Approach | ||
06H133Z | Insertion of Infusion Device into Splenic Vein, Percutaneous Approach | ||
06H143Z | Insertion of Infusion Device into Splenic Vein, Percutaneous Endoscopic Approach | ||
06H203Z | Insertion of Infusion Device into Gastric Vein, Open Approach | ||
06H233Z | Insertion of Infusion Device into Gastric Vein, Percutaneous Approach | ||
06H243Z | Insertion of Infusion Device into Gastric Vein, Percutaneous Endoscopic Approach | ||
06H303Z | Insertion of Infusion Device into Esophageal Vein, Open Approach | ||
06H333Z | Insertion of Infusion Device into Esophageal Vein, Percutaneous Approach | ||
06H343Z | Insertion of Infusion Device into Esophageal Vein, Percutaneous Endoscopic Approach | ||
06H403Z | Insertion of Infusion Device into Hepatic Vein, Open Approach | ||
06H433Z | Insertion of Infusion Device into Hepatic Vein, Percutaneous Approach | ||
06H443Z | Insertion of Infusion Device into Hepatic Vein, Percutaneous Endoscopic Approach | ||
06H503Z | Insertion of Infusion Device into Superior Mesenteric Vein, Open Approach | ||
06H533Z | Insertion of Infusion Device into Superior Mesenteric Vein, Percutaneous Approach | ||
06H543Z | Insertion of Infusion Device into Superior Mesenteric Vein, Percutaneous Endoscopic Approach | ||
06H603Z | Insertion of Infusion Device into Inferior Mesenteric Vein, Open Approach | ||
06H633Z | Insertion of Infusion Device into Inferior Mesenteric Vein, Percutaneous Approach | ||
06H643Z | Insertion of Infusion Device into Inferior Mesenteric Vein, Percutaneous Endoscopic Approach | ||
06H703Z | Insertion of Infusion Device into Colic Vein, Open Approach | ||
06H733Z | Insertion of Infusion Device into Colic Vein, Percutaneous Approach | ||
06H743Z | Insertion of Infusion Device into Colic Vein, Percutaneous Endoscopic Approach | ||
06H803Z | Insertion of Infusion Device into Portal Vein, Open Approach | ||
06H833Z | Insertion of Infusion Device into Portal Vein, Percutaneous Approach | ||
06H843Z | Insertion of Infusion Device into Portal Vein, Percutaneous Endoscopic Approach | ||
06H903Z | Insertion of Infusion Device into Right Renal Vein, Open Approach | ||
06H933Z | Insertion of Infusion Device into Right Renal Vein, Percutaneous Approach | ||
06H943Z | Insertion of Infusion Device into Right Renal Vein, Percutaneous Endoscopic Approach | ||
06HB03Z | Insertion of Infusion Device into Left Renal Vein, Open Approach | ||
06HB33Z | Insertion of Infusion Device into Left Renal Vein, Percutaneous Approach | ||
06HB43Z | Insertion of Infusion Device into Left Renal Vein, Percutaneous Endoscopic Approach | ||
06HC03Z | Insertion of Infusion Device into Right Common Iliac Vein, Open Approach | ||
06HC33Z | Insertion of Infusion Device into Right Common Iliac Vein, Percutaneous Approach | ||
06HC43Z | Insertion of Infusion Device into Right Common Iliac Vein, Percutaneous Endoscopic Approach | ||
06HD03Z | Insertion of Infusion Device into Left Common Iliac Vein, Open Approach | ||
06HD33Z | Insertion of Infusion Device into Left Common Iliac Vein, Percutaneous Approach | ||
06HD43Z | Insertion of Infusion Device into Left Common Iliac Vein, Percutaneous Endoscopic Approach | ||
06HF03Z | Insertion of Infusion Device into Right External Iliac Vein, Open Approach | ||
06HF33Z | Insertion of Infusion Device into Right External Iliac Vein, Percutaneous Approach | ||
06HF43Z | Insertion of Infusion Device into Right External Iliac Vein, Percutaneous Endoscopic Approach | ||
06HG03Z | Insertion of Infusion Device into Left External Iliac Vein, Open Approach | ||
06HG33Z | Insertion of Infusion Device into Left External Iliac Vein, Percutaneous Approach | ||
06HG43Z | Insertion of Infusion Device into Left External Iliac Vein, Percutaneous Endoscopic Approach | ||
06HH03Z | Insertion of Infusion Device into Right Hypogastric Vein, Open Approach | ||
06HH33Z | Insertion of Infusion Device into Right Hypogastric Vein, Percutaneous Approach | ||
06HH43Z | Insertion of Infusion Device into Right Hypogastric Vein, Percutaneous Endoscopic Approach | ||
06HJ03Z | Insertion of Infusion Device into Left Hypogastric Vein, Open Approach | ||
06HJ33Z | Insertion of Infusion Device into Left Hypogastric Vein, Percutaneous Approach | ||
06HJ43Z | Insertion of Infusion Device into Left Hypogastric Vein, Percutaneous Endoscopic Approach | ||
06HM03Z | Insertion of Infusion Device into Right Femoral Vein, Open Approach | ||
06HM33Z | Insertion of Infusion Device into Right Femoral Vein, Percutaneous Approach | ||
06HM43Z | Insertion of Infusion Device into Right Femoral Vein, Percutaneous Endoscopic Approach | ||
06HN03Z | Insertion of Infusion Device into Left Femoral Vein, Open Approach | ||
06HN33Z | Insertion of Infusion Device into Left Femoral Vein, Percutaneous Approach | ||
06HN43Z | Insertion of Infusion Device into Left Femoral Vein, Percutaneous Endoscopic Approach | ||
06HP03Z | Insertion of Infusion Device into Right Greater Saphenous Vein, Open Approach | ||
06HP33Z | Insertion of Infusion Device into Right Greater Saphenous Vein, Percutaneous Approach | ||
06HP43Z | Insertion of Infusion Device into Right Greater Saphenous Vein, Percutaneous Endoscopic Approach | ||
06HQ03Z | Insertion of Infusion Device into Left Greater Saphenous Vein, Open Approach | ||
06HQ33Z | Insertion of Infusion Device into Left Greater Saphenous Vein, Percutaneous Approach | ||
06HQ43Z | Insertion of Infusion Device into Left Greater Saphenous Vein, Percutaneous Endoscopic Approach | ||
06HR03Z | Insertion of Infusion Device into Right Lesser Saphenous Vein, Open Approach | ||
06HR33Z | Insertion of Infusion Device into Right Lesser Saphenous Vein, Percutaneous Approach | ||
06HR43Z | Insertion of Infusion Device into Right Lesser Saphenous Vein, Percutaneous Endoscopic Approach | ||
06HS03Z | Insertion of Infusion Device into Left Lesser Saphenous Vein, Open Approach | ||
06HS33Z | Insertion of Infusion Device into Left Lesser Saphenous Vein, Percutaneous Approach | ||
06HS43Z | Insertion of Infusion Device into Left Lesser Saphenous Vein, Percutaneous Endoscopic Approach | ||
06HT03Z | Insertion of Infusion Device into Right Foot Vein, Open Approach | ||
06HT33Z | Insertion of Infusion Device into Right Foot Vein, Percutaneous Approach | ||
06HT43Z | Insertion of Infusion Device into Right Foot Vein, Percutaneous Endoscopic Approach | ||
06HV03Z | Insertion of Infusion Device into Left Foot Vein, Open Approach | ||
06HV33Z | Insertion of Infusion Device into Left Foot Vein, Percutaneous Approach | ||
06HV43Z | Insertion of Infusion Device into Left Foot Vein, Percutaneous Endoscopic Approach | ||
06HY03Z | Insertion of Infusion Device into Lower Vein, Open Approach | ||
06HY33Z | Insertion of Infusion Device into Lower Vein, Percutaneous Approach | ||
06HY43Z | Insertion of Infusion Device into Lower Vein, Percutaneous Endoscopic Approach | ||
0JH60XZ | Insertion of Vascular Access Device into Chest Subcutaneous Tissue and Fascia, Open Approach | ||
0JH63XZ | Insertion of Vascular Access Device into Chest Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
0JH80XZ | Insertion of Vascular Access Device into Abdomen Subcutaneous Tissue and Fascia, Open Approach | ||
0JH83XZ | Insertion of Vascular Access Device into Abdomen Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
0JHD0XZ | Insertion of Vascular Access Device into Right Upper Arm Subcutaneous Tissue and Fascia, Open Approach | ||
0JHD3XZ | Insertion of Vascular Access Device into Right Upper Arm Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
0JHF0XZ | Insertion of Vascular Access Device into Left Upper Arm Subcutaneous Tissue and Fascia, Open Approach | ||
0JHF3XZ | Insertion of Vascular Access Device into Left Upper Arm Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
0JHG0XZ | Insertion of Vascular Access Device into Right Lower Arm Subcutaneous Tissue and Fascia, Open Approach | ||
0JHG3XZ | Insertion of Vascular Access Device into Right Lower Arm Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
0JHH0XZ | Insertion of Vascular Access Device into Left Lower Arm Subcutaneous Tissue and Fascia, Open Approach | ||
0JHH3XZ | Insertion of Vascular Access Device into Left Lower Arm Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
0JHL0XZ | Insertion of Vascular Access Device into Right Upper Leg Subcutaneous Tissue and Fascia, Open Approach | ||
0JHL3XZ | Insertion of Vascular Access Device into Right Upper Leg Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
0JHM0XZ | Insertion of Vascular Access Device into Left Upper Leg Subcutaneous Tissue and Fascia, Open Approach | ||
0JHM3XZ | Insertion of Vascular Access Device into Left Upper Leg Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
0JHN0XZ | Insertion of Vascular Access Device into Right Lower Leg Subcutaneous Tissue and Fascia, Open Approach | ||
0JHN3XZ | Insertion of Vascular Access Device into Right Lower Leg Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
0JHP0XZ | Insertion of Vascular Access Device into Left Lower Leg Subcutaneous Tissue and Fascia, Open Approach | ||
0JHP3XZ | Insertion of Vascular Access Device into Left Lower Leg Subcutaneous Tissue and Fascia, Percutaneous Approach | ||
39.42 | Revision of arteriovenous shunt for renal dialysis | 031209D | Bypass Innominate Artery to Upper Arm Vein with Autologous Venous Tissue, Open Approach |
031209F | Bypass Innominate Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach | ||
03120AD | Bypass Innominate Artery to Upper Arm Vein with Autologous Arterial Tissue, Open Approach | ||
03120AF | Bypass Innominate Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach | ||
03120JD | Bypass Innominate Artery to Upper Arm Vein with Synthetic Substitute, Open Approach | ||
03120JF | Bypass Innominate Artery to Lower Arm Vein with Synthetic Substitute, Open Approach | ||
03120KD | Bypass Innominate Artery to Upper Arm Vein with Nonautologous Tissue Substitute, Open Approach | ||
03120KF | Bypass Innominate Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach | ||
03120ZD | Bypass Innominate Artery to Upper Arm Vein, Open Approach | ||
03120ZF | Bypass Innominate Artery to Lower Arm Vein, Open Approach | ||
031309D | Bypass Right Subclavian Artery to Upper Arm Vein with Autologous Venous Tissue, Open Approach | ||
031309F | Bypass Right Subclavian Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach | ||
03130AD | Bypass Right Subclavian Artery to Upper Arm Vein with Autologous Arterial Tissue, Open Approach | ||
03130AF | Bypass Right Subclavian Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach | ||
03130JD | Bypass Right Subclavian Artery to Upper Arm Vein with Synthetic Substitute, Open Approach | ||
03130JF | Bypass Right Subclavian Artery to Lower Arm Vein with Synthetic Substitute, Open Approach | ||
03130KD | Bypass Right Subclavian Artery to Upper Arm Vein with Nonautologous Tissue Substitute, Open Approach | ||
03130KF | Bypass Right Subclavian Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach | ||
03130ZD | Bypass Right Subclavian Artery to Upper Arm Vein, Open Approach | ||
03130ZF | Bypass Right Subclavian Artery to Lower Arm Vein, Open Approach | ||
031409D | Bypass Left Subclavian Artery to Upper Arm Vein with Autologous Venous Tissue, Open Approach | ||
031409F | Bypass Left Subclavian Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach | ||
03140AD | Bypass Left Subclavian Artery to Upper Arm Vein with Autologous Arterial Tissue, Open Approach | ||
03140AF | Bypass Left Subclavian Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach | ||
03140JD | Bypass Left Subclavian Artery to Upper Arm Vein with Synthetic Substitute, Open Approach | ||
03140JF | Bypass Left Subclavian Artery to Lower Arm Vein with Synthetic Substitute, Open Approach | ||
03140KD | Bypass Left Subclavian Artery to Upper Arm Vein with Nonautologous Tissue Substitute, Open Approach | ||
03140KF | Bypass Left Subclavian Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach | ||
03140ZD | Bypass Left Subclavian Artery to Upper Arm Vein, Open Approach | ||
03140ZF | Bypass Left Subclavian Artery to Lower Arm Vein, Open Approach | ||
031509D | Bypass Right Axillary Artery to Upper Arm Vein with Autologous Venous Tissue, Open Approach | ||
031509F | Bypass Right Axillary Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach | ||
03150AD | Bypass Right Axillary Artery to Upper Arm Vein with Autologous Arterial Tissue, Open Approach | ||
03150AF | Bypass Right Axillary Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach | ||
03150JD | Bypass Right Axillary Artery to Upper Arm Vein with Synthetic Substitute, Open Approach | ||
03150JF | Bypass Right Axillary Artery to Lower Arm Vein with Synthetic Substitute, Open Approach | ||
03150KD | Bypass Right Axillary Artery to Upper Arm Vein with Nonautologous Tissue Substitute, Open Approach | ||
03150KF | Bypass Right Axillary Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach | ||
03150ZD | Bypass Right Axillary Artery to Upper Arm Vein, Open Approach | ||
03150ZF | Bypass Right Axillary Artery to Lower Arm Vein, Open Approach | ||
031609D | Bypass Left Axillary Artery to Upper Arm Vein with Autologous Venous Tissue, Open Approach | ||
031609F | Bypass Left Axillary Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach | ||
03160AD | Bypass Left Axillary Artery to Upper Arm Vein with Autologous Arterial Tissue, Open Approach | ||
03160AF | Bypass Left Axillary Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach | ||
03160JD | Bypass Left Axillary Artery to Upper Arm Vein with Synthetic Substitute, Open Approach | ||
03160JF | Bypass Left Axillary Artery to Lower Arm Vein with Synthetic Substitute, Open Approach | ||
03160KD | Bypass Left Axillary Artery to Upper Arm Vein with Nonautologous Tissue Substitute, Open Approach | ||
03160KF | Bypass Left Axillary Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach | ||
03160ZD | Bypass Left Axillary Artery to Upper Arm Vein, Open Approach | ||
03160ZF | Bypass Left Axillary Artery to Lower Arm Vein, Open Approach | ||
031709D | Bypass Right Brachial Artery to Upper Arm Vein with Autologous Venous Tissue, Open Approach | ||
031709F | Bypass Right Brachial Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach | ||
03170AD | Bypass Right Brachial Artery to Upper Arm Vein with Autologous Arterial Tissue, Open Approach | ||
03170AF | Bypass Right Brachial Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach | ||
03170JD | Bypass Right Brachial Artery to Upper Arm Vein with Synthetic Substitute, Open Approach | ||
03170JF | Bypass Right Brachial Artery to Lower Arm Vein with Synthetic Substitute, Open Approach | ||
03170KD | Bypass Right Brachial Artery to Upper Arm Vein with Nonautologous Tissue Substitute, Open Approach | ||
03170KF | Bypass Right Brachial Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach | ||
03170ZD | Bypass Right Brachial Artery to Upper Arm Vein, Open Approach | ||
03170ZF | Bypass Right Brachial Artery to Lower Arm Vein, Open Approach | ||
031809D | Bypass Left Brachial Artery to Upper Arm Vein with Autologous Venous Tissue, Open Approach | ||
031809F | Bypass Left Brachial Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach | ||
03180AD | Bypass Left Brachial Artery to Upper Arm Vein with Autologous Arterial Tissue, Open Approach | ||
03180AF | Bypass Left Brachial Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach | ||
03180JD | Bypass Left Brachial Artery to Upper Arm Vein with Synthetic Substitute, Open Approach | ||
03180JF | Bypass Left Brachial Artery to Lower Arm Vein with Synthetic Substitute, Open Approach | ||
03180KD | Bypass Left Brachial Artery to Upper Arm Vein with Nonautologous Tissue Substitute, Open Approach | ||
03180KF | Bypass Left Brachial Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach | ||
03180ZD | Bypass Left Brachial Artery to Upper Arm Vein, Open Approach | ||
03180ZF | Bypass Left Brachial Artery to Lower Arm Vein, Open Approach | ||
031909F | Bypass Right Ulnar Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach | ||
03190AF | Bypass Right Ulnar Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach | ||
03190JF | Bypass Right Ulnar Artery to Lower Arm Vein with Synthetic Substitute, Open Approach | ||
03190KF | Bypass Right Ulnar Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach | ||
03190ZF | Bypass Right Ulnar Artery to Lower Arm Vein, Open Approach | ||
031A09F | Bypass Left Ulnar Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach | ||
031A0AF | Bypass Left Ulnar Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach | ||
031A0JF | Bypass Left Ulnar Artery to Lower Arm Vein with Synthetic Substitute, Open Approach | ||
031A0KF | Bypass Left Ulnar Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach | ||
031A0ZF | Bypass Left Ulnar Artery to Lower Arm Vein, Open Approach | ||
031B09F | Bypass Right Radial Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach | ||
031B0AF | Bypass Right Radial Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach | ||
031B0JF | Bypass Right Radial Artery to Lower Arm Vein with Synthetic Substitute, Open Approach | ||
031B0KF | Bypass Right Radial Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach | ||
031B0ZF | Bypass Right Radial Artery to Lower Arm Vein, Open Approach | ||
031C09F | Bypass Left Radial Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach | ||
031C0AF | Bypass Left Radial Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach | ||
031C0JF | Bypass Left Radial Artery to Lower Arm Vein with Synthetic Substitute, Open Approach | ||
031C0KF | Bypass Left Radial Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach | ||
031C0ZF | Bypass Left Radial Artery to Lower Arm Vein, Open Approach | ||
39.49 | Other revisions of vascular procedure | 03CY0ZZ | Extirpation of Matter from Upper Artery, Open Approach |
03CY3ZZ | Extirpation of Matter from Upper Artery, Percutaneous Approach | ||
03CY4ZZ | Extirpation of Matter from Upper Artery, Percutaneous Endoscopic Approach | ||
03QY0ZZ | Repair Upper Artery, Open Approach | ||
03QY3ZZ | Repair Upper Artery, Percutaneous Approach | ||
03QY4ZZ | Repair Upper Artery, Percutaneous Endoscopic Approach | ||
04CY0ZZ | Extirpation of Matter from Lower Artery, Open Approach | ||
04CY3ZZ | Extirpation of Matter from Lower Artery, Percutaneous Approach | ||
04CY4ZZ | Extirpation of Matter from Lower Artery, Percutaneous Endoscopic Approach | ||
04QY0ZZ | Repair Lower Artery, Open Approach | ||
04QY3ZZ | Repair Lower Artery, Percutaneous Approach | ||
04QY4ZZ | Repair Lower Artery, Percutaneous Endoscopic Approach | ||
05CY0ZZ | Extirpation of Matter from Upper Vein, Open Approach | ||
05CY3ZZ | Extirpation of Matter from Upper Vein, Percutaneous Approach | ||
05CY4ZZ | Extirpation of Matter from Upper Vein, Percutaneous Endoscopic Approach | ||
05QY0ZZ | Repair Upper Vein, Open Approach | ||
05QY3ZZ | Repair Upper Vein, Percutaneous Approach | ||
05QY4ZZ | Repair Upper Vein, Percutaneous Endoscopic Approach | ||
06CY0ZZ | Extirpation of Matter from Lower Vein, Open Approach | ||
06CY3ZZ | Extirpation of Matter from Lower Vein, Percutaneous Approach | ||
06CY4ZZ | Extirpation of Matter from Lower Vein, Percutaneous Endoscopic Approach | ||
06QY0ZZ | Repair Lower Vein, Open Approach | ||
06QY3ZZ | Repair Lower Vein, Percutaneous Approach | ||
06QY4ZZ | Repair Lower Vein, Percutaneous Endoscopic Approach | ||
39.94 | Replacement of vessel-to-vessel cannula | 031B0JF | Bypass Right Radial Artery to Lower Arm Vein with Synthetic Substitute, Open Approach |
031C0JF | Bypass Left Radial Artery to Lower Arm Vein with Synthetic Substitute, Open Approach | ||
03PY0JZ | Removal of Synthetic Substitute from Upper Artery, Open Approach | ||
03PY3JZ | Removal of Synthetic Substitute from Upper Artery, Percutaneous Approach | ||
03PY4JZ | Removal of Synthetic Substitute from Upper Artery, Percutaneous Endoscopic Approach | ||
03WY0JZ | Revision of Synthetic Substitute in Upper Artery, Open Approach | ||
03WY3JZ | Revision of Synthetic Substitute in Upper Artery, Percutaneous Approach | ||
03WY4JZ | Revision of Synthetic Substitute in Upper Artery, Percutaneous Endoscopic Approach | ||
03WYXJZ | Revision of Synthetic Substitute in Upper Artery, External Approach | ||
Reimbursement information provided by Edwards Lifesciences is gathered from third-party sources and is presented for informational purposes only. Edwards makes no representation, warranty or guarantee as to the timeliness, accuracy or completeness of the information and such information is not, and should not be construed as reimbursement, coding or legal advice. Any and all references to reimbursement codes are provided as examples only and are not intended to be a recommendation or advice as to the appropriate code for the a particular patient, diagnosis, product or procedure or a guarantee or promise of coverage or payment, nor does Edwards Lifesciences warranty that codes listed are appropriate in all related clinical scenarios. It is the responsibility of the provider to determine if coverage exists and what requirements are necessary for submitting a proper claim for reimbursement to a health plan or payer, including the appropriate code(s) for products provided or services rendered. Laws, regulations, and payer policies concerning reimbursement are complex and change frequently; service providers are responsible for all decisions relating to coding and reimbursement submissions. Medicare’s Correct Coding Initiative and commercial payer policies are reviewed and updated several times each year. Accordingly, Edwards strongly recommends consultation with payers, reimbursement specialists and/or legal counsel regarding appropriate product or procedure codes, coverage, and reimbursement matters.
References- Current Procedural Terminology (CPT) copyright 2015, American Medical Association (AMA). All rights reserved. CPT is a registered trademark of the AMA. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. Applicable FARS/DFARS restrictions apply to government use.
- Not all codes provided are applicable for the clinical scenarios in which Edwards Lifesciences’ Vascular technologies are used. The provider is responsible for selecting the most appropriate code(s) for the patient’s clinical presentation. When radiologic guidance is used for catheter placement, it may be appropriate to add applicable codes according to the service provided following correct coding guidelines. Services that are considered a component of another procedure may not always be coded and billed separately.
- Where applicable, a physician may be required to report CPT codes for radiological supervision and interpretation with CPT codes for interventional procedures. The use of modifier-26 may be required with various radiological supervision and interpretation CPT codes unless radiological equipment is owned by the physician performing these services. Radiological services are often packaged and do not qualify for separate payment by Medicare when performed in conjunction with interventional procedures. Consult with coding and billing staff, as well as payer policy for further guidance.
- For all Medicare payments for physician, hospital outpatient, and ASC services, the multiple procedure reduction rule may apply. Consult with coding and billing staff, and payer policy for further guidance. National average Medicare payment is calculated using the Conversion Factor of $35.8279 per the Medicare Physician Fee Schedule for Calendar Year 2016 Final Rule issued October 30, 2015. National average is based on factors such as geography, teaching vs. non-teaching hospital, rural vs. urban area, etc. and your payment may be different based on these factors. This payment will differ for commercial payers. Payments are effective January 1, 2016 through December 31, 2016.
- Various radiological services are often packaged in APC payments and do not qualify for separate payment by Medicare when performed in conjunction with the interventional procedure. For Medicare claims submission and processing, applicable device-related C codes must also be reported.
- CPT code 36147 should not be used in conjunction with 75791.
- CPT code 36148 may be used in conjunction with 36147.
- National Uniform Billing Committee, American Hospital Association.
- Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Rules and Regulations: This final rule adopts modifications to two of the code set standards adopted in the Transactions and Code Sets final rule published in the Federal Register pursuant to certain provisions of the Administrative Simplification subtitle of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Specifically, this final rule modifies the standard medical data code sets (hereinafter ‘‘code sets’’) for coding diagnoses and inpatient hospital procedures by concurrently adopting the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) for diagnosis coding, including the Official ICD-10-CM Guidelines for Coding and Reporting, as maintained and distributed by the U.S. Department of Health and Human Services (HHS), hereinafter referred to as ICD-10-CM, and the International Classification of Diseases, 10th Revision, Procedure Coding System (ICD-10-PCS) for inpatient hospital procedure coding, including the Official ICD-10-PCS Guidelines for Coding and Reporting, as maintained and distributed by the HHS, hereinafter referred to as ICD-10-PCS. These new codes replace the International Classification of Diseases, 9th Revision, Clinical Modification, Volumes 1 and 2, including the Official ICD-9-CM Guidelines for Coding and Reporting, hereinafter referred to as ICD-9-CM Volumes 1 and 2, and the International Classification of Diseases, 9th Revision, Clinical Modification, Volume 3, including the Official ICD-9-CM Guidelines for Coding and Reporting, hereinafter referred to as ICD-9-CM Volume 3, for diagnosis and procedure codes, respectively. DATES: The effective date of this regulation is March 17, 2009. The effective date is the date that the policies herein take effect, and new policies are considered to be officially adopted. The compliance date, which is different than the effective date, is the date on which entities are required to have implemented the policies adopted in this rule. The compliance date for this regulation is October 1, 2015.
- International Classification of Diseases, 9th Revision, Clinical Modification 2015 ICD-9-CM for hospitals, volume 1, 2, & 3.
- International Classification of Diseases, 10th Revision, Procedure Coding System 2015 Draft.
Reimbursement information provided by Edwards Lifesciences is gathered from third-party sources and is presented for informational purposes only. Edwards makes no representation, warranty or guarantee as to the timeliness, accuracy or completeness of the information and such information is not, and should not be construed as reimbursement, coding or legal advice. Any and all references to reimbursement codes are provided as examples only and are not intended to be a recommendation or advice as to the appropriate code for the a particular patient, diagnosis, product or procedure or a guarantee or promise of coverage or payment, nor does Edwards Lifesciences warranty that codes listed are appropriate in all related clinical scenarios. It is the responsibility of the provider to determine if coverage exists and what requirements are necessary for submitting a proper claim for reimbursement to a health plan or payer, including the appropriate code(s) for products provided or services rendered. Laws, regulations, and payer policies concerning reimbursement are complex and change frequently; service providers are responsible for all decisions relating to coding and reimbursement submissions. Medicare’s Correct Coding Initiative and commercial payer policies are reviewed and updated several times each year. Accordingly, Edwards strongly recommends consultation with payers, reimbursement specialists and/or legal counsel regarding appropriate product or procedure codes, coverage, and reimbursement matters.
Please update your browser
Please update to a current version of your preferred browser, this site will perform effectively on the following:
Unable to update your browser?If you are on a computer, that is maintained by an admin and you cannot install a new browser, ask your admin about it. If you can't change your browser because of compatibility issues, think about installing a second browser for browsing and keep this old one for compatibility